action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,2370214,[],CHEMBL982812,Inhibition of recombinant PARP2 by flashplate scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL1140140,J Med Chem,2008,"{'bei': '20.71', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,0,http://www.openphacts.org/units/Nanomolar,746511,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.001
,,2709345,[],CHEMBL1060806,Inhibition of human PARP2 expressed in baculovirus system,B,,,BAO_0000190,BAO_0000019,assay format,O=C1NCCc2c1ccc1[nH]cc(CCNC(=O)N3CCNCC3)c21,,,CHEMBL1153049,Bioorg Med Chem Lett,2009,"{'bei': '21.95', 'le': '0.41', 'lle': '6.88', 'sei': '8.40'}",CHEMBL558845,,CHEMBL558845,7.50,0,http://www.openphacts.org/units/Nanomolar,826696,=,1,1,=,,IC50,nM,,32.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,32.0
,,2709346,[],CHEMBL1060806,Inhibition of human PARP2 expressed in baculovirus system,B,,,BAO_0000190,BAO_0000019,assay format,O=C1NCCc2c1ccc1[nH]cc(CCNC(=O)N3CCCNCC3)c21,,,CHEMBL1153049,Bioorg Med Chem Lett,2009,"{'bei': '21.86', 'le': '0.41', 'lle': '6.77', 'sei': '8.70'}",CHEMBL560790,,CHEMBL560790,7.77,0,http://www.openphacts.org/units/Nanomolar,826697,=,1,1,=,,IC50,nM,,17.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,17.0
,,3084121,[],CHEMBL1074654,Inhibition of PARP2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCC2c3c(cccc31)CCN2C(=O)Cc1cccnc1,,,CHEMBL1153250,Bioorg Med Chem Lett,2010,"{'bei': '29.28', 'le': '0.53', 'lle': '7.51', 'sei': '14.45'}",CHEMBL595018,,CHEMBL595018,9.00,0,http://www.openphacts.org/units/Nanomolar,873989,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
,,3084122,[],CHEMBL1074654,Inhibition of PARP2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCC2c3c(cccc31)CCN2C(=O)CCc1cnccn1,,,CHEMBL1153250,Bioorg Med Chem Lett,2010,"{'bei': '27.92', 'le': '0.51', 'lle': '7.72', 'sei': '11.97'}",CHEMBL609002,,CHEMBL609002,9.00,0,http://www.openphacts.org/units/Nanomolar,873992,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
,,3270465,[],CHEMBL1115413,Inhibition of human PARP2 by trichloroacetic acid precipitation assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL1157008,J Med Chem,2009,"{'bei': '27.08', 'le': '0.49', 'lle': '6.09', 'sei': '11.90'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,8.68,0,http://www.openphacts.org/units/Nanomolar,905675,=,1,1,=,,IC50,nM,,2.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.1
,,3367434,[],CHEMBL1176209,Inhibition of PARP2,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(CCCN2CC=C(c3ccc(F)cc3)CC2)nc2c(Cl)cccc12,,,CHEMBL1177697,J Med Chem,2010,"{'bei': '15.84', 'le': '0.31', 'lle': '1.86', 'sei': '12.86'}",CHEMBL251030,,CHEMBL251030,6.30,0,http://www.openphacts.org/units/Nanomolar,924964,=,1,1,=,,IC50,nM,,500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,500.0
,,3367435,[],CHEMBL1176209,Inhibition of PARP2,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(-c2cnc3cccc(C(N)=O)c3n2)cc1,,,CHEMBL1177697,J Med Chem,2010,"{'bei': '29.52', 'le': '0.53', 'lle': '5.83', 'sei': '8.74'}",CHEMBL481603,,CHEMBL481603,8.10,0,http://www.openphacts.org/units/Nanomolar,924966,=,1,1,=,,IC50,nM,,8.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,8.0
,,10859401,[],CHEMBL2020830,Inhibition of PARP2 autoPARsylation measuring nicotinamide concentration after 2 hrs by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,,,CHEMBL2016557,J Med Chem,2012,,CHEMBL1552719,,CHEMBL1552719,,0,http://www.openphacts.org/units/Nanomolar,1634061,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,10859410,[],CHEMBL2020830,Inhibition of PARP2 autoPARsylation measuring nicotinamide concentration after 2 hrs by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL2016557,J Med Chem,2012,"{'bei': '22.01', 'le': '0.45', 'lle': '3.21', 'sei': '14.94'}",CHEMBL1086580,,CHEMBL1086580,6.87,0,http://www.openphacts.org/units/Nanomolar,1634058,=,1,1,=,,IC50,nM,,134.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.134
,,10859418,[],CHEMBL2020830,Inhibition of PARP2 autoPARsylation measuring nicotinamide concentration after 2 hrs by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c(C)nnc2SCc2nc(-c3ccc(OC)c(OC)c3)no2)cc1,,,CHEMBL2016557,J Med Chem,2012,,CHEMBL1867804,,CHEMBL1867804,,0,http://www.openphacts.org/units/Nanomolar,1634364,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,10859425,[],CHEMBL2020830,Inhibition of PARP2 autoPARsylation measuring nicotinamide concentration after 2 hrs by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2noc(CSc3nnc(C)n3-c3ccc(OC)cc3)n2)cc1,,,CHEMBL2016557,J Med Chem,2012,,CHEMBL1898239,,CHEMBL1898239,,0,http://www.openphacts.org/units/Nanomolar,1634363,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,10887257,[],CHEMBL2034620,Inhibition of PARP2,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL2029260,J Med Chem,2012,"{'bei': '22.23', 'le': '0.45', 'lle': '3.28', 'sei': '15.09'}",CHEMBL1086580,,CHEMBL1086580,6.94,0,http://www.openphacts.org/units/Nanomolar,1642356,=,1,1,=,,IC50,nM,,114.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,114.0
,,10887274,[],CHEMBL2034627,Inhibition of human PARP2 using NAD+ as substrate after 90 mins by fluorescence analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,,,CHEMBL2029260,J Med Chem,2012,"{'bei': '10.88', 'le': '0.20', 'lle': '0.66', 'sei': '5.61'}",CHEMBL562310,,CHEMBL562310,4.46,0,http://www.openphacts.org/units/Nanomolar,1642355,=,1,1,=,,IC50,nM,,35000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,35.0
,,10887279,[],CHEMBL2034620,Inhibition of PARP2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,,,CHEMBL2029260,J Med Chem,2012,,CHEMBL562310,,CHEMBL562310,,0,http://www.openphacts.org/units/Nanomolar,1642355,>,1,1,>,,IC50,nM,,18700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,18.7
,,12642521,[],CHEMBL2317529,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1NC(=O)c1ccc(NC(=O)CCc2nc3ccccc3c(=O)[nH]2)cc1,,,CHEMBL2311538,J Med Chem,2013,"{'bei': '13.63', 'le': '0.25', 'lle': '2.27', 'sei': '5.33'}",CHEMBL2314698,,CHEMBL2314698,6.03,0,http://www.openphacts.org/units/Nanomolar,1844833,=,1,1,=,,IC50,nM,,931.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.931
,,12642522,[],CHEMBL2317529,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL2311538,J Med Chem,2013,"{'bei': '26.89', 'le': '0.55', 'lle': '4.74', 'sei': '18.25'}",CHEMBL1086580,,CHEMBL1086580,8.40,0,http://www.openphacts.org/units/Nanomolar,1844834,=,1,1,=,,IC50,nM,,4.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.0
,Not Determined,12642523,[],CHEMBL2317529,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccnc2c(NC(=O)c3ccc(N4C(=O)[C@@H]5[C@H](C4=O)[C@@H]4C=C[C@H]5C4)cc3)cccc12,,,CHEMBL2311538,J Med Chem,2013,,CHEMBL1257010,,CHEMBL1257010,,0,,1844835,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,12642524,[],CHEMBL2317529,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,,,CHEMBL2311538,J Med Chem,2013,,CHEMBL562310,,CHEMBL562310,,0,http://www.openphacts.org/units/Nanomolar,1844836,>,1,1,>,,IC50,nM,,25000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,25.0
,,13297609,[],CHEMBL2382488,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL2380224,J Med Chem,2013,"{'bei': '23.49', 'le': '0.48', 'lle': '3.68', 'sei': '15.95'}",CHEMBL1086580,,CHEMBL1086580,7.34,0,http://www.openphacts.org/units/Nanomolar,1894252,=,1,1,=,,IC50,nM,,46.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.046
,,13297610,[],CHEMBL2382488,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(=O)[nH]c2cc(-c3ccccc3F)ccc12,,,CHEMBL2380224,J Med Chem,2013,,CHEMBL2381633,,CHEMBL2381633,,0,http://www.openphacts.org/units/Nanomolar,1894259,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,13301079,[],CHEMBL2384484,Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](n3c(=O)[nH]c4c(F)c(C#N)ccc43)CC2)[C@H]1c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2380263,J Med Chem,2013,,CHEMBL2381946,,CHEMBL2381946,,0,http://www.openphacts.org/units/Nanomolar,1894636,>,1,1,>,,IC50,nM,,170000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,170.0
,,13301082,[],CHEMBL2384484,Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](n3c(=O)[nH]c4cc(C#N)c(F)cc43)CC2)[C@H]1c1ccccc1,,,CHEMBL2380263,J Med Chem,2013,"{'bei': '12.61', 'le': '0.23', 'lle': '0.86', 'sei': '6.21'}",CHEMBL2381945,,CHEMBL2381945,5.66,0,http://www.openphacts.org/units/Nanomolar,1894635,=,1,1,=,,IC50,nM,,2200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.2
,,13301131,[],CHEMBL2384484,Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](NC(=O)c3ccnc4cc(F)cnc34)CC2)[C@H]1c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2380263,J Med Chem,2013,,CHEMBL2381936,,CHEMBL2381936,,0,http://www.openphacts.org/units/Nanomolar,1894626,>,1,1,>,,IC50,nM,,170000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,170.0
,,13302221,[],CHEMBL2384484,Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N(c2ccc(C(=O)Nc3cccc4cccnc34)cc2)[C@H]1c1ccccc1,,,CHEMBL2380263,J Med Chem,2013,,CHEMBL2381958,,CHEMBL2381958,,0,http://www.openphacts.org/units/Nanomolar,1894648,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,13302222,[],CHEMBL2384484,Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2380263,J Med Chem,2013,,CHEMBL562310,,CHEMBL562310,,0,http://www.openphacts.org/units/Nanomolar,1894651,>,1,1,>,,IC50,nM,,170000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,170.0
,,13435239,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,,,CHEMBL2417384,J Med Chem,2013,"{'bei': '9.09', 'le': '0.17', 'lle': '2.31', 'sei': '4.29'}",CHEMBL2419706,,CHEMBL2419706,4.50,0,http://www.openphacts.org/units/Nanomolar,1915742,=,1,1,=,,IC50,nM,,32000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,32.0
,,13435240,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(F)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL2417384,J Med Chem,2013,"{'bei': '12.84', 'le': '0.24', 'lle': '4.31', 'sei': '5.27'}",CHEMBL2419697,,CHEMBL2419697,5.50,0,http://www.openphacts.org/units/Nanomolar,1915733,=,1,1,=,,IC50,nM,,3150.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.15
,,13435241,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)N(Cc1ccsc1)Cc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL2417384,J Med Chem,2013,"{'bei': '12.17', 'le': '0.23', 'lle': '1.91', 'sei': '6.62'}",CHEMBL2419716,,CHEMBL2419716,4.98,0,http://www.openphacts.org/units/Nanomolar,1915752,=,1,1,=,,IC50,nM,,10400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.4
,,13435242,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)N(Cc1nc2c(c(=O)[nH]1)COCC2)Cc1cccs1,,,CHEMBL2417384,J Med Chem,2013,"{'bei': '10.38', 'le': '0.20', 'lle': '1.18', 'sei': '5.64'}",CHEMBL2419712,,CHEMBL2419712,4.25,0,http://www.openphacts.org/units/Nanomolar,1915748,=,1,1,=,,IC50,nM,,56400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,56.4
,,13435243,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2c1SCCC2,,,CHEMBL2417384,J Med Chem,2013,"{'bei': '17.26', 'le': '0.35', 'lle': '1.90', 'sei': '11.78'}",CHEMBL2419889,,CHEMBL2419889,5.39,0,http://www.openphacts.org/units/Nanomolar,1915980,=,1,1,=,,IC50,nM,,4080.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.08
,,13435244,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL2417384,J Med Chem,2013,"{'bei': '22.33', 'le': '0.45', 'lle': '3.31', 'sei': '15.16'}",CHEMBL1086580,,CHEMBL1086580,6.97,0,http://www.openphacts.org/units/Nanomolar,1915979,=,1,1,=,,IC50,nM,,106.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.106
,,13435300,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419703,,CHEMBL2419703,,0,http://www.openphacts.org/units/Nanomolar,1915739,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13435301,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419702,,CHEMBL2419702,,0,http://www.openphacts.org/units/Nanomolar,1915738,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13435302,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419701,,CHEMBL2419701,,0,http://www.openphacts.org/units/Nanomolar,1915737,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13435303,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2ccccn2)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419700,,CHEMBL2419700,,0,http://www.openphacts.org/units/Nanomolar,1915736,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13435304,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2ccccc2)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419699,,CHEMBL2419699,,0,http://www.openphacts.org/units/Nanomolar,1915735,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13435305,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)Cc2cccs2)CC1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419698,,CHEMBL2419698,,0,http://www.openphacts.org/units/Nanomolar,1915734,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13435306,[],CHEMBL2422477,Inhibition of PARP2 (unknown origin) assessed as nicotinamide concentration by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1cccc(O)c1)N(Cc1nc2c(c(=O)[nH]1)COCC2)Cc1cccs1,,,CHEMBL2417384,J Med Chem,2013,,CHEMBL2419694,,CHEMBL2419694,,0,http://www.openphacts.org/units/Nanomolar,1915730,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13442733,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccc(Cl)cc1Cl)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,"{'bei': '15.52', 'le': '0.35', 'lle': '2.07', 'sei': '8.91'}",CHEMBL2425813,,CHEMBL2425813,5.33,0,http://www.openphacts.org/units/Nanomolar,1918895,=,1,1,=,,IC50,nM,,4700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.7
,,13442734,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1cccc(Cl)c1Cl)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,"{'bei': '15.79', 'le': '0.35', 'lle': '2.16', 'sei': '9.06'}",CHEMBL2425812,,CHEMBL2425812,5.42,0,http://www.openphacts.org/units/Nanomolar,1918894,=,1,1,=,,IC50,nM,,3800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.8
,,13442735,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1c(Cl)cccc1Cl)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425810,,CHEMBL2425810,,0,http://www.openphacts.org/units/Nanomolar,1918892,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,Not Determined,13442736,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1Cl)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425809,,CHEMBL2425809,,0,,1918891,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442737,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCC1CCCCC1)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425801,,CHEMBL2425801,,0,,1918883,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442738,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCC1CCCC1)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425800,,CHEMBL2425800,,0,,1918882,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442739,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1nnc2n1CCCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425793,,CHEMBL2425793,,0,,1918874,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442740,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL1714570,,CHEMBL1714570,,0,,1918873,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442741,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)Nc1nnc2n1CCCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425792,,CHEMBL2425792,,0,,1918872,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442742,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)Nc1nnc2n1CCS2,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL1707591,,CHEMBL1707591,,0,,1918871,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442743,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nnc2n1CCCS2)c1ccccc1,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425791,,CHEMBL2425791,,0,,1918870,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,13442744,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1nnc2n1CCS2)c1ccccc1,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL1714359,,CHEMBL1714359,,0,,1918869,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,13442745,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(C(=O)Nc2nnc3n2CCCS3)cc1,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL2425790,,CHEMBL2425790,,0,http://www.openphacts.org/units/Nanomolar,1918868,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13442746,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(C(=O)Nc2nnc3n2CCS3)cc1,,,CHEMBL2424545,J Med Chem,2013,,CHEMBL1594868,,CHEMBL1594868,,0,http://www.openphacts.org/units/Nanomolar,1918867,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
,,13442747,[],CHEMBL2428871,Inhibition of PARP2 (unknown origin) after 60 mins by LC-MS analysis,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL2424545,J Med Chem,2013,"{'bei': '22.33', 'le': '0.45', 'lle': '3.31', 'sei': '15.16'}",CHEMBL1086580,,CHEMBL1086580,6.97,1,http://www.openphacts.org/units/Nanomolar,1918900,=,1,1,=,,IC50,nM,,106.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.106
,,13470609,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2c1CCSC2,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '20.24', 'le': '0.41', 'lle': '3.07', 'sei': '13.81'}",CHEMBL2431805,,CHEMBL2431805,6.32,0,http://www.openphacts.org/units/Nanomolar,1922773,=,1,1,=,,IC50,nM,,478.63,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.32
,,13470610,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '16.87', 'le': '0.30', 'lle': '-0.12', 'sei': '14.76'}",CHEMBL2431867,,CHEMBL2431867,4.46,0,http://www.openphacts.org/units/Nanomolar,1922904,=,1,1,=,,IC50,nM,,34673.69,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,4.46
,,13470611,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(=O)c3ccccc3o2)cc1,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '19.30', 'le': '0.35', 'lle': '0.79', 'sei': '15.09'}",CHEMBL16861,,CHEMBL16861,4.56,0,http://www.openphacts.org/units/Nanomolar,1922903,=,1,1,=,,IC50,nM,,27542.29,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,4.56
,,13470612,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2ccccc12,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '19.01', 'le': '0.35', 'lle': '1.71', 'sei': '6.93'}",CHEMBL64780,,CHEMBL64780,5.08,0,http://www.openphacts.org/units/Nanomolar,1922902,=,1,1,=,,IC50,nM,,8317.64,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.08
,,13471563,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2c1CCSC2,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '20.23', 'le': '0.41', 'lle': '3.07', 'sei': '13.81'}",CHEMBL2431805,,CHEMBL2431805,6.32,0,http://www.openphacts.org/units/Nanomolar,1922773,=,1,1,=,,IC50,nM,,479.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,479.0
,,13471564,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2cc(=O)c3ccccc3o2)cc1,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '16.86', 'le': '0.30', 'lle': '-0.12', 'sei': '14.75'}",CHEMBL2431867,,CHEMBL2431867,4.46,0,http://www.openphacts.org/units/Nanomolar,1922904,=,1,1,=,,IC50,nM,,34900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,34.9
,,13471565,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(=O)c3ccccc3o2)cc1,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '19.28', 'le': '0.35', 'lle': '0.79', 'sei': '15.08'}",CHEMBL16861,,CHEMBL16861,4.56,0,http://www.openphacts.org/units/Nanomolar,1922903,=,1,1,=,,IC50,nM,,27800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,27.8
,,13471566,[],CHEMBL2433123,Inhibition of human full length ARTD2 using NAD+ as substrate by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2ccccc12,,,CHEMBL2429767,J Med Chem,2013,"{'bei': '19.01', 'le': '0.35', 'lle': '1.71', 'sei': '6.93'}",CHEMBL64780,,CHEMBL64780,5.08,0,http://www.openphacts.org/units/Nanomolar,1922902,=,1,1,=,,IC50,nM,,8300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,8.3
,Not Determined,13863552,[],CHEMBL3102005,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](c3ccc(N)nc3)CC2)[C@H]1c1ccccc1,,,CHEMBL3098003,ACS Med Chem Lett,2013,,CHEMBL3098146,,CHEMBL3098146,,0,,1956961,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,13863553,[],CHEMBL3102005,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(C#N)c3)CC2)[C@H]1c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3098003,ACS Med Chem Lett,2013,,CHEMBL3099718,,CHEMBL3099718,,0,http://www.openphacts.org/units/Nanomolar,1956960,>,1,1,>,,IC50,nM,,170000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,170.0
,Not Determined,13863554,[],CHEMBL3102005,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1,,,CHEMBL3098003,ACS Med Chem Lett,2013,,CHEMBL3099717,,CHEMBL3099717,,0,,1956959,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,13863555,[],CHEMBL3102005,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3098003,ACS Med Chem Lett,2013,,CHEMBL3099716,,CHEMBL3099716,,0,http://www.openphacts.org/units/Nanomolar,1956958,>,1,1,>,,IC50,nM,,170000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,170.0
,,13863556,[],CHEMBL3102005,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3098003,ACS Med Chem Lett,2013,,CHEMBL3099720,,CHEMBL3099720,,0,http://www.openphacts.org/units/Nanomolar,1956963,>,1,1,>,,IC50,nM,,170000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,170.0
,,13898832,[],CHEMBL3111451,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(O[C@H]2CC[C@H](NC(=O)CCSc3nc4ccccc4c(=O)[nH]3)CC2)cc1,,,CHEMBL3108694,J Med Chem,2013,"{'bei': '12.83', 'le': '0.25', 'lle': '1.97', 'sei': '5.33'}",CHEMBL3110100,,CHEMBL3110100,5.75,0,http://www.openphacts.org/units/Nanomolar,1962852,=,1,1,=,,IC50,nM,,1760.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.76
,,13898833,[],CHEMBL3111451,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCSc1nc2ccccc2c(=O)[nH]1)N[C@H]1CC[C@H](c2nnc(-c3ccccc3)o2)CC1,,,CHEMBL3108694,J Med Chem,2013,"{'bei': '11.80', 'le': '0.23', 'lle': '1.31', 'sei': '4.93'}",CHEMBL3110117,,CHEMBL3110117,5.61,0,http://www.openphacts.org/units/Nanomolar,1962869,=,1,1,=,,IC50,nM,,2450.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.45
,,14574446,[],CHEMBL3243247,Inhibition of recombinant human PARP-2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(NCCc2ccc(O)cc2)c2nncn2n1,,,CHEMBL3232733,J Med Chem,2014,,CHEMBL3238252,,CHEMBL3238252,,0,http://www.openphacts.org/units/Nanomolar,2087799,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,15649844,[],CHEMBL3595282,Inhibition of full-length human ARTD2 using 500 nM NAD substrate after 3 hrs incubation,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(C2NC(=O)c3ccccc3N2)cc1,,,CHEMBL3593161,Bioorg Med Chem,2015,,CHEMBL3594137,,CHEMBL3594137,,0,http://www.openphacts.org/units/Nanomolar,2488677,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,15649845,[],CHEMBL3595282,Inhibition of full-length human ARTD2 using 500 nM NAD substrate after 3 hrs incubation,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(C2NC(=O)c3ccccc3N2)cc1,,,CHEMBL3593161,Bioorg Med Chem,2015,,CHEMBL3594136,,CHEMBL3594136,,0,http://www.openphacts.org/units/Nanomolar,2488676,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,15649846,[],CHEMBL3595282,Inhibition of full-length human ARTD2 using 500 nM NAD substrate after 3 hrs incubation,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1,,,CHEMBL3593161,Bioorg Med Chem,2015,"{'bei': '21.92', 'le': '0.41', 'lle': '5.04', 'sei': '10.42'}",CHEMBL3593716,,CHEMBL3593716,5.44,0,http://www.openphacts.org/units/Nanomolar,2488081,=,1,1,=,,IC50,nM,,3600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.6
,,15649847,[],CHEMBL3595282,Inhibition of full-length human ARTD2 using 500 nM NAD substrate after 3 hrs incubation,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCN(Cc3ccncc3)CC2)nc2c1CCCC2,,,CHEMBL3593161,Bioorg Med Chem,2015,"{'bei': '16.52', 'le': '0.31', 'lle': '4.01', 'sei': '8.26'}",CHEMBL3593715,,CHEMBL3593715,5.38,0,http://www.openphacts.org/units/Nanomolar,2488080,=,1,1,=,,IC50,nM,,4200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.2
,,16407237,[],CHEMBL3743826,Inhibition of human PARP2 (2 to 583 residues) expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccnc1N1CCN(C(=O)c2cccc(Cc3n[nH]c(=O)c4ccccc34)c2)CC1,,,CHEMBL3739394,Bioorg Med Chem Lett,2015,"{'bei': '19.98', 'le': '0.36', 'lle': '6.26', 'sei': '8.49'}",CHEMBL3740104,,CHEMBL3740104,9.00,0,http://www.openphacts.org/units/Nanomolar,2739749,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.001
,,16407300,[],CHEMBL3743826,Inhibition of human PARP2 (2 to 583 residues) expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1Cn2c(nnc2C(C)(F)F)CN1C(=O)c1cccc(C(F)(F)c2n[nH]c(=O)c3ccccc23)c1,,,CHEMBL3739394,Bioorg Med Chem Lett,2015,,CHEMBL3740897,,CHEMBL3740897,,0,http://www.openphacts.org/units/Nanomolar,2739769,<,1,1,<,,IC50,nM,,30.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.03
,,16407360,[],CHEMBL3743826,Inhibition of human PARP2 (2 to 583 residues) expressed in Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL3739394,Bioorg Med Chem Lett,2015,"{'bei': '19.62', 'le': '0.36', 'lle': '6.17', 'sei': '9.87'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.52,0,http://www.openphacts.org/units/Nanomolar,2739770,=,1,1,=,,IC50,nM,,3.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.003
,,16436198,[],CHEMBL3757401,Inhibition of human ARTD2 by fluorescence analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2(CNC(=O)c3ccc(NC(=O)c4ccco4)cc3Cl)CCOCC2)cc1,,,CHEMBL3751785,Bioorg Med Chem Lett,2016,,CHEMBL3752386,,CHEMBL3752386,,0,http://www.openphacts.org/units/Nanomolar,2746193,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,16436216,[],CHEMBL3757401,Inhibition of human ARTD2 by fluorescence analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)Nc2ccc(C(=O)N(c3ccncn3)c3ccccc3Cl)cc2)cc1,,,CHEMBL3751785,Bioorg Med Chem Lett,2016,,CHEMBL3752492,,CHEMBL3752492,,0,http://www.openphacts.org/units/Nanomolar,2746195,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,16644829,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccc(-c2nc3ccccc3c(=O)[nH]2)cc1)OCc1ccccc1,,,CHEMBL3826913,Eur J Med Chem,2016,,CHEMBL3828579,,CHEMBL3828579,,0,http://www.openphacts.org/units/Nanomolar,2788163,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10000.0
,,16644830,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(=O)[nH]c(-c3ccc(CNC(=O)OCc4ccccc4)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,,CHEMBL3098935,,CHEMBL3098935,,0,http://www.openphacts.org/units/Nanomolar,2788224,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100000.0
,,16655882,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(C(F)(F)F)cc2)nc2ccccc12,,,CHEMBL3826913,Eur J Med Chem,2016,,CHEMBL2419892,,CHEMBL2419892,,0,http://www.openphacts.org/units/Nanomolar,2788154,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10000.0
,,16655883,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(Cl)cc2)nc2ccccc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '21.76', 'le': '0.42', 'lle': '2.35', 'sei': '12.21'}",CHEMBL1163173,,CHEMBL1163173,5.58,0,http://www.openphacts.org/units/Nanomolar,2788152,=,1,1,=,,IC50,nM,,2600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2600.0
,,16655884,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc(Br)cc2)nc2ccccc12,,,CHEMBL3826913,Eur J Med Chem,2016,,CHEMBL2058057,,CHEMBL2058057,,0,http://www.openphacts.org/units/Nanomolar,2788153,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100000.0
,,16655885,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(F)cc2)nc2ccccc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '22.18', 'le': '0.40', 'lle': '2.19', 'sei': '11.58'}",CHEMBL18688,,CHEMBL18688,5.33,0,http://www.openphacts.org/units/Nanomolar,2788158,=,1,1,=,,IC50,nM,,4688.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4688.0
,,16655886,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(-c2ccc([N+](=O)[O-])cc2)nc2ccccc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '21.27', 'le': '0.39', 'lle': '3.19', 'sei': '6.40'}",CHEMBL1164165,,CHEMBL1164165,5.68,0,http://www.openphacts.org/units/Nanomolar,2788159,=,1,1,=,,IC50,nM,,2064.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2064.0
,,16655887,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(O)nc(-c3ccccc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '23.04', 'le': '0.42', 'lle': '2.80', 'sei': '10.52'}",CHEMBL126871,,CHEMBL126871,5.81,0,http://www.openphacts.org/units/Nanomolar,2788164,=,1,1,=,,IC50,nM,,1539.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1539.0
,,16655888,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(O)nc(-c3ccc(C(F)(F)F)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '19.50', 'le': '0.37', 'lle': '2.21', 'sei': '11.30'}",CHEMBL123798,,CHEMBL123798,6.24,0,http://www.openphacts.org/units/Nanomolar,2788166,=,1,1,=,,IC50,nM,,570.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,570.0
,,16655889,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(=O)[nH]c(-c3ccc(Cl)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '18.21', 'le': '0.36', 'lle': '1.97', 'sei': '9.49'}",CHEMBL3098936,,CHEMBL3098936,5.22,0,http://www.openphacts.org/units/Nanomolar,2788167,=,1,1,=,,IC50,nM,,6022.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6022.0
,,16655890,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(=O)[nH]c(-c3ccc(Br)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '19.89', 'le': '0.45', 'lle': '3.23', 'sei': '11.98'}",CHEMBL3827963,,CHEMBL3827963,6.59,0,http://www.openphacts.org/units/Nanomolar,2788168,=,1,1,=,,IC50,nM,,259.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,259.0
,,16655891,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(=O)[nH]c(-c3ccc(F)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '21.48', 'le': '0.40', 'lle': '3.07', 'sei': '10.56'}",CHEMBL3827770,,CHEMBL3827770,5.81,0,http://www.openphacts.org/units/Nanomolar,2788169,=,1,1,=,,IC50,nM,,1562.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1562.0
,,16655892,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(O)nc(-c3ccc([N+](=O)[O-])cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '20.29', 'le': '0.37', 'lle': '3.11', 'sei': '6.13'}",CHEMBL125154,,CHEMBL125154,6.03,0,http://www.openphacts.org/units/Nanomolar,2788170,=,1,1,=,,IC50,nM,,928.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,928.0
,,16655893,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(O)nc(-c3ccc(C(F)(F)F)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '18.11', 'le': '0.34', 'lle': '1.18', 'sei': '11.97'}",CHEMBL346886,,CHEMBL346886,5.51,0,http://www.openphacts.org/units/Nanomolar,2788183,=,1,1,=,,IC50,nM,,3098.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3098.0
,,16655894,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(=O)[nH]c(-c3ccc(Cl)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '19.20', 'le': '0.37', 'lle': '1.65', 'sei': '11.36'}",CHEMBL3098939,,CHEMBL3098939,5.20,0,http://www.openphacts.org/units/Nanomolar,2788184,=,1,1,=,,IC50,nM,,6350.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6350.0
,,16655895,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(=O)[nH]c(-c3ccc(Br)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '15.79', 'le': '0.36', 'lle': '1.32', 'sei': '10.88'}",CHEMBL3098937,,CHEMBL3098937,4.98,0,http://www.openphacts.org/units/Nanomolar,2788185,=,1,1,=,,IC50,nM,,10529.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10529.0
,,16655896,[],CHEMBL3829027,Inhibition of human PARP-2 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(=O)[nH]c(-c3ccc(F)cc3)nc12,,,CHEMBL3826913,Eur J Med Chem,2016,"{'bei': '24.25', 'le': '0.44', 'lle': '3.13', 'sei': '13.48'}",CHEMBL3098938,,CHEMBL3098938,6.17,0,http://www.openphacts.org/units/Nanomolar,2788186,=,1,1,=,,IC50,nM,,683.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,683.0
,335243,17713461,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(C3CCN(Cc4nc5c(c(=O)[nH]4)COCC5)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,"{'bei': '11.29', 'le': '0.21', 'lle': '3.72', 'sei': '5.02'}",CHEMBL3929005,,CHEMBL3929005,5.27,0,http://www.openphacts.org/units/Nanomolar,2843942,=,37,1,=,,IC50,nM,,5400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5400.0
,335244,17713462,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN([C@H]3CCN(Cc4nc5c(c(=O)[nH]4)COCC5)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,"{'bei': '11.40', 'le': '0.21', 'lle': '3.77', 'sei': '5.07'}",CHEMBL3897483,,CHEMBL3897483,5.32,0,http://www.openphacts.org/units/Nanomolar,2843943,=,37,1,=,,IC50,nM,,4800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4800.0
,335245,17713463,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(C3CCN(Cc4nc5c(cnn5C)c(=O)[nH]4)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,,CHEMBL3945237,,CHEMBL3945237,,0,http://www.openphacts.org/units/Nanomolar,2843946,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,335246,17713464,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(Cl)cc1)C1CCN(C2CCN(Cc3nc4c(c(=O)[nH]3)COCC4)C2=O)CC1,,,CHEMBL3886167,,2015,"{'bei': '11.33', 'le': '0.22', 'lle': '3.15', 'sei': '5.58'}",CHEMBL3941919,,CHEMBL3941919,5.33,0,http://www.openphacts.org/units/Nanomolar,2843949,=,37,1,=,,IC50,nM,,4620.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4620.0
,335247,17713465,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(C2CCN(Cc3nc4c(c(=O)[nH]3)COCC4)C2=O)CC1,,,CHEMBL3886167,,2015,"{'bei': '11.08', 'le': '0.21', 'lle': '3.36', 'sei': '5.27'}",CHEMBL3956961,,CHEMBL3956961,5.04,0,http://www.openphacts.org/units/Nanomolar,2843950,=,37,1,=,,IC50,nM,,9200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9200.0
,335248,17713466,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN([C@H]2CCN(Cc3nc4c(c(=O)[nH]3)COCC4)C2=O)CC1,,,CHEMBL3886167,,2015,"{'bei': '10.98', 'le': '0.21', 'lle': '3.31', 'sei': '5.22'}",CHEMBL3929392,,CHEMBL3929392,4.99,0,http://www.openphacts.org/units/Nanomolar,2843951,=,37,1,=,,IC50,nM,,10200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10200.0
,335249,17713467,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN([C@H]3CCN(Cc4nc5c(c(=O)[nH]4)COCC5)C3=O)CC2)cc1C,,,CHEMBL3886167,,2015,"{'bei': '11.23', 'le': '0.21', 'lle': '3.54', 'sei': '5.15'}",CHEMBL3918110,,CHEMBL3918110,5.40,0,http://www.openphacts.org/units/Nanomolar,2843953,=,37,1,=,,IC50,nM,,4000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4000.0
,335250,17713468,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(C3CCN(Cc4nc5c(c(=O)[nH]4)CCC5)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,"{'bei': '11.03', 'le': '0.21', 'lle': '3.01', 'sei': '5.20'}",CHEMBL3927023,,CHEMBL3927023,4.97,0,http://www.openphacts.org/units/Nanomolar,2843959,=,37,1,=,,IC50,nM,,10700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10700.0
,335251,17713469,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(=O)[nH]c(CN2CCC(N3CCC(C(=O)c4ccc(OC)cc4)CC3)C2=O)n1,,,CHEMBL3886167,,2015,,CHEMBL3900374,,CHEMBL3900374,,0,http://www.openphacts.org/units/Nanomolar,2843962,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,335252,17713470,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(C3CCN(Cc4ncc(C)c(=O)[nH]4)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,,CHEMBL3931845,,CHEMBL3931845,,0,http://www.openphacts.org/units/Nanomolar,2843963,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,335253,17713471,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(C3CCN(Cc4nc(C)c(C)c(=O)[nH]4)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,,CHEMBL3909379,,CHEMBL3909379,,0,http://www.openphacts.org/units/Nanomolar,2843964,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,335254,17713472,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN([C@H]3CCN(Cc4nc5ccccc(=O)c5[nH]4)C3=O)CC2)cc1C,,,CHEMBL3886167,,2015,"{'bei': '11.67', 'le': '0.22', 'lle': '2.60', 'sei': '5.79'}",CHEMBL3921853,,CHEMBL3921853,5.54,0,http://www.openphacts.org/units/Nanomolar,2843966,=,37,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2900.0
,335255,17713473,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN([C@@H]3CCN(Cc4nc5ccccc(=O)c5[nH]4)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,"{'bei': '10.85', 'le': '0.20', 'lle': '2.37', 'sei': '5.23'}",CHEMBL4111286,,CHEMBL4111286,5.00,0,http://www.openphacts.org/units/Nanomolar,2843969,=,37,1,=,,IC50,nM,,10100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10100.0
,335256,17713474,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(C3CCN(CC(=O)Nc4nnc5n4CCS5)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,"{'bei': '10.92', 'le': '0.21', 'lle': '3.76', 'sei': '4.83'}",CHEMBL3897864,,CHEMBL3897864,5.29,0,http://www.openphacts.org/units/Nanomolar,2843970,=,37,1,=,,IC50,nM,,5090.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5090.0
,335257,17713475,[],CHEMBL3887382,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 uM of p-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of p-NAD+. The % Inhibition was calculated as: (Control-Sample)/(Control-Background)*100. ""Control"" is the average value of 8 wells without compound; and ""Background"" is the average of 8 wells mixed with 5x quenching solution measured prior to initiation of the reaction.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN([C@@H]3CCN(CC(=O)Nc4nnc5n4CCS5)C3=O)CC2)cc1,,,CHEMBL3886167,,2015,"{'bei': '10.73', 'le': '0.21', 'lle': '3.67', 'sei': '4.74'}",CHEMBL3964994,,CHEMBL3964994,5.20,0,http://www.openphacts.org/units/Nanomolar,2843972,=,37,1,=,,IC50,nM,,6300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6300.0
,342075,17719610,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(F)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '12.86', 'le': '0.24', 'lle': '4.32', 'sei': '5.28'}",CHEMBL2419697,,CHEMBL2419697,5.51,0,http://www.openphacts.org/units/Nanomolar,2848578,=,37,1,=,,IC50,nM,,3100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3100.0
,342076,17719611,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(Cl)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '12.56', 'le': '0.25', 'lle': '3.88', 'sei': '5.35'}",CHEMBL3925030,,CHEMBL3925030,5.59,0,http://www.openphacts.org/units/Nanomolar,2848579,=,37,1,=,,IC50,nM,,2590.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2590.0
,342077,17719612,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '12.12', 'le': '0.23', 'lle': '3.84', 'sei': '5.00'}",CHEMBL3947374,,CHEMBL3947374,5.68,0,http://www.openphacts.org/units/Nanomolar,2848580,=,37,1,=,,IC50,nM,,2100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2100.0
,342078,17719613,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](c1ccccc1)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL4110589,,CHEMBL4110589,,0,http://www.openphacts.org/units/Nanomolar,2848581,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342079,17719614,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,,,CHEMBL3886352,,2015,,CHEMBL2419706,,CHEMBL2419706,,0,http://www.openphacts.org/units/Nanomolar,2848582,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342080,17719615,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)CCCC4)CC3CC3)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '10.23', 'le': '0.19', 'lle': '2.05', 'sei': '5.27'}",CHEMBL3961412,,CHEMBL3961412,5.04,0,http://www.openphacts.org/units/Nanomolar,2848585,=,37,1,=,,IC50,nM,,9140.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9140.0
,342081,17719616,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)CCCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '15.08', 'le': '0.28', 'lle': '4.74', 'sei': '6.34'}",CHEMBL3933931,,CHEMBL3933931,6.61,0,http://www.openphacts.org/units/Nanomolar,2848586,=,37,1,=,,IC50,nM,,243.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,243.0
,342082,17719617,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(F)cc2)CC1)NCc1nc2c(c(=O)[nH]1)CCCC2,,,CHEMBL3886352,,2015,"{'bei': '14.43', 'le': '0.27', 'lle': '4.15', 'sei': '6.47'}",CHEMBL3966085,,CHEMBL3966085,6.16,0,http://www.openphacts.org/units/Nanomolar,2848587,=,37,1,=,,IC50,nM,,700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,700.0
,342083,17719618,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)CCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '12.57', 'le': '0.24', 'lle': '3.86', 'sei': '5.11'}",CHEMBL3932754,,CHEMBL3932754,5.33,0,http://www.openphacts.org/units/Nanomolar,2848588,=,37,1,=,,IC50,nM,,4620.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4620.0
,342084,17719619,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)NCc3nc(C)c(C)c(=O)[nH]3)CC2)cc1,,,CHEMBL3886352,,2015,,CHEMBL3901978,,CHEMBL3901978,,0,http://www.openphacts.org/units/Nanomolar,2848589,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342085,17719620,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)Cc2cccs2)CC1,,,CHEMBL3886352,,2015,,CHEMBL2419698,,CHEMBL2419698,,1,http://www.openphacts.org/units/Nanomolar,2848590,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342086,17719621,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)CN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3929923,,CHEMBL3929923,,0,http://www.openphacts.org/units/Nanomolar,2848591,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342087,17719622,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2ccc(F)cc2)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL3886352,,2015,,CHEMBL3914416,,CHEMBL3914416,,0,http://www.openphacts.org/units/Nanomolar,2848592,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342088,17719623,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CN(Cc2nc3c(c(=O)[nH]2)COCC3)C(=O)CN2CCC(C(=O)c3ccc(F)cc3)CC2)cc1,,,CHEMBL3886352,,2015,,CHEMBL3938947,,CHEMBL3938947,,0,http://www.openphacts.org/units/Nanomolar,2848593,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342089,17719624,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)Cc2nc3ccccc3s2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3956490,,CHEMBL3956490,,0,http://www.openphacts.org/units/Nanomolar,2848594,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342090,17719625,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CN(Cc2nc3c(c(=O)[nH]2)COCC3)C(=O)CN2CCC(C(=O)c3ccc(F)cc3)CC2)c1,,,CHEMBL3886352,,2015,,CHEMBL3985156,,CHEMBL3985156,,0,http://www.openphacts.org/units/Nanomolar,2848595,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342091,17719626,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2cccc(F)c2)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL3886352,,2015,,CHEMBL3937250,,CHEMBL3937250,,0,http://www.openphacts.org/units/Nanomolar,2848596,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342092,17719627,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2ccccn2)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL3886352,,2015,,CHEMBL2419700,,CHEMBL2419700,,1,http://www.openphacts.org/units/Nanomolar,2848599,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342093,17719628,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](c1ccccc1)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3919581,,CHEMBL3919581,,0,http://www.openphacts.org/units/Nanomolar,2848600,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342094,17719629,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)CC2CC2)CC1,,,CHEMBL3886352,,2015,,CHEMBL2419705,,CHEMBL2419705,,0,http://www.openphacts.org/units/Nanomolar,2848601,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342095,17719630,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)CN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3964642,,CHEMBL3964642,,0,http://www.openphacts.org/units/Nanomolar,2848602,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342096,17719631,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL2419701,,CHEMBL2419701,,1,http://www.openphacts.org/units/Nanomolar,2848603,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342097,17719632,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,C#CCN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3965278,,CHEMBL3965278,,0,http://www.openphacts.org/units/Nanomolar,2848604,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342098,17719633,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)C[C@@H]2CCCO2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3892864,,CHEMBL3892864,,0,http://www.openphacts.org/units/Nanomolar,2848605,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342099,17719634,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)C[C@H]2CCCO2)CC1,,,CHEMBL3886352,,2015,,CHEMBL4110045,,CHEMBL4110045,,0,http://www.openphacts.org/units/Nanomolar,2848606,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342100,17719635,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](C)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3898270,,CHEMBL3898270,,0,http://www.openphacts.org/units/Nanomolar,2848608,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342101,17719636,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](C)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL4109734,,CHEMBL4109734,,0,http://www.openphacts.org/units/Nanomolar,2848609,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342102,17719637,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3907294,,CHEMBL3907294,,0,http://www.openphacts.org/units/Nanomolar,2848610,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342103,17719638,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL2419702,,CHEMBL2419702,,1,http://www.openphacts.org/units/Nanomolar,2848611,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342104,17719639,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](c1ccc(F)cc1)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL4113551,,CHEMBL4113551,,0,http://www.openphacts.org/units/Nanomolar,2848613,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342105,17719640,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1ccc(F)cc1F)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3987175,,CHEMBL3987175,,0,http://www.openphacts.org/units/Nanomolar,2848614,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342106,17719641,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2ccccc2)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL3886352,,2015,,CHEMBL2419699,,CHEMBL2419699,,1,http://www.openphacts.org/units/Nanomolar,2848615,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342107,17719642,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)Cc2ccccc2F)CC1,,,CHEMBL3886352,,2015,,CHEMBL3945618,,CHEMBL3945618,,0,http://www.openphacts.org/units/Nanomolar,2848616,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342108,17719643,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)Cc2ccc(F)cc2F)CC1,,,CHEMBL3886352,,2015,,CHEMBL3933577,,CHEMBL3933577,,0,http://www.openphacts.org/units/Nanomolar,2848617,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342109,17719644,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](C1CC1)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL4112739,,CHEMBL4112739,,0,http://www.openphacts.org/units/Nanomolar,2848618,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342110,17719645,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](C1CC1)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3940284,,CHEMBL3940284,,0,http://www.openphacts.org/units/Nanomolar,2848619,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342111,17719646,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(CCF)Cc2nc3c(c(=O)[nH]2)COCC3)CC1,,,CHEMBL3886352,,2015,,CHEMBL3922251,,CHEMBL3922251,,0,http://www.openphacts.org/units/Nanomolar,2848621,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342112,17719647,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)CC(F)F)CC1,,,CHEMBL3886352,,2015,,CHEMBL3983088,,CHEMBL3983088,,0,http://www.openphacts.org/units/Nanomolar,2848622,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342113,17719648,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CN(Cc2nc3c(c(=O)[nH]2)COCC3)C(=O)CN2CCC(C(=O)c3ccc(F)cc3)CC2)s1,,,CHEMBL3886352,,2015,,CHEMBL3913243,,CHEMBL3913243,,0,http://www.openphacts.org/units/Nanomolar,2848623,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342114,17719649,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)CC(F)(F)F)CC1,,,CHEMBL3886352,,2015,,CHEMBL3941313,,CHEMBL3941313,,0,http://www.openphacts.org/units/Nanomolar,2848625,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342115,17719650,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1cccs1)N(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(F)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3986804,,CHEMBL3986804,,0,http://www.openphacts.org/units/Nanomolar,2848626,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342116,17719651,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC(F)F)CC2)cc1,,,CHEMBL3886352,,2015,,CHEMBL3935111,,CHEMBL3935111,,0,http://www.openphacts.org/units/Nanomolar,2848627,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342117,17719652,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(c2noc3cc(F)ccc23)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '12.48', 'le': '0.24', 'lle': '3.89', 'sei': '4.86'}",CHEMBL3978546,,CHEMBL3978546,5.51,0,http://www.openphacts.org/units/Nanomolar,2848628,=,37,1,=,,IC50,nM,,3090.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3090.0
,342118,17719653,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(Cc1nc2c(c(=O)[nH]1)COCC2)C(=O)CN1CCC(C(=O)c2ccc(OC)cc2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3940683,,CHEMBL3940683,,0,http://www.openphacts.org/units/Nanomolar,2848631,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342119,17719654,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC2(CC1)Cc1cc(F)ccc1C2=O)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,,CHEMBL3955207,,CHEMBL3955207,,0,http://www.openphacts.org/units/Nanomolar,2848638,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342120,17719655,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '12.09', 'le': '0.23', 'lle': '4.04', 'sei': '4.84'}",CHEMBL3903965,,CHEMBL3903965,5.50,0,http://www.openphacts.org/units/Nanomolar,2848643,=,37,1,=,,IC50,nM,,3200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3200.0
,342121,17719656,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '12.35', 'le': '0.23', 'lle': '4.38', 'sei': '4.79'}",CHEMBL3986246,,CHEMBL3986246,5.44,0,http://www.openphacts.org/units/Nanomolar,2848644,=,37,1,=,,IC50,nM,,3640.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3640.0
,342122,17719657,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(OC(F)(F)F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)CC2CC2)CC1,,,CHEMBL3886352,,2015,,CHEMBL3891789,,CHEMBL3891789,,0,http://www.openphacts.org/units/Nanomolar,2848647,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342123,17719658,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(OC(F)(F)F)cc1)C1CCN(CC(=O)N(Cc2nc3c(c(=O)[nH]2)COCC3)CC(F)F)CC1,,,CHEMBL3886352,,2015,"{'bei': '8.83', 'le': '0.17', 'lle': '2.00', 'sei': '4.70'}",CHEMBL3975140,,CHEMBL3975140,4.93,0,http://www.openphacts.org/units/Nanomolar,2848648,=,37,1,=,,IC50,nM,,11760.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11760.0
,342124,17719659,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC(F)F)CC2)c1,,,CHEMBL3886352,,2015,,CHEMBL3946798,,CHEMBL3946798,,0,http://www.openphacts.org/units/Nanomolar,2848650,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342125,17719660,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CC#CCOc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,,,CHEMBL3886352,,2015,,CHEMBL3955426,,CHEMBL3955426,,0,http://www.openphacts.org/units/Nanomolar,2848655,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,342126,17719661,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(n2c(=O)[nH]c3ccccc32)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '12.63', 'le': '0.24', 'lle': '5.10', 'sei': '4.43'}",CHEMBL3902386,,CHEMBL3902386,5.54,0,http://www.openphacts.org/units/Nanomolar,2848659,=,37,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2900.0
,342127,17719662,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '13.28', 'le': '0.25', 'lle': '4.28', 'sei': '5.40'}",CHEMBL3943283,,CHEMBL3943283,5.64,0,http://www.openphacts.org/units/Nanomolar,2848660,=,37,1,=,,IC50,nM,,2300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2300.0
,342128,17719663,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '12.10', 'le': '0.23', 'lle': '3.83', 'sei': '4.99'}",CHEMBL3906833,,CHEMBL3906833,5.67,0,http://www.openphacts.org/units/Nanomolar,2848661,=,37,1,=,,IC50,nM,,2130.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2130.0
,342129,17719664,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(OCC3CC3)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '11.87', 'le': '0.22', 'lle': '3.87', 'sei': '5.02'}",CHEMBL3928915,,CHEMBL3928915,5.71,0,http://www.openphacts.org/units/Nanomolar,2848662,=,37,1,=,,IC50,nM,,1970.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1970.0
,342130,17719665,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(OCC3CCC3)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '12.24', 'le': '0.23', 'lle': '3.82', 'sei': '5.33'}",CHEMBL3944854,,CHEMBL3944854,6.05,0,http://www.openphacts.org/units/Nanomolar,2848663,=,37,1,=,,IC50,nM,,885.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,885.0
,342131,17719666,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(OC3CCOCC3)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '10.86', 'le': '0.20', 'lle': '3.94', 'sei': '4.52'}",CHEMBL3903427,,CHEMBL3903427,5.55,0,http://www.openphacts.org/units/Nanomolar,2848664,=,37,1,=,,IC50,nM,,2840.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2840.0
,342132,17719667,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '11.61', 'le': '0.22', 'lle': '4.55', 'sei': '4.58'}",CHEMBL3956527,,CHEMBL3956527,5.62,0,http://www.openphacts.org/units/Nanomolar,2848665,=,37,1,=,,IC50,nM,,2370.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2370.0
,342133,17719668,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc(OCCC3CC3)cc2)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '12.20', 'le': '0.23', 'lle': '3.81', 'sei': '5.31'}",CHEMBL3944401,,CHEMBL3944401,6.04,0,http://www.openphacts.org/units/Nanomolar,2848666,=,37,1,=,,IC50,nM,,920.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,920.0
,342134,17719669,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCC(C(=O)c2ccc3c(c2)CCO3)CC1)NCc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886352,,2015,"{'bei': '11.81', 'le': '0.22', 'lle': '4.35', 'sei': '4.70'}",CHEMBL3939009,,CHEMBL3939009,5.34,0,http://www.openphacts.org/units/Nanomolar,2848668,=,37,1,=,,IC50,nM,,4530.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4530.0
,342135,17719670,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)NCc3nc4c(c(=O)[nH]3)COCC4)CC2)cc1C,,,CHEMBL3886352,,2015,"{'bei': '11.82', 'le': '0.22', 'lle': '4.00', 'sei': '4.73'}",CHEMBL3967549,,CHEMBL3967549,5.37,0,http://www.openphacts.org/units/Nanomolar,2848670,=,37,1,=,,IC50,nM,,4260.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4260.0
,342136,17719671,[],CHEMBL3887525,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 μL of compound in 8-point serial dilutions with concentrations ranging from 0.0086 to 18.75 μM, 20 nM of purified enzyme, and 250 μM of β-NAD+ in the 1× Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 μL of 5× quenching solution (20% formic acid and 500 nM [d]-nicotinamide in water). For the background control wells, 10 μL of the 5× quenching solution per well was added prior to the addition of β-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)NCc3cc4c(c(=O)[nH]3)COCC4)CC2)cc1,,,CHEMBL3886352,,2015,"{'bei': '13.51', 'le': '0.25', 'lle': '4.27', 'sei': '5.90'}",CHEMBL3946751,,CHEMBL3946751,5.94,0,http://www.openphacts.org/units/Nanomolar,2848674,=,37,1,=,,IC50,nM,,1150.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1150.0
,355774,17731605,[],CHEMBL3887811,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in beta-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 nM of beta-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d4]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of beta-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)N(Cc1nc2c(c(=O)[nH]1)COCC2)Cc1cccs1,,,CHEMBL3886458,,2016,,CHEMBL2419712,,CHEMBL2419712,,0,http://www.openphacts.org/units/Nanomolar,2855936,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,355775,17731606,[],CHEMBL3887811,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in beta-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 nM of beta-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d4]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of beta-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1cccc(O)c1)N(Cc1nc2c(c(=O)[nH]1)COCC2)Cc1cccs1,,,CHEMBL3886458,,2016,,CHEMBL2419694,,CHEMBL2419694,,1,http://www.openphacts.org/units/Nanomolar,2855942,>,37,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19000.0
,355776,17731607,[],CHEMBL3887811,"Biochemical Assay: The autoparsylation activity of the TNKS 1/2 or PARP1/2 enzymes was measured by the liquid chromatography-mass spectrometry (LC/MS) detection of nicotinamide as readout. Compound activity in inhibiting the TNKS and PARP autoparsylation was evaluated by IC50 measurements. In the compound screening assays, the reaction is composed of 5 uL of compound in beta-point serial dilutions with concentrations ranging from 0.0086 to 18.75 uM, 20 nM of purified enzyme, and 250 nM of beta-NAD+ in the 1x Assay Buffer. After 60 min incubation at room temperature, the reactions were quenched by the addition of 10 uL of 5x quenching solution (20% formic acid and 500 nM [d4]-nicotinamide in water). For the background control wells, 10 uL of the 5x quenching solution per well was added prior to the addition of beta-NAD+.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)N(Cc1ccsc1)Cc1nc2c(c(=O)[nH]1)COCC2,,,CHEMBL3886458,,2016,"{'bei': '12.17', 'le': '0.23', 'lle': '1.91', 'sei': '6.62'}",CHEMBL2419716,,CHEMBL2419716,4.98,1,http://www.openphacts.org/units/Nanomolar,2855953,=,37,1,=,,IC50,nM,,10400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10400.0
,364740,17739883,[],CHEMBL3887958,"Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)Cc2nnc(C(F)(F)F)n21,,,CHEMBL3886517,,2016,"{'bei': '19.85', 'le': '0.38', 'lle': '6.18', 'sei': '9.98'}",CHEMBL3907010,,CHEMBL3907010,9.66,0,http://www.openphacts.org/units/Nanomolar,2861247,=,37,1,=,,IC50,nM,,0.22,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.22
,364746,17739889,[],CHEMBL3887958,"Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL3886517,,2016,"{'bei': '21.51', 'le': '0.40', 'lle': '7.00', 'sei': '10.82'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.35,0,http://www.openphacts.org/units/Nanomolar,2861244,=,37,1,=,,IC50,nM,,0.45,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.45
,366719,17741760,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3[nH]c4cccc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '38.72', 'le': '0.70', 'lle': '6.77', 'sei': '15.23'}",CHEMBL3891329,,CHEMBL3891329,8.72,0,http://www.openphacts.org/units/Nanomolar,2862723,=,37,1,=,,IC50,nM,,1.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.9
,366720,17741761,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCCc3[nH]c4cccc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '37.44', 'le': '0.68', 'lle': '6.62', 'sei': '15.65'}",CHEMBL3969742,,CHEMBL3969742,8.96,0,http://www.openphacts.org/units/Nanomolar,2862724,=,37,1,=,,IC50,nM,,1.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.1
,366721,17741762,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '36.65', 'le': '0.67', 'lle': '6.57', 'sei': '15.32'}",CHEMBL3915929,,CHEMBL3915929,8.77,0,http://www.openphacts.org/units/Nanomolar,2862725,=,37,1,=,,IC50,nM,,1.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.7
,366722,17741763,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CC(c3ccccc3)Cc3[nH]c4cccc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '29.19', 'le': '0.52', 'lle': '5.45', 'sei': '15.36'}",CHEMBL3892363,,CHEMBL3892363,8.80,0,http://www.openphacts.org/units/Nanomolar,2862727,=,37,1,=,,IC50,nM,,1.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.6
,366723,17741764,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '33.51', 'le': '0.61', 'lle': '6.13', 'sei': '15.65'}",CHEMBL3907218,,CHEMBL3907218,8.96,0,http://www.openphacts.org/units/Nanomolar,2862728,=,37,1,=,,IC50,nM,,1.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.1
,366724,17741765,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3[nH]c4cc(F)cc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '37.40', 'le': '0.69', 'lle': '7.01', 'sei': '15.89'}",CHEMBL3929705,,CHEMBL3929705,9.10,0,http://www.openphacts.org/units/Nanomolar,2862729,=,37,1,=,,IC50,nM,,0.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.8
,366725,17741766,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCc2[nH]c3cc(F)cc4c3c2C1=NNC4=O,,,CHEMBL3886532,,2016,"{'bei': '33.74', 'le': '0.63', 'lle': '6.42', 'sei': '15.99'}",CHEMBL3914932,,CHEMBL3914932,9.15,0,http://www.openphacts.org/units/Nanomolar,2862736,=,37,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
,366726,17741767,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '36.41', 'le': '0.66', 'lle': '6.63', 'sei': '16.11'}",CHEMBL3972156,,CHEMBL3972156,9.22,0,http://www.openphacts.org/units/Nanomolar,2862737,=,37,1,=,,IC50,nM,,0.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.6
,366727,17741768,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3c(F)ccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '33.74', 'le': '0.63', 'lle': '6.42', 'sei': '15.99'}",CHEMBL3901034,,CHEMBL3901034,9.15,0,http://www.openphacts.org/units/Nanomolar,2862738,=,37,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
,366728,17741769,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCc2[nH]c3cc(F)cc4c3c2C1=NNC4=O,,,CHEMBL3886532,,2016,"{'bei': '33.74', 'le': '0.63', 'lle': '6.42', 'sei': '15.99'}",CHEMBL3914932,,CHEMBL3914932,9.15,0,http://www.openphacts.org/units/Nanomolar,2862736,=,37,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
,366729,17741770,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)OCc3ccccc3)Cc3[nH]c4cccc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '25.81', 'le': '0.47', 'lle': '6.53', 'sei': '10.72'}",CHEMBL3955609,,CHEMBL3955609,9.30,0,http://www.openphacts.org/units/Nanomolar,2862741,=,37,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
,366730,17741771,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)OCc3ccccc3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '25.17', 'le': '0.46', 'lle': '6.61', 'sei': '10.97'}",CHEMBL3933450,,CHEMBL3933450,9.52,0,http://www.openphacts.org/units/Nanomolar,2862742,=,37,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
,366731,17741772,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1=O,,,CHEMBL3886532,,2016,"{'bei': '31.71', 'le': '0.59', 'lle': '6.68', 'sei': '12.17'}",CHEMBL3961684,,CHEMBL3961684,9.05,0,http://www.openphacts.org/units/Nanomolar,2862747,=,37,1,=,,IC50,nM,,0.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.9
,366732,17741773,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CCN2CCCCC2)C1,,,CHEMBL3886532,,2016,"{'bei': '26.61', 'le': '0.49', 'lle': '6.15', 'sei': '19.54'}",CHEMBL3984980,,CHEMBL3984980,9.70,0,http://www.openphacts.org/units/Nanomolar,2862752,=,37,1,=,,IC50,nM,,0.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.2
,366733,17741774,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1c2c3c4c(cccc41)C(=O)NN=C3CC(C)(C)C2,,,CHEMBL3886532,,2016,"{'bei': '27.02', 'le': '0.50', 'lle': '6.12', 'sei': '19.19'}",CHEMBL3926240,,CHEMBL3926240,9.52,0,http://www.openphacts.org/units/Nanomolar,2862754,=,37,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
,366734,17741775,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CC2CO2)C1,,,CHEMBL3886532,,2016,"{'bei': '24.82', 'le': '0.46', 'lle': '5.22', 'sei': '13.03'}",CHEMBL3940569,,CHEMBL3940569,7.68,0,http://www.openphacts.org/units/Nanomolar,2862762,=,37,1,=,,IC50,nM,,21.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,21.0
,366735,17741776,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '33.90', 'le': '0.62', 'lle': '7.26', 'sei': '15.04'}",CHEMBL3907535,,CHEMBL3907535,9.10,0,http://www.openphacts.org/units/Nanomolar,2862766,=,37,1,=,,IC50,nM,,0.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.8
,366736,17741777,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)C3CC3)Cc3[nH]c4cccc1c4c32,,,CHEMBL3886532,,2016,"{'bei': '32.36', 'le': '0.59', 'lle': '8.15', 'sei': '12.28'}",CHEMBL3922789,,CHEMBL3922789,9.52,0,http://www.openphacts.org/units/Nanomolar,2862768,=,37,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
,366737,17741778,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)N1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '28.63', 'le': '0.53', 'lle': '6.89', 'sei': '11.46'}",CHEMBL3978989,,CHEMBL3978989,8.89,0,http://www.openphacts.org/units/Nanomolar,2862772,=,37,1,=,,IC50,nM,,1.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.3
,366738,17741779,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)C(=O)N1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL3886532,,2016,"{'bei': '28.91', 'le': '0.53', 'lle': '8.31', 'sei': '8.69'}",CHEMBL3970252,,CHEMBL3970252,9.00,0,http://www.openphacts.org/units/Nanomolar,2862783,=,37,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
,366739,17741780,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]12CCCN1CC1=NNC(=O)c3cccc4[nH]c2c1c34,,,CHEMBL3886532,,2016,"{'bei': '33.52', 'le': '0.61', 'lle': '7.46', 'sei': '15.54'}",CHEMBL4107982,,CHEMBL4107982,9.40,0,http://www.openphacts.org/units/Nanomolar,2862789,=,37,1,=,,IC50,nM,,0.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.4
,366740,17741781,[],CHEMBL3887990,"PARP-2 and PARP-3 Enzymatic Assay: PARP-2 and PARP-3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34,,,CHEMBL3886532,,2016,"{'bei': '31.18', 'le': '0.58', 'lle': '7.22', 'sei': '15.38'}",CHEMBL4112930,PAMIPARIB,CHEMBL4112930,9.30,0,http://www.openphacts.org/units/Nanomolar,2862790,=,37,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
,392491,17763536,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCC2=C(C1)c1n[nH]c(=O)c3cccc(c13)N2,,,CHEMBL3886679,,2016,"{'bei': '34.25', 'le': '0.63', 'lle': '5.88', 'sei': '15.84'}",CHEMBL3955370,,CHEMBL3955370,9.15,0,http://www.openphacts.org/units/Nanomolar,2877355,=,37,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
,392492,17763537,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCCC1,,,CHEMBL3886679,,2016,"{'bei': '38.09', 'le': '0.69', 'lle': '6.48', 'sei': '15.77'}",CHEMBL3952089,,CHEMBL3952089,9.11,0,http://www.openphacts.org/units/Nanomolar,2877356,=,37,1,=,,IC50,nM,,0.77,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.77
,392493,17763538,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCCCCC1,,,CHEMBL3886679,,2016,"{'bei': '34.18', 'le': '0.62', 'lle': '5.73', 'sei': '15.81'}",CHEMBL3939501,,CHEMBL3939501,9.14,0,http://www.openphacts.org/units/Nanomolar,2877357,=,37,1,=,,IC50,nM,,0.73,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.73
,392494,17763539,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCCCC1,,,CHEMBL3886679,,2016,"{'bei': '35.71', 'le': '0.65', 'lle': '6.03', 'sei': '15.66'}",CHEMBL3893294,,CHEMBL3893294,9.05,0,http://www.openphacts.org/units/Nanomolar,2877358,=,37,1,=,,IC50,nM,,0.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.9
,392495,17763540,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N1CCC2=C(C1)Nc1cccc3c(=O)[nH]nc2c13,,,CHEMBL3886679,,2016,"{'bei': '27.33', 'le': '0.51', 'lle': '6.60', 'sei': '10.65'}",CHEMBL3901232,,CHEMBL3901232,9.30,0,http://www.openphacts.org/units/Nanomolar,2877367,=,37,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
,392496,17763541,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCNC1,,,CHEMBL3886679,,2016,"{'bei': '37.13', 'le': '0.68', 'lle': '7.87', 'sei': '12.78'}",CHEMBL3978225,,CHEMBL3978225,8.92,0,http://www.openphacts.org/units/Nanomolar,2877368,=,37,1,=,,IC50,nM,,1.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.2
,392497,17763542,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCN(Cc2ccccc2)C1,,,CHEMBL3886679,,2016,"{'bei': '26.71', 'le': '0.48', 'lle': '5.85', 'sei': '14.46'}",CHEMBL3939375,,CHEMBL3939375,8.82,0,http://www.openphacts.org/units/Nanomolar,2877372,=,37,1,=,,IC50,nM,,1.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.5
,392498,17763543,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCC2=C(C1)c1n[nH]c(=O)c3cccc(c13)N2,,,CHEMBL3886679,,2016,"{'bei': '28.97', 'le': '0.53', 'lle': '4.47', 'sei': '13.40'}",CHEMBL3955370,,CHEMBL3955370,7.75,0,http://www.openphacts.org/units/Nanomolar,2877355,=,37,1,=,,IC50,nM,,18.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,18.0
,392499,17763544,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCCCCC1,,,CHEMBL3886679,,2016,"{'bei': '28.44', 'le': '0.52', 'lle': '4.19', 'sei': '13.16'}",CHEMBL3939501,,CHEMBL3939501,7.60,0,http://www.openphacts.org/units/Nanomolar,2877357,=,37,1,=,,IC50,nM,,25.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,25.0
,392500,17763545,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCCCC1,,,CHEMBL3886679,,2016,"{'bei': '29.68', 'le': '0.54', 'lle': '4.50', 'sei': '13.01'}",CHEMBL3893294,,CHEMBL3893294,7.52,0,http://www.openphacts.org/units/Nanomolar,2877358,=,37,1,=,,IC50,nM,,30.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,30.3
,392501,17763546,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N1CCC2=C(C1)Nc1cccc3c(=O)[nH]nc2c13,,,CHEMBL3886679,,2016,"{'bei': '19.30', 'le': '0.36', 'lle': '3.87', 'sei': '7.52'}",CHEMBL3901232,,CHEMBL3901232,6.57,0,http://www.openphacts.org/units/Nanomolar,2877367,=,37,1,=,,IC50,nM,,270.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,270.0
,392502,17763547,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCNC1,,,CHEMBL3886679,,2016,"{'bei': '32.23', 'le': '0.59', 'lle': '6.69', 'sei': '11.09'}",CHEMBL3978225,,CHEMBL3978225,7.75,0,http://www.openphacts.org/units/Nanomolar,2877368,=,37,1,=,,IC50,nM,,18.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,18.0
,392503,17763548,[],CHEMBL3888363,"Chemiluminescent Assay: PARP2 and PARP3 enzymatic assays were conducted using commercial PARP-2/PARP-3 Chemiluminescent Assay Kit (BPS Biosciences) and the protocols with the kits. Briefly, histones were coated in a high binding plate first, and incubated with PARP-2 or PARP-3, and increasing concentrations of compounds for 0.5 h. Then, biotinylated NAD and activated DNA were added to the wells. The biotinylated PARsylation product was measured by adding streptavidin-HRP and HRP substrates which produce chemiluminescence.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)NC1=C2CCN(Cc2ccccc2)C1,,,CHEMBL3886679,,2016,"{'bei': '17.25', 'le': '0.31', 'lle': '2.73', 'sei': '9.34'}",CHEMBL3939375,,CHEMBL3939375,5.70,0,http://www.openphacts.org/units/Nanomolar,2877372,=,37,1,=,,IC50,nM,,2000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2000.0
,,17967313,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '15.19', 'le': '0.28', 'lle': '4.25', 'sei': '7.64'}",CHEMBL521686,OLAPARIB,CHEMBL521686,6.60,0,http://www.openphacts.org/units/Nanomolar,2977205,=,1,1,=,,IC50,nM,,251.19,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.6
,,17967314,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '21.21', 'le': '0.39', 'lle': '3.88', 'sei': '12.05'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,6.86,0,http://www.openphacts.org/units/Nanomolar,2977207,=,1,1,=,,IC50,nM,,138.04,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.86
,,17967315,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '21.74', 'le': '0.40', 'lle': '4.24', 'sei': '9.85'}",CHEMBL372303,PJ34,CHEMBL372303,6.42,0,http://www.openphacts.org/units/Nanomolar,2977208,=,1,1,=,,IC50,nM,,380.19,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.42
,,17967333,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(N2C[C@@H](C)N[C@@H](C)C2)ncc1-c1ccc(-c2nc3c(ccn3C)c(=O)[nH]2)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '14.02', 'le': '0.26', 'lle': '2.52', 'sei': '7.62'}",CHEMBL4101890,,CHEMBL4101890,6.01,0,http://www.openphacts.org/units/Nanomolar,2977210,=,1,1,=,,IC50,nM,,977.24,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.01
,,17967334,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(COc1cccc2c(=O)[nH]ccc12)c1ccccc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '21.37', 'le': '0.39', 'lle': '3.18', 'sei': '10.09'}",CHEMBL4089840,,CHEMBL4089840,5.97,0,http://www.openphacts.org/units/Nanomolar,2977209,=,1,1,=,,IC50,nM,,1071.52,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.97
,,17967356,[],CHEMBL3995378,Inhibition of recombinant human His6-tagged PARP2 autophosphorylation at ADP-ribosyltransferase domain by LC-MS/MS method,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '22.23', 'le': '0.45', 'lle': '3.28', 'sei': '15.09'}",CHEMBL1086580,,CHEMBL1086580,6.94,1,http://www.openphacts.org/units/Nanomolar,2977212,=,1,1,=,,IC50,nM,,114.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,114.0
,,17967360,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '28.08', 'le': '0.52', 'lle': '5.60', 'sei': '8.19'}",CHEMBL506871,VELIPARIB,CHEMBL506871,6.86,0,http://www.openphacts.org/units/Nanomolar,2977203,=,1,1,=,,IC50,nM,,138.04,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.86
,,17967361,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '24.24', 'le': '0.49', 'lle': '3.91', 'sei': '16.45'}",CHEMBL1086580,,CHEMBL1086580,7.57,0,http://www.openphacts.org/units/Nanomolar,2977212,=,1,1,=,,IC50,nM,,26.92,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.57
,,17967366,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncnc1[C@@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@H]1c1ccc(F)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '22.03', 'le': '0.41', 'lle': '5.75', 'sei': '9.47'}",CHEMBL3764816,,CHEMBL3764816,8.38,0,http://www.openphacts.org/units/Nanomolar,2977206,=,1,1,=,,IC50,nM,,4.169,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.38
,,17967367,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '23.35', 'le': '0.43', 'lle': '4.57', 'sei': '13.26'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,7.55,0,http://www.openphacts.org/units/Nanomolar,2977207,=,1,1,=,,IC50,nM,,28.18,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.55
,,17967374,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '31.76', 'le': '0.59', 'lle': '6.50', 'sei': '9.26'}",CHEMBL506871,VELIPARIB,CHEMBL506871,7.76,0,http://www.openphacts.org/units/Nanomolar,2977203,=,1,1,=,,IC50,nM,,17.38,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.76
,,17967375,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '24.38', 'le': '0.44', 'lle': '5.22', 'sei': '10.71'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,7.81,0,http://www.openphacts.org/units/Nanomolar,2977204,=,1,1,=,,IC50,nM,,15.49,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.81
,,17967379,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '18.21', 'le': '0.34', 'lle': '5.56', 'sei': '9.16'}",CHEMBL521686,OLAPARIB,CHEMBL521686,7.91,0,http://www.openphacts.org/units/Nanomolar,2977205,=,1,1,=,,IC50,nM,,12.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.91
,,17967380,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '25.33', 'le': '0.46', 'lle': '5.30', 'sei': '11.47'}",CHEMBL372303,PJ34,CHEMBL372303,7.48,0,http://www.openphacts.org/units/Nanomolar,2977208,=,1,1,=,,IC50,nM,,33.11,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.48
,,17967433,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '21.73', 'le': '0.40', 'lle': '4.24', 'sei': '9.84'}",CHEMBL372303,PJ34,CHEMBL372303,6.42,0,http://www.openphacts.org/units/Nanomolar,2977208,=,1,1,=,,IC50,nM,,382.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,382.0
,,17967434,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '21.21', 'le': '0.39', 'lle': '3.88', 'sei': '12.05'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,6.86,0,http://www.openphacts.org/units/Nanomolar,2977207,=,1,1,=,,IC50,nM,,138.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,138.0
,,17967435,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '15.19', 'le': '0.28', 'lle': '4.25', 'sei': '7.64'}",CHEMBL521686,OLAPARIB,CHEMBL521686,6.60,0,http://www.openphacts.org/units/Nanomolar,2977205,=,1,1,=,,IC50,nM,,251.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,251.0
,,17967436,[],CHEMBL3995361,Inhibition of recombinant human His6-tagged PARP2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '28.09', 'le': '0.52', 'lle': '5.60', 'sei': '8.19'}",CHEMBL506871,VELIPARIB,CHEMBL506871,6.86,0,http://www.openphacts.org/units/Nanomolar,2977203,=,1,1,=,,IC50,nM,,137.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,137.0
,,17967437,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '24.24', 'le': '0.49', 'lle': '3.91', 'sei': '16.45'}",CHEMBL1086580,,CHEMBL1086580,7.57,0,http://www.openphacts.org/units/Nanomolar,2977212,=,1,1,=,,IC50,nM,,26.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,30.0,26.9
,Not Active,17967438,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,,,CHEMBL3994596,J Med Chem,2017,,CHEMBL562310,,CHEMBL562310,,0,,2977211,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,17967439,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(N2C[C@@H](C)N[C@@H](C)C2)ncc1-c1ccc(-c2nc3c(ccn3C)c(=O)[nH]2)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '14.01', 'le': '0.26', 'lle': '2.51', 'sei': '7.62'}",CHEMBL4101890,,CHEMBL4101890,6.00,0,http://www.openphacts.org/units/Nanomolar,2977210,=,1,1,=,,IC50,nM,,990.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,990.0
,,17967440,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(COc1cccc2c(=O)[nH]ccc12)c1ccccc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '21.48', 'le': '0.39', 'lle': '3.21', 'sei': '10.14'}",CHEMBL4089840,,CHEMBL4089840,6.00,0,http://www.openphacts.org/units/Nanomolar,2977209,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1000.0
,,17967441,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '25.31', 'le': '0.46', 'lle': '5.29', 'sei': '11.46'}",CHEMBL372303,PJ34,CHEMBL372303,7.47,0,http://www.openphacts.org/units/Nanomolar,2977208,=,1,1,=,,IC50,nM,,33.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,33.5
,,17967442,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '23.35', 'le': '0.43', 'lle': '4.57', 'sei': '13.26'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,7.55,0,http://www.openphacts.org/units/Nanomolar,2977207,=,1,1,=,,IC50,nM,,28.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,28.2
,,17967443,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncnc1[C@@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@H]1c1ccc(F)cc1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '22.05', 'le': '0.41', 'lle': '5.76', 'sei': '9.48'}",CHEMBL3764816,,CHEMBL3764816,8.39,0,http://www.openphacts.org/units/Nanomolar,2977206,=,1,1,=,,IC50,nM,,4.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.1
,,17967444,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '18.21', 'le': '0.34', 'lle': '5.56', 'sei': '9.16'}",CHEMBL521686,OLAPARIB,CHEMBL521686,7.91,0,http://www.openphacts.org/units/Nanomolar,2977205,=,1,1,=,,IC50,nM,,12.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,12.3
,,17967445,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '24.39', 'le': '0.44', 'lle': '5.23', 'sei': '10.71'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,7.82,0,http://www.openphacts.org/units/Nanomolar,2977204,=,1,1,=,,IC50,nM,,15.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,15.3
,,17967446,[],CHEMBL3995360,Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL3994596,J Med Chem,2017,"{'bei': '31.75', 'le': '0.59', 'lle': '6.50', 'sei': '9.26'}",CHEMBL506871,VELIPARIB,CHEMBL506871,7.76,0,http://www.openphacts.org/units/Nanomolar,2977203,=,1,1,=,,IC50,nM,,17.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,17.5
,,18007455,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2c(=O)[nH]c(CCC(=O)Nc3ccc(C(=O)Nc4cccc5cccnc45)cc3)nc12,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '10.35', 'le': '0.19', 'lle': '0.34', 'sei': '4.23'}",CHEMBL4069447,,CHEMBL4069447,4.94,0,http://www.openphacts.org/units/Nanomolar,2984019,=,1,1,=,,IC50,nM,,11481.54,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,4.94
,,18007456,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCc1nc2ccccc2c(=O)[nH]1)Nc1ccc(C(=O)Nc2cccc3cccnc23)cc1,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '11.13', 'le': '0.20', 'lle': '0.87', 'sei': '4.42'}",CHEMBL4098188,,CHEMBL4098188,5.16,0,http://www.openphacts.org/units/Nanomolar,2984018,=,1,1,=,,IC50,nM,,6918.31,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.16
,,18007457,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2c(=O)[nH]c(CCC(=O)O)nc12,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '29.45', 'le': '0.55', 'lle': '5.59', 'sei': '8.24'}",CHEMBL4080163,,CHEMBL4080163,6.84,0,http://www.openphacts.org/units/Nanomolar,2984017,=,1,1,=,,IC50,nM,,144.54,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.84
,,18007458,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCc1nc(O)c2ccccc2n1,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '31.62', 'le': '0.59', 'lle': '5.55', 'sei': '8.28'}",CHEMBL1892587,,CHEMBL1892587,6.90,0,http://www.openphacts.org/units/Nanomolar,2984016,=,1,1,=,,IC50,nM,,125.89,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.9
,,18007459,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1SCCc2nc(-c3ccc(C(F)(F)F)cc3)[nH]c(=O)c21,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '20.99', 'le': '0.43', 'lle': '3.96', 'sei': '10.90'}",CHEMBL4059827,,CHEMBL4059827,6.85,0,http://www.openphacts.org/units/Nanomolar,2984013,=,1,1,=,,IC50,nM,,141.25,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,6.85
,,18007564,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2c(=O)[nH]c(CCC(=O)Nc3ccc(C(=O)Nc4cccc5cccnc45)cc3)nc12,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '10.34', 'le': '0.19', 'lle': '0.34', 'sei': '4.22'}",CHEMBL4069447,,CHEMBL4069447,4.94,0,http://www.openphacts.org/units/Nanomolar,2984019,=,1,1,=,,IC50,nM,,11600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,11.6
,,18007565,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCc1nc2ccccc2c(=O)[nH]1)Nc1ccc(C(=O)Nc2cccc3cccnc23)cc1,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '11.14', 'le': '0.20', 'lle': '0.87', 'sei': '4.42'}",CHEMBL4098188,,CHEMBL4098188,5.16,0,http://www.openphacts.org/units/Nanomolar,2984018,=,1,1,=,,IC50,nM,,6900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,6.9
,,18007566,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2c(=O)[nH]c(CCC(=O)O)nc12,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '29.45', 'le': '0.55', 'lle': '5.59', 'sei': '8.23'}",CHEMBL4080163,,CHEMBL4080163,6.84,0,http://www.openphacts.org/units/Nanomolar,2984017,=,1,1,=,,IC50,nM,,145.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,145.0
,,18007567,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCc1nc(O)c2ccccc2n1,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '31.64', 'le': '0.59', 'lle': '5.55', 'sei': '8.29'}",CHEMBL1892587,,CHEMBL1892587,6.90,0,http://www.openphacts.org/units/Nanomolar,2984016,=,1,1,=,,IC50,nM,,125.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,125.0
,Not Determined,18007568,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(C(=O)Nc2cccc3cccnc23)cc1,,,CHEMBL4002591,J Med Chem,2017,,CHEMBL4063631,,CHEMBL4063631,,0,,2984015,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18007569,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@@H]4CC[C@@H](C4)[C@@H]3C2=O)cc1,,,CHEMBL4002591,J Med Chem,2017,,CHEMBL1956162,,CHEMBL1956162,,0,http://www.openphacts.org/units/Nanomolar,2984014,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100000.0
,,18007570,[],CHEMBL4003518,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells measured after 1 hr by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1SCCc2nc(-c3ccc(C(F)(F)F)cc3)[nH]c(=O)c21,,,CHEMBL4002591,J Med Chem,2017,"{'bei': '21.00', 'le': '0.43', 'lle': '3.96', 'sei': '10.91'}",CHEMBL4059827,,CHEMBL4059827,6.85,0,http://www.openphacts.org/units/Nanomolar,2984013,=,1,1,=,,IC50,nM,,141.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,141.0
,,18059418,[],CHEMBL4012885,Binding affinity to PARP2 in human Jurkat cell extract after 45 mins by mass spectrometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL4011625,J Med Chem,2017,,CHEMBL1086580,,CHEMBL1086580,,0,http://www.openphacts.org/units/Nanomolar,2993211,<,1,1,>,,IC50,nM,,5011.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.3
,,18059446,[],CHEMBL4012885,Binding affinity to PARP2 in human Jurkat cell extract after 45 mins by mass spectrometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(Nc2nc3ccccc3n3nnnc23)cc1,,,CHEMBL4011625,J Med Chem,2017,,CHEMBL4064332,,CHEMBL4064332,,0,http://www.openphacts.org/units/Nanomolar,2993218,<,1,1,>,,IC50,nM,,5011.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.3
,,18059491,[],CHEMBL4012885,Binding affinity to PARP2 in human Jurkat cell extract after 45 mins by mass spectrometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(Nc2nc3ccccc3n3nnnc23)cc1)N1CCOCC1,,,CHEMBL4011625,J Med Chem,2017,,CHEMBL4087876,,CHEMBL4087876,,0,http://www.openphacts.org/units/Nanomolar,2993230,<,1,1,>,,IC50,nM,,5011.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.3
,,18059527,[],CHEMBL4012885,Binding affinity to PARP2 in human Jurkat cell extract after 45 mins by mass spectrometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(Nc2nc3ccccc3n3nnnc23)cc1)N1CCN(c2ncccn2)CC1,,,CHEMBL4011625,J Med Chem,2017,,CHEMBL4087470,,CHEMBL4087470,,0,http://www.openphacts.org/units/Nanomolar,2993239,<,1,1,>,,IC50,nM,,5011.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.3
,,18059560,[],CHEMBL4012885,Binding affinity to PARP2 in human Jurkat cell extract after 45 mins by mass spectrometric analysis,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cnc(C(=O)N2CCN(C(=O)c3ccc(Nc4nc5ccccc5n5nnnc45)cc3)CC2)c1,,,CHEMBL4011625,J Med Chem,2017,,CHEMBL4060134,,CHEMBL4060134,,0,http://www.openphacts.org/units/Nanomolar,2993245,<,1,1,>,,IC50,nM,,5011.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,5.3
,,18134879,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2[nH]c(C(=O)NC3CCN(CC(F)(F)F)CC3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '18.95', 'le': '0.37', 'lle': '5.58', 'sei': '6.72'}",CHEMBL4100391,,CHEMBL4100391,7.00,0,http://www.openphacts.org/units/Nanomolar,3008062,=,1,1,=,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18134880,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2[nH]c(C(=O)NC3CCN(CC4CC4)CC3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '20.17', 'le': '0.38', 'lle': '5.62', 'sei': '6.61'}",CHEMBL4081066,,CHEMBL4081066,6.89,0,http://www.openphacts.org/units/Nanomolar,3008067,=,1,1,=,,IC50,nM,,130.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,130.0
,Not Determined,18134881,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2[nH]c(C(=O)NC3CCNCC3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,,CHEMBL4060514,,CHEMBL4060514,,0,,3008074,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18134882,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCC(NC(=O)c2nc3c(C(N)=O)cc(F)cc3[nH]2)CC1,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '18.99', 'le': '0.36', 'lle': '5.09', 'sei': '6.85'}",CHEMBL4076845,,CHEMBL4076845,7.13,0,http://www.openphacts.org/units/Nanomolar,3008075,=,1,1,=,,IC50,nM,,74.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,74.0
,,18134883,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2[nH]c(C(=O)N3CCC(N)C3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '26.78', 'le': '0.50', 'lle': '7.48', 'sei': '6.20'}",CHEMBL4091897,,CHEMBL4091897,7.32,0,http://www.openphacts.org/units/Nanomolar,3008078,=,1,1,=,,IC50,nM,,48.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,48.0
,,18134884,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CCCNC1CCN(C(=O)c2nc3c(C(N)=O)cccc3[nH]2)C1,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '22.59', 'le': '0.42', 'lle': '6.24', 'sei': '6.84'}",CHEMBL4070559,,CHEMBL4070559,7.12,0,http://www.openphacts.org/units/Nanomolar,3008079,=,1,1,=,,IC50,nM,,75.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,75.0
,,18134885,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2[nH]c(C(=O)N3CCC(NC4CCCCC4)C3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '19.81', 'le': '0.37', 'lle': '5.24', 'sei': '6.76'}",CHEMBL4077812,,CHEMBL4077812,7.04,0,http://www.openphacts.org/units/Nanomolar,3008081,=,1,1,=,,IC50,nM,,91.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,91.0
,,18134886,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cc(F)cc2[nH]c(C(=O)N3CCC(N)C3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '26.51', 'le': '0.50', 'lle': '7.75', 'sei': '6.54'}",CHEMBL4076271,,CHEMBL4076271,7.72,0,http://www.openphacts.org/units/Nanomolar,3008085,=,1,1,=,,IC50,nM,,19.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,19.0
,,18134887,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cc(F)cc2[nH]c(C(=O)N3CCC(NC4CCCCC4)C3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '19.87', 'le': '0.38', 'lle': '5.48', 'sei': '7.13'}",CHEMBL4081378,,CHEMBL4081378,7.42,0,http://www.openphacts.org/units/Nanomolar,3008086,=,1,1,=,,IC50,nM,,38.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,38.0
,,18134888,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2[nH]c(C(=O)N3CCC(N)CC3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '24.84', 'le': '0.46', 'lle': '6.91', 'sei': '6.04'}",CHEMBL4079788,,CHEMBL4079788,7.14,0,http://www.openphacts.org/units/Nanomolar,3008088,=,1,1,=,,IC50,nM,,73.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,73.0
,,18134889,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cc(F)cc2[nH]c(C(=O)N3CCC(N)CC3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '24.96', 'le': '0.47', 'lle': '7.26', 'sei': '6.45'}",CHEMBL4080699,,CHEMBL4080699,7.62,0,http://www.openphacts.org/units/Nanomolar,3008093,=,1,1,=,,IC50,nM,,24.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,24.0
,,18134890,[],CHEMBL4029619,Inhibition of recombinant human PARP2 expressed in Escherichia coli BL21(DE3) using histone as substrate measured after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cc(F)cc2[nH]c(C(=O)N3CCC(NC4CCCCC4)CC3)nc12,,,CHEMBL4028811,Eur J Med Chem,2017,"{'bei': '19.28', 'le': '0.36', 'lle': '5.14', 'sei': '7.17'}",CHEMBL4098745,,CHEMBL4098745,7.47,0,http://www.openphacts.org/units/Nanomolar,3008094,=,1,1,=,,IC50,nM,,34.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,34.0
,,18148002,[],CHEMBL4032828,Inhibition of human GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cell expression system using NAD+ as substrate after 4 hrs by fluorescence assay,B,,,BAO_0000190,BAO_0000019,assay format,N#Cc1ccc2c(c1)[nH]c(=O)n2[C@H]1C[C@H](c2nnc(-c3ccncn3)n2-c2ccccc2Cl)C1,,,CHEMBL4028904,J Med Chem,2017,,CHEMBL4095003,,CHEMBL4095003,,0,http://www.openphacts.org/units/Nanomolar,3010472,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,18255750,[],CHEMBL4055670,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(CCNC(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)cc1)NO,,,CHEMBL4052667,Bioorg Med Chem,2017,"{'bei': '17.06', 'le': '0.31', 'lle': '5.16', 'sei': '6.68'}",CHEMBL4096060,,CHEMBL4096060,8.30,0,http://www.openphacts.org/units/Nanomolar,3029363,=,1,1,=,,IC50,nM,,5.02,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.02
,,18255763,[],CHEMBL4055670,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4052667,Bioorg Med Chem,2017,"{'bei': '19.68', 'le': '0.36', 'lle': '6.20', 'sei': '9.90'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.55,0,http://www.openphacts.org/units/Nanomolar,3029364,=,1,1,=,,IC50,nM,,2.81,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.81
,,18255774,[],CHEMBL4055670,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(/C=C/c1ccc(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)cc1)NO,,,CHEMBL4052667,Bioorg Med Chem,2017,"{'bei': '15.87', 'le': '0.29', 'lle': '5.47', 'sei': '7.25'}",CHEMBL4078014,,CHEMBL4078014,8.60,0,http://www.openphacts.org/units/Nanomolar,3029362,=,1,1,=,,IC50,nM,,2.53,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.53
,,18255808,[],CHEMBL4055670,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1ccc(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)cc1)NO,,,CHEMBL4052667,Bioorg Med Chem,2017,"{'bei': '13.80', 'le': '0.26', 'lle': '4.65', 'sei': '6.16'}",CHEMBL4075511,,CHEMBL4075511,7.31,0,http://www.openphacts.org/units/Nanomolar,3029361,=,1,1,=,,IC50,nM,,49.12,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,49.12
,,18255823,[],CHEMBL4055670,Inhibition of recombinant human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by UV/Vis spectrophotometric analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NO)c1ccc(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)cc1,,,CHEMBL4052667,Bioorg Med Chem,2017,"{'bei': '14.55', 'le': '0.27', 'lle': '4.77', 'sei': '6.32'}",CHEMBL4097093,,CHEMBL4097093,7.50,0,http://www.openphacts.org/units/Nanomolar,3029360,=,1,1,=,,IC50,nM,,31.52,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,31.52
,,18256406,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '20.18', 'le': '0.37', 'lle': '6.42', 'sei': '10.15'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.77,0,http://www.openphacts.org/units/Nanomolar,3029507,=,1,1,=,,IC50,nM,,1.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.7
,,18256407,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(c2ccccc2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '18.25', 'le': '0.34', 'lle': '5.65', 'sei': '8.38'}",CHEMBL4100719,,CHEMBL4100719,8.39,0,http://www.openphacts.org/units/Nanomolar,3029506,=,1,1,=,,IC50,nM,,4.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.1
,,18256408,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(Cc2ccncc2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '17.36', 'le': '0.32', 'lle': '6.11', 'sei': '7.29'}",CHEMBL4082728,,CHEMBL4082728,8.24,0,http://www.openphacts.org/units/Nanomolar,3029505,=,1,1,=,,IC50,nM,,5.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.8
,,18256409,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(Cc2ccccc2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '17.46', 'le': '0.32', 'lle': '5.54', 'sei': '8.26'}",CHEMBL4093008,,CHEMBL4093008,8.27,0,http://www.openphacts.org/units/Nanomolar,3029504,=,1,1,=,,IC50,nM,,5.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.4
,,18256410,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(C(=O)C2CC2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '18.49', 'le': '0.35', 'lle': '6.88', 'sei': '7.12'}",CHEMBL4072243,,CHEMBL4072243,8.35,0,http://www.openphacts.org/units/Nanomolar,3029503,=,1,1,=,,IC50,nM,,4.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.5
,,18256411,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(C2CCC(F)(F)CC2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '15.80', 'le': '0.30', 'lle': '4.81', 'sei': '7.92'}",CHEMBL4095389,,CHEMBL4095389,7.92,0,http://www.openphacts.org/units/Nanomolar,3029502,=,1,1,=,,IC50,nM,,11.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11.9
,,18256412,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(CCC2CC2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '19.93', 'le': '0.37', 'lle': '6.67', 'sei': '8.99'}",CHEMBL4067999,,CHEMBL4067999,9.00,0,http://www.openphacts.org/units/Nanomolar,3029501,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
,,18256413,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(CCC(F)(F)F)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '17.81', 'le': '0.34', 'lle': '6.05', 'sei': '8.53'}",CHEMBL4083291,,CHEMBL4083291,8.54,0,http://www.openphacts.org/units/Nanomolar,3029499,=,1,1,=,,IC50,nM,,2.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.9
,,18256414,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(CC2CC2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '19.30', 'le': '0.36', 'lle': '6.50', 'sei': '8.44'}",CHEMBL4061458,,CHEMBL4061458,8.44,0,http://www.openphacts.org/units/Nanomolar,3029500,=,1,1,=,,IC50,nM,,3.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.6
,,18256415,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCN(CC(F)(F)F)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '17.06', 'le': '0.33', 'lle': '5.85', 'sei': '7.93'}",CHEMBL4099732,,CHEMBL4099732,7.94,0,http://www.openphacts.org/units/Nanomolar,3029498,=,1,1,=,,IC50,nM,,11.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11.5
,,18256416,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1[N+](=O)[O-])[C@H]1CCNC1,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4072851,,CHEMBL4072851,,0,http://www.openphacts.org/units/Nanomolar,3029497,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256417,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1Br)[C@H]1CCNC1.O=C(O)C(F)(F)F,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4091988,,CHEMBL4116672,,0,http://www.openphacts.org/units/Nanomolar,3029496,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256418,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1Cl)[C@H]1CCNC1.O=C(O)C(F)(F)F,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4064245,,CHEMBL4117353,,0,http://www.openphacts.org/units/Nanomolar,3029495,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256419,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cncc(Cn2c(=O)[nH]c(=O)c3ccccc32)c1)[C@H]1CCNC1.O=C(O)C(F)(F)F,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '18.22', 'le': '0.34', 'lle': '5.98', 'sei': '6.11'}",CHEMBL4084234,,CHEMBL4116950,6.66,0,http://www.openphacts.org/units/Nanomolar,3029494,=,1,1,=,,IC50,nM,,220.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,220.0
,,18256420,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1Br)[C@H]1CCNC1.O=C(O)C(F)(F)F,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4102201,,CHEMBL4116949,,0,http://www.openphacts.org/units/Nanomolar,3029493,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256421,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1Cl)[C@H]1CCNC1.O=C(O)C(F)(F)F,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '18.50', 'le': '0.36', 'lle': '6.07', 'sei': '6.79'}",CHEMBL4101084,,CHEMBL4117682,7.40,0,http://www.openphacts.org/units/Nanomolar,3029492,=,1,1,=,,IC50,nM,,40.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,40.0
,,18256422,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)cnc1F)[C@H]1CCNC1.O=C(O)C(F)(F)F,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '18.51', 'le': '0.35', 'lle': '6.28', 'sei': '6.52'}",CHEMBL4083109,,CHEMBL4117146,7.10,0,http://www.openphacts.org/units/Nanomolar,3029491,=,1,1,=,,IC50,nM,,80.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,80.0
,,18256423,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2N)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4097709,,CHEMBL4097709,,0,http://www.openphacts.org/units/Nanomolar,3029490,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256424,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2O)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4079674,,CHEMBL4079674,,0,http://www.openphacts.org/units/Nanomolar,3029489,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256425,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2[N+](=O)[O-])C1,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4105422,,CHEMBL4105422,,0,http://www.openphacts.org/units/Nanomolar,3029488,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256426,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2Br)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '13.19', 'le': '0.28', 'lle': '3.47', 'sei': '6.31'}",CHEMBL4087554,,CHEMBL4087554,7.17,0,http://www.openphacts.org/units/Nanomolar,3029487,=,1,1,=,,IC50,nM,,68.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,68.0
,,18256427,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2Cl)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '16.12', 'le': '0.31', 'lle': '4.45', 'sei': '7.08'}",CHEMBL4082114,,CHEMBL4082114,8.04,0,http://www.openphacts.org/units/Nanomolar,3029486,=,1,1,=,,IC50,nM,,9.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9.1
,,18256428,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cncc(Cn3c(=O)[nH]c(=O)c4ccccc43)c2)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4060222,,CHEMBL4060222,,0,http://www.openphacts.org/units/Nanomolar,3029485,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256429,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)cnc2Br)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,,CHEMBL4089975,,CHEMBL4089975,,0,http://www.openphacts.org/units/Nanomolar,3029484,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,18256456,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)cnc2F)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '16.68', 'le': '0.31', 'lle': '5.60', 'sei': '6.38'}",CHEMBL4092324,,CHEMBL4092324,8.07,0,http://www.openphacts.org/units/Nanomolar,3029482,=,1,1,=,,IC50,nM,,8.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,8.6
,,18256457,[],CHEMBL4055846,Inhibition of recombinant human PARP-2 expressed in Escherichia coli BL21 (DE3) using sheared DNA as substrate in presence of biotinylated NAD after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)OC(=O)N1CC[C@H](C(=O)Nc2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)cnc2Cl)C1,,,CHEMBL4052674,Bioorg Med Chem,2017,"{'bei': '15.83', 'le': '0.31', 'lle': '4.93', 'sei': '6.26'}",CHEMBL4068890,,CHEMBL4068890,7.91,0,http://www.openphacts.org/units/Nanomolar,3029483,=,1,1,=,,IC50,nM,,12.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,12.2
,,18292057,[],CHEMBL4122814,Inhibition of full length recombinant His6-tagged PARP2 catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(Oc2ccc(C(N)=O)cc2)cc1,,,CHEMBL4118166,Bioorg Med Chem Lett,2018,,CHEMBL1438938,,CHEMBL1438938,,0,http://www.openphacts.org/units/Nanomolar,3036382,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,18701351,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCC1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '19.86', 'le': '0.39', 'lle': '3.71', 'sei': '8.16'}",CHEMBL4277995,,CHEMBL4277995,6.84,0,http://www.openphacts.org/units/Nanomolar,3105866,=,1,1,=,,IC50,nM,,145.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,145.0
,,18701352,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '18.10', 'le': '0.35', 'lle': '2.97', 'sei': '7.74'}",CHEMBL4285923,,CHEMBL4285923,6.49,0,http://www.openphacts.org/units/Nanomolar,3105867,=,1,1,=,,IC50,nM,,324.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,324.0
,,18701353,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCC1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '17.34', 'le': '0.34', 'lle': '2.55', 'sei': '7.71'}",CHEMBL4293136,,CHEMBL4293136,6.46,0,http://www.openphacts.org/units/Nanomolar,3105868,=,1,1,=,,IC50,nM,,348.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,348.0
,,18701354,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '18.71', 'le': '0.37', 'lle': '3.34', 'sei': '8.00'}",CHEMBL4282534,,CHEMBL4282534,6.71,0,http://www.openphacts.org/units/Nanomolar,3105869,=,1,1,=,,IC50,nM,,196.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,196.0
,,18701355,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2[nH]c(-c3cc4c(s3)C(C3CC3)NCC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '18.58', 'le': '0.36', 'lle': '3.49', 'sei': '7.90'}",CHEMBL4289750,,CHEMBL4289750,6.62,0,http://www.openphacts.org/units/Nanomolar,3105870,=,1,1,=,,IC50,nM,,239.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,239.0
,,18701356,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '18.97', 'le': '0.37', 'lle': '3.31', 'sei': '8.43'}",CHEMBL4279065,,CHEMBL4279065,7.07,0,http://www.openphacts.org/units/Nanomolar,3105871,=,1,1,=,,IC50,nM,,86.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,86.0
,,18701357,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '17.88', 'le': '0.35', 'lle': '2.90', 'sei': '7.95'}",CHEMBL4286332,,CHEMBL4286332,6.66,0,http://www.openphacts.org/units/Nanomolar,3105872,=,1,1,=,,IC50,nM,,219.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,219.0
,,18701358,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC1Cc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc2CN1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '23.77', 'le': '0.47', 'lle': '5.29', 'sei': '9.37'}",CHEMBL4294222,,CHEMBL4294222,7.85,0,http://www.openphacts.org/units/Nanomolar,3105873,=,1,1,=,,IC50,nM,,14.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,14.0
,,18701359,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2nc3c(C(N)=O)cc(F)cc3[nH]2)sc2c1CCNC2,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '22.77', 'le': '0.45', 'lle': '5.04', 'sei': '8.98'}",CHEMBL4291682,,CHEMBL4291682,7.52,0,http://www.openphacts.org/units/Nanomolar,3105874,=,1,1,=,,IC50,nM,,30.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,30.0
,,18701360,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2cc3c(s2)CNCC3)nc2c(C(N)=O)cc(F)cc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '22.33', 'le': '0.44', 'lle': '5.19', 'sei': '10.11'}",CHEMBL4281045,,CHEMBL4281045,7.38,0,http://www.openphacts.org/units/Nanomolar,3105875,=,1,1,=,,IC50,nM,,42.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,42.0
,,18701361,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(-c2cc3c(s2)CNCC3)nc2c(C(N)=O)cc(F)cc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '18.71', 'le': '0.37', 'lle': '3.77', 'sei': '8.84'}",CHEMBL4281379,,CHEMBL4281379,6.45,0,http://www.openphacts.org/units/Nanomolar,3105876,=,1,1,=,,IC50,nM,,359.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,359.0
,,18701362,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2cc3c(s2)C(C(C)(C)C)NCC3)nc2c(C(N)=O)cc(F)cc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '16.78', 'le': '0.33', 'lle': '2.71', 'sei': '8.89'}",CHEMBL4291992,,CHEMBL4291992,6.48,0,http://www.openphacts.org/units/Nanomolar,3105877,=,1,1,=,,IC50,nM,,328.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,328.0
,,18701363,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4n3C)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '17.93', 'le': '0.35', 'lle': '3.16', 'sei': '9.50'}",CHEMBL4277920,,CHEMBL4277920,6.93,0,http://www.openphacts.org/units/Nanomolar,3105878,=,1,1,=,,IC50,nM,,117.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,117.0
,,18701364,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2[nH]c(-c3cc4c(o3)CNCC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '22.78', 'le': '0.42', 'lle': '5.13', 'sei': '7.06'}",CHEMBL4288572,,CHEMBL4288572,6.84,0,http://www.openphacts.org/units/Nanomolar,3105879,=,1,1,=,,IC50,nM,,144.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,144.0
,,18701365,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2nc3c(C(N)=O)cc(F)cc3[nH]2)s1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '23.64', 'le': '0.47', 'lle': '4.94', 'sei': '8.58'}",CHEMBL4293056,,CHEMBL4293056,7.19,0,http://www.openphacts.org/units/Nanomolar,3105880,=,1,1,=,,IC50,nM,,64.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,64.0
,,18701366,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2[nH]c(C3=NC4CCNCC4S3)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.38', 'le': '0.42', 'lle': '5.81', 'sei': '7.10'}",CHEMBL4285227,,CHEMBL4285227,6.83,0,http://www.openphacts.org/units/Nanomolar,3105881,=,1,1,=,,IC50,nM,,149.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,149.0
,,18701367,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(-c3cc4c(s3)CCNC4)nc3cc(F)cc1c32,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.35', 'le': '0.42', 'lle': '5.02', 'sei': '12.40'}",CHEMBL4289667,,CHEMBL4289667,7.31,0,http://www.openphacts.org/units/Nanomolar,3105882,=,1,1,=,,IC50,nM,,49.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,49.0
,,18701368,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(-c3cc4c(s3)CNCC4)nc3cc(F)cc1c32,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '20.46', 'le': '0.40', 'lle': '4.71', 'sei': '11.88'}",CHEMBL4281789,,CHEMBL4281789,7.00,0,http://www.openphacts.org/units/Nanomolar,3105883,=,1,1,=,,IC50,nM,,99.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,99.0
,,18701369,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@H]1NCCC2C=C(c3nc4c(C(=O)O)cc(F)cc4[nH]3)SC21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '19.06', 'le': '0.38', 'lle': '3.27', 'sei': '9.17'}",CHEMBL4286249,,CHEMBL4286249,7.16,0,http://www.openphacts.org/units/Nanomolar,3105884,=,1,1,=,,IC50,nM,,70.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,70.0
,,18701370,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@H]1NCCC2C=C(c3nc4c(C(=O)O)cc(F)cc4[nH]3)SC21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '17.17', 'le': '0.34', 'lle': '2.57', 'sei': '8.27'}",CHEMBL4278332,,CHEMBL4278332,6.45,0,http://www.openphacts.org/units/Nanomolar,3105885,=,1,1,=,,IC50,nM,,356.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,356.0
,,18701380,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC1NCCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc21,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.37', 'le': '0.42', 'lle': '4.32', 'sei': '8.43'}",CHEMBL4282620,,CHEMBL4282620,7.06,0,http://www.openphacts.org/units/Nanomolar,3105865,=,1,1,=,,IC50,nM,,87.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,87.0
,,18701381,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '29.29', 'le': '0.54', 'lle': '5.89', 'sei': '8.54'}",CHEMBL506871,VELIPARIB,CHEMBL506871,7.16,0,http://www.openphacts.org/units/Nanomolar,3105864,=,1,1,=,,IC50,nM,,70.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,70.0
,,18701382,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '19.62', 'le': '0.36', 'lle': '6.17', 'sei': '9.87'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.52,1,http://www.openphacts.org/units/Nanomolar,3105863,=,1,1,=,,IC50,nM,,3.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.0
,,18701383,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCc2sc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)cc2C1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.43', 'le': '0.42', 'lle': '4.56', 'sei': '9.44'}",CHEMBL4291982,,CHEMBL4291982,7.08,0,http://www.openphacts.org/units/Nanomolar,3105862,=,1,1,=,,IC50,nM,,83.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,83.0
,,18701384,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2[nH]c(-c3cc4c(s3)CCNC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '22.56', 'le': '0.44', 'lle': '4.96', 'sei': '8.52'}",CHEMBL4280657,,CHEMBL4280657,7.14,0,http://www.openphacts.org/units/Nanomolar,3105861,=,1,1,=,,IC50,nM,,73.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,73.0
,,18701385,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCc2cc(-c3nc4c(C(N)=O)cc(F)cc4[nH]3)sc2C1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.07', 'le': '0.41', 'lle': '4.44', 'sei': '9.28'}",CHEMBL4288557,,CHEMBL4288557,6.96,0,http://www.openphacts.org/units/Nanomolar,3105860,=,1,1,=,,IC50,nM,,109.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,109.0
,,18701386,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2[nH]c(-c3cc4c(s3)CNCC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.83', 'le': '0.43', 'lle': '4.73', 'sei': '8.24'}",CHEMBL4290904,,CHEMBL4290904,6.91,0,http://www.openphacts.org/units/Nanomolar,3105859,=,1,1,=,,IC50,nM,,124.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,124.0
,,18701387,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)cc2[nH]c(-c3cc4c(s3)CNCC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '19.28', 'le': '0.40', 'lle': '3.73', 'sei': '7.66'}",CHEMBL4280264,,CHEMBL4280264,6.42,0,http://www.openphacts.org/units/Nanomolar,3105858,=,1,1,=,,IC50,nM,,382.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,382.0
,,18701388,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C(N)=O)c2nc(-c3cc4c(s3)CNCC4)[nH]c2c1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '20.97', 'le': '0.41', 'lle': '4.21', 'sei': '7.82'}",CHEMBL4287485,,CHEMBL4287485,6.55,0,http://www.openphacts.org/units/Nanomolar,3105857,=,1,1,=,,IC50,nM,,281.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,281.0
,,18701389,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCc2cc(-c3nc4c(C(N)=O)cccc4[nH]3)sc2C1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.15', 'le': '0.41', 'lle': '4.23', 'sei': '8.81'}",CHEMBL4276836,,CHEMBL4276836,6.61,0,http://www.openphacts.org/units/Nanomolar,3105856,=,1,1,=,,IC50,nM,,247.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,247.0
,,18701390,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2[nH]c(-c3cc4c(s3)CNCC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '24.38', 'le': '0.47', 'lle': '5.24', 'sei': '8.68'}",CHEMBL4289496,,CHEMBL4289496,7.28,0,http://www.openphacts.org/units/Nanomolar,3105855,=,1,1,=,,IC50,nM,,53.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,53.0
,,18701391,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCc2sc(-c3nc4c(C(N)=O)cccc4[nH]3)cc2C1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '21.00', 'le': '0.41', 'lle': '4.08', 'sei': '9.14'}",CHEMBL4278820,,CHEMBL4278820,6.85,0,http://www.openphacts.org/units/Nanomolar,3105854,=,1,1,=,,IC50,nM,,140.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,140.0
,,18701392,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCc2sc(-c3nc4c(C(N)=O)cccc4[nH]3)cc2C1,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '22.03', 'le': '0.43', 'lle': '4.50', 'sei': '9.18'}",CHEMBL4279230,,CHEMBL4279230,6.88,0,http://www.openphacts.org/units/Nanomolar,3105853,=,1,1,=,,IC50,nM,,131.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,131.0
,,18701393,[],CHEMBL4254941,Inhibition of recombinant human PARP2 using histone as substrate after 1.5 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2[nH]c(-c3cc4c(s3)CCNC4)nc12,,,CHEMBL4251650,Eur J Med Chem,2018,"{'bei': '23.28', 'le': '0.45', 'lle': '4.91', 'sei': '8.29'}",CHEMBL4287147,,CHEMBL4287147,6.95,0,http://www.openphacts.org/units/Nanomolar,3105852,=,1,1,=,,IC50,nM,,113.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,113.0
,,18785144,[],CHEMBL4271463,Inhibition of recombinant human PARP2 using DNase I-activated herring sperm DNA and [3H]nicotinamide after 2 mins by scintillation counting method,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)N=C(CN1Cc3ccccc3C1)N2,,,CHEMBL4270509,Eur J Med Chem,2017,"{'bei': '28.36', 'le': '0.51', 'lle': '6.61', 'sei': '12.26'}",CHEMBL3644587,2X-121,CHEMBL3644587,9.00,0,http://www.openphacts.org/units/Nanomolar,3121639,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
,,18790739,[],CHEMBL4272743,Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD2 (1 to 583 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(Oc2ccc(C=O)cc2)cc1,,,CHEMBL4270552,Eur J Med Chem,2018,,CHEMBL4287655,,CHEMBL4287655,,0,http://www.openphacts.org/units/Nanomolar,3122616,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,18790756,[],CHEMBL4272743,Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD2 (1 to 583 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(Oc2ccc(C(=O)O)cc2)cc1,,,CHEMBL4270552,Eur J Med Chem,2018,,CHEMBL4287262,,CHEMBL4287262,,0,http://www.openphacts.org/units/Nanomolar,3122615,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,18790783,[],CHEMBL4272743,Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD2 (1 to 583 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(N)=O)cc1,,,CHEMBL4270552,Eur J Med Chem,2018,"{'bei': '27.21', 'le': '0.51', 'lle': '3.32', 'sei': '7.86'}",CHEMBL449635,,CHEMBL449635,4.11,0,http://www.openphacts.org/units/Nanomolar,3122608,=,1,1,=,,IC50,nM,,77000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,77.0
,,18790829,[],CHEMBL4272743,Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD2 (1 to 583 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(OCc2ccccc2F)cc1,,,CHEMBL4270552,Eur J Med Chem,2018,,CHEMBL4208737,,CHEMBL4208737,,0,http://www.openphacts.org/units/Nanomolar,3122637,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,18790854,[],CHEMBL4272743,Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD2 (1 to 583 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(Oc2ccc(C(N)=O)cc2)cc1,,,CHEMBL4270552,Eur J Med Chem,2018,,CHEMBL1438938,,CHEMBL1438938,,1,http://www.openphacts.org/units/Nanomolar,3122606,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,Not Determined,18847766,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccccc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL3290468,,CHEMBL3290468,,0,,3145682,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847767,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-c3ccccc3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4453142,,CHEMBL4453142,,0,,3145683,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847768,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-c3nccs3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4574744,,CHEMBL4574744,,0,,3145684,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847769,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-n3cncn3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4574000,,CHEMBL4574000,,0,,3145685,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847770,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-c3nn[nH]n3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '26.04', 'le': '0.47', 'lle': '7.10', 'sei': '7.01'}",CHEMBL4454914,,CHEMBL4454914,8.68,0,http://www.openphacts.org/units/Nanomolar,3145686,=,1,1,=,,IC50,nM,,2.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.1
,,18847771,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-c3nn[nH]n3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '26.07', 'le': '0.47', 'lle': '7.11', 'sei': '7.02'}",CHEMBL4454914,,CHEMBL4454914,8.69,0,http://www.openphacts.org/units/Nanomolar,3145686,=,1,1,=,,IC50,nM,,2.042,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.69
,Not Determined,18847772,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-c3cc[nH]n3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4454471,,CHEMBL4454471,,0,,3145687,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847773,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(-c3nn[nH]n3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4476020,,CHEMBL4476020,,0,http://www.openphacts.org/units/Nanomolar,3145688,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,Not Determined,18847774,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc2)CC1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4474430,,CHEMBL4474430,,0,,3145689,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847775,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(N3CCN(Cc4ccccc4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4472061,,CHEMBL4472061,,0,,3145690,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847776,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4439730,,CHEMBL4439730,,0,http://www.openphacts.org/units/Nanomolar,3145691,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847777,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(-c3nn[nH]n3)c(F)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4462563,,CHEMBL4462563,,0,http://www.openphacts.org/units/Nanomolar,3145669,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847778,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(-c2nn[nH]n2)ccc1/C=C1\Oc2c(C(N)=O)cccc2C1=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '24.21', 'le': '0.44', 'lle': '7.21', 'sei': '6.61'}",CHEMBL4518901,,CHEMBL4518901,8.80,0,http://www.openphacts.org/units/Nanomolar,3145670,=,1,1,=,,IC50,nM,,1.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.6
,,18847779,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(-c2nn[nH]n2)ccc1/C=C1\Oc2c(C(N)=O)cccc2C1=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '24.22', 'le': '0.45', 'lle': '7.21', 'sei': '6.61'}",CHEMBL4518901,,CHEMBL4518901,8.80,0,http://www.openphacts.org/units/Nanomolar,3145670,=,1,1,=,,IC50,nM,,1.585,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.8
,Not Determined,18847780,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1nnc(-c2ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc2)n1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4519830,,CHEMBL4519830,,0,,3145671,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847781,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)O)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4592442,,CHEMBL4592442,,0,,3145672,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847782,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '21.41', 'le': '0.40', 'lle': '6.95', 'sei': '10.77'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.30,0,http://www.openphacts.org/units/Nanomolar,3145673,=,1,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
,,18847783,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '21.64', 'le': '0.40', 'lle': '7.05', 'sei': '10.88'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.40,0,http://www.openphacts.org/units/Nanomolar,3145673,=,1,1,=,,IC50,nM,,0.3981,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,9.4
,,18847784,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL506871,VELIPARIB,CHEMBL506871,,0,http://www.openphacts.org/units/Nanomolar,3145674,<,1,1,<,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,Not Determined,18847785,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4ccccc4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4561926,,CHEMBL4561926,,0,,3145675,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847786,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4ccccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4578950,,CHEMBL4578950,,0,,3145676,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847787,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4ncccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4591947,,CHEMBL4591947,,0,http://www.openphacts.org/units/Nanomolar,3145677,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847788,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4cnccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4539846,,CHEMBL4539846,,0,http://www.openphacts.org/units/Nanomolar,3145678,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,Not Determined,18847789,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4ncncn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4469097,,CHEMBL4469097,,0,,3145679,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847790,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4nnc(C(F)(F)F)s4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4544714,,CHEMBL4544714,,0,,3145680,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847791,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4ncccc4C(F)(F)F)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4567050,,CHEMBL4567050,,0,,3145681,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847792,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccnc1N1CCN(C(=O)c2ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc2)CC1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4453735,,CHEMBL4453735,,0,,3145657,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847793,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccnc(N2CCN(C(=O)c3ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc3)CC2)n1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4457849,,CHEMBL4457849,,0,http://www.openphacts.org/units/Nanomolar,3145658,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,Not Determined,18847794,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cnc(N2CCN(C(=O)c3ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc3)CC2)nc1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4528490,,CHEMBL4528490,,0,,3145659,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847795,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COCc1nc(-c2ccnc(N3CCN(C(=O)c4ccc(/C=C5\Oc6c(C(N)=O)cccc6C5=O)cc4)CC3)n2)no1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4557232,,CHEMBL4557232,,0,http://www.openphacts.org/units/Nanomolar,3145660,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847796,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(C(=O)N3CCN(c4ncccn4)CC3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4437403,,CHEMBL4437403,,0,http://www.openphacts.org/units/Nanomolar,3145661,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847797,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccnc(N2CCN(C(=O)c3cccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)c3)CC2)n1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4445035,,CHEMBL4445035,,0,http://www.openphacts.org/units/Nanomolar,3145662,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847798,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(C(=O)N3CCN(c4cnccn4)CC3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4582095,,CHEMBL4582095,,0,http://www.openphacts.org/units/Nanomolar,3145663,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,Not Determined,18847799,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(S(=O)(=O)N3CCN(c4ncccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4460296,,CHEMBL4460296,,0,,3145664,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847800,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(CN3CCN(c4ncccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4562749,,CHEMBL4562749,,0,http://www.openphacts.org/units/Nanomolar,3145665,<,1,1,<,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,Not Determined,18847801,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)NC3CCN(c4ncccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4473851,,CHEMBL4473851,,0,,3145666,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847802,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCC(c4ncccn4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4464740,,CHEMBL4464740,,0,http://www.openphacts.org/units/Nanomolar,3145667,>,1,1,>,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
,,18847803,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4cnnc4C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4584942,,CHEMBL4584942,,0,http://www.openphacts.org/units/Nanomolar,3145668,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847804,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nnc2n1CCN(C(=O)c1ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc1)C2,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4571844,,CHEMBL4571844,,0,http://www.openphacts.org/units/Nanomolar,3145638,<,1,1,<,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847805,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C(F)(F)F)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.00', 'le': '0.34', 'lle': '6.03', 'sei': '7.22'}",CHEMBL4519178,,CHEMBL4519178,8.70,0,http://www.openphacts.org/units/Nanomolar,3145639,=,1,1,=,,IC50,nM,,2.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.0
,,18847806,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C(F)(F)F)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.20', 'le': '0.34', 'lle': '6.13', 'sei': '7.31'}",CHEMBL4519178,,CHEMBL4519178,8.80,0,http://www.openphacts.org/units/Nanomolar,3145639,=,1,1,=,,IC50,nM,,1.585,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.8
,,18847807,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1nnc2n1CCN(C(=O)c1ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc1)C2,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.30', 'le': '0.32', 'lle': '6.60', 'sei': '5.75'}",CHEMBL4539194,,CHEMBL4539194,8.43,0,http://www.openphacts.org/units/Nanomolar,3145640,=,1,1,=,,IC50,nM,,3.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.7
,,18847808,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1nnc2n1CCN(C(=O)c1ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc1)C2,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.31', 'le': '0.32', 'lle': '6.61', 'sei': '5.75'}",CHEMBL4539194,,CHEMBL4539194,8.44,0,http://www.openphacts.org/units/Nanomolar,3145640,=,1,1,=,,IC50,nM,,3.631,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.44
,,18847809,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C4CC4)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '19.15', 'le': '0.35', 'lle': '6.19', 'sei': '7.24'}",CHEMBL4575227,,CHEMBL4575227,8.72,0,http://www.openphacts.org/units/Nanomolar,3145641,=,1,1,=,,IC50,nM,,1.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.9
,,18847810,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C4CC4)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '19.15', 'le': '0.35', 'lle': '6.19', 'sei': '7.24'}",CHEMBL4575227,,CHEMBL4575227,8.72,0,http://www.openphacts.org/units/Nanomolar,3145641,=,1,1,=,,IC50,nM,,1.905,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.72
,,18847811,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(Cc5cccc(F)c5)nnc4C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4458607,,CHEMBL4458607,,0,http://www.openphacts.org/units/Nanomolar,3145642,<,1,1,<,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847812,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C(F)F)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.31', 'le': '0.34', 'lle': '5.93', 'sei': '7.08'}",CHEMBL4446105,,CHEMBL4446105,8.52,0,http://www.openphacts.org/units/Nanomolar,3145643,=,1,1,=,,IC50,nM,,3.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.0
,,18847813,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C(F)F)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.31', 'le': '0.34', 'lle': '5.93', 'sei': '7.08'}",CHEMBL4446105,,CHEMBL4446105,8.52,0,http://www.openphacts.org/units/Nanomolar,3145643,=,1,1,=,,IC50,nM,,3.02,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.52
,,18847814,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(CC5CC5)nnc4C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.01', 'le': '0.33', 'lle': '5.86', 'sei': '7.02'}",CHEMBL4450747,,CHEMBL4450747,8.46,0,http://www.openphacts.org/units/Nanomolar,3145644,=,1,1,=,,IC50,nM,,3.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.5
,,18847815,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(CC5CC5)nnc4C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.02', 'le': '0.33', 'lle': '5.86', 'sei': '7.03'}",CHEMBL4450747,,CHEMBL4450747,8.46,0,http://www.openphacts.org/units/Nanomolar,3145644,=,1,1,=,,IC50,nM,,3.467,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.46
,,18847816,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(CO)nnc4C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4470212,,CHEMBL4470212,,0,http://www.openphacts.org/units/Nanomolar,3145645,<,1,1,<,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847817,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1nnc2n1CCN(C(=O)c1ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc1)C2,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.22', 'le': '0.33', 'lle': '5.57', 'sei': '6.92'}",CHEMBL4435102,,CHEMBL4435102,8.34,0,http://www.openphacts.org/units/Nanomolar,3145646,=,1,1,=,,IC50,nM,,4.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.6
,,18847818,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1nnc2n1CCN(C(=O)c1ccc(/C=C3\Oc4c(C(N)=O)cccc4C3=O)cc1)C2,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.23', 'le': '0.34', 'lle': '5.57', 'sei': '6.93'}",CHEMBL4435102,,CHEMBL4435102,8.34,0,http://www.openphacts.org/units/Nanomolar,3145646,=,1,1,=,,IC50,nM,,4.571,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.34
,,18847819,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C4CCCC4)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.39', 'le': '0.32', 'lle': '5.10', 'sei': '6.98'}",CHEMBL4469675,,CHEMBL4469675,8.41,0,http://www.openphacts.org/units/Nanomolar,3145647,=,1,1,=,,IC50,nM,,3.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.9
,,18847820,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCn4c(nnc4C4CCCC4)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.41', 'le': '0.32', 'lle': '5.11', 'sei': '6.99'}",CHEMBL4469675,,CHEMBL4469675,8.42,0,http://www.openphacts.org/units/Nanomolar,3145647,=,1,1,=,,IC50,nM,,3.802,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.42
,,18847821,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cnc(-c2nnc3n2CCN(C(=O)c2ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc2)C3)c1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.12', 'le': '0.31', 'lle': '6.43', 'sei': '6.14'}",CHEMBL4586938,,CHEMBL4586938,8.48,0,http://www.openphacts.org/units/Nanomolar,3145648,=,1,1,=,,IC50,nM,,3.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.3
,,18847822,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cnc(-c2nnc3n2CCN(C(=O)c2ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc2)C3)c1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.11', 'le': '0.31', 'lle': '6.43', 'sei': '6.13'}",CHEMBL4586938,,CHEMBL4586938,8.48,0,http://www.openphacts.org/units/Nanomolar,3145648,=,1,1,=,,IC50,nM,,3.311,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.48
,,18847823,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(C(=O)N3CCn4cnnc4C3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4542683,,CHEMBL4542683,,0,http://www.openphacts.org/units/Nanomolar,3145649,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847824,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(C(=O)N3CCn4c(nnc4C(F)(F)F)C3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4470680,,CHEMBL4470680,,0,http://www.openphacts.org/units/Nanomolar,3145650,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847825,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)NCCc3nc4ccccc4[nH]3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.68', 'le': '0.32', 'lle': '4.75', 'sei': '6.29'}",CHEMBL4515830,,CHEMBL4515830,8.00,0,http://www.openphacts.org/units/Nanomolar,3145651,=,1,1,=,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847826,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2[nH]c(CCNC(=O)c3ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc3)nc2c1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.79', 'le': '0.32', 'lle': '4.74', 'sei': '6.53'}",CHEMBL4446923,,CHEMBL4446923,8.30,0,http://www.openphacts.org/units/Nanomolar,3145652,=,1,1,=,,IC50,nM,,5.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.0
,,18847827,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2[nH]c(CCNC(=O)c3ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc3)nc2c1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.83', 'le': '0.32', 'lle': '4.76', 'sei': '6.54'}",CHEMBL4446923,,CHEMBL4446923,8.32,0,http://www.openphacts.org/units/Nanomolar,3145652,=,1,1,=,,IC50,nM,,4.786,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.32
,,18847828,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)NCCc3nc4cc(F)ccc4[nH]3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4450242,,CHEMBL4450242,,0,http://www.openphacts.org/units/Nanomolar,3145653,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847829,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(C(=O)NCCc3nc4ccccc4[nH]3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4544913,,CHEMBL4544913,,0,http://www.openphacts.org/units/Nanomolar,3145654,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847830,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1cccc(C(=O)NCCc3nc4cc(F)ccc4[nH]3)c1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4471547,,CHEMBL4471547,,0,http://www.openphacts.org/units/Nanomolar,3145655,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847831,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2[nH]c(CCNC(=O)c3ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc3)nc2c1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4576573,,CHEMBL4576573,,0,http://www.openphacts.org/units/Nanomolar,3145656,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847832,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)NCCc3nc4c(C(N)=O)cccc4[nH]3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.48', 'le': '0.34', 'lle': '6.80', 'sei': '5.38'}",CHEMBL4529965,,CHEMBL4529965,9.15,0,http://www.openphacts.org/units/Nanomolar,3145628,=,1,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
,,18847833,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)NCCc3nc4c(C(N)=O)cccc4[nH]3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '18.55', 'le': '0.34', 'lle': '6.84', 'sei': '5.40'}",CHEMBL4529965,,CHEMBL4529965,9.19,0,http://www.openphacts.org/units/Nanomolar,3145628,=,1,1,=,,IC50,nM,,0.6457,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,9.19
,,18847834,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(Cc1nc2ccccc2[nH]1)NC(=O)c1ccc(/C=C2\Oc3c(C(N)=O)cccc3C2=O)cc1,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4475399,,CHEMBL4475399,,0,http://www.openphacts.org/units/Nanomolar,3145629,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847835,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)NCCCc3nc4ccccc4[nH]3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4538616,,CHEMBL4538616,,0,http://www.openphacts.org/units/Nanomolar,3145630,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847836,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CC(c4nc5ccccc5[nH]4)C3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4437358,,CHEMBL4437358,,0,http://www.openphacts.org/units/Nanomolar,3145631,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,,18847837,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4nc5ccccc5[nH]4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.02', 'le': '0.31', 'lle': '5.16', 'sei': '6.91'}",CHEMBL4474593,,CHEMBL4474593,8.40,0,http://www.openphacts.org/units/Nanomolar,3145632,=,1,1,=,,IC50,nM,,4.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.0
,,18847838,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCN(c4nc5ccccc5[nH]4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '17.02', 'le': '0.31', 'lle': '5.16', 'sei': '6.91'}",CHEMBL4474593,,CHEMBL4474593,8.40,0,http://www.openphacts.org/units/Nanomolar,3145632,=,1,1,=,,IC50,nM,,3.981,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.4
,,18847839,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1cccc2c1O/C(=C\c1ccc(C(=O)N3CCC(c4nc5ccccc5[nH]4)CC3)cc1)C2=O,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4583398,,CHEMBL4583398,,0,http://www.openphacts.org/units/Nanomolar,3145633,>,1,1,>,,IC50,nM,,10.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.0
,Not Determined,18847840,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cccc2nc(CCNC(=O)c3ccc(/C=C4\Oc5c(C(N)=O)cccc5C4=O)cc3)[nH]c12,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL4475182,,CHEMBL4475182,,0,,3145634,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,18847841,[],CHEMBL4305044,Inhibition of human N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells using histone as substrate measured after 1 hr by horseradish peroxidase-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL4304742,J Med Chem,2019,,CHEMBL1086580,,CHEMBL1086580,,0,,3145635,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,18847945,[],CHEMBL4305078,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '28.76', 'le': '0.53', 'lle': '6.32', 'sei': '16.34'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,9.30,0,http://www.openphacts.org/units/Nanomolar,3145636,=,1,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
,,18847947,[],CHEMBL4305080,Inhibition of human PARP2 expressed in Escherichia coli using biotinylated histone H1 as substrate measured in presence of [3H]NAD+ by topcount scintillation counting method,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL4304742,J Med Chem,2019,"{'bei': '34.95', 'le': '0.65', 'lle': '7.28', 'sei': '10.19'}",CHEMBL506871,VELIPARIB,CHEMBL506871,8.54,0,http://www.openphacts.org/units/Nanomolar,3145674,=,1,1,=,,IC50,nM,,2.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.9
,,18880645,[],CHEMBL4311841,Inhibition of full length human PARP2 assessed as reduction in MARylation of SRPK2 substrate after 60 mins in presence of 6-a-NAD+ by chemifluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2ccnc(C(F)(F)F)c2)ccc2c1CCNC2=O,,,CHEMBL4308918,ACS Med Chem Lett,2019,,CHEMBL4545565,,CHEMBL4545565,,0,http://www.openphacts.org/units/Nanomolar,3150478,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,18916953,[],CHEMBL4322264,Inhibition of N-terminal GST-tagged recombinant human PARP2 (2 to 583 residues) expressed in Baculovirus infected Sf9 cells using biotinylated substrate after 1 hr by chemiluminescence method,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)c1ccc(-c2nc3c(F)cc(F)cc3c(=O)[nH]2)cc1,,,CHEMBL4321794,J Med Chem,2019,"{'bei': '18.97', 'le': '0.36', 'lle': '2.90', 'sei': '9.09'}",CHEMBL4437173,,CHEMBL4437173,6.00,0,http://www.openphacts.org/units/Nanomolar,3155744,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.0
,,19010825,[],CHEMBL4345423,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARylation using histone as substrate measured after 45 mins in presence of biotinylated-NAD+ by ELISA,A,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCC3(CC2)CN(CCO)c2cc(F)cc(F)c23)nc2c1CCCC2,,,CHEMBL4342498,J Med Chem,2020,,CHEMBL4448872,,CHEMBL4448872,5.57,1,http://www.openphacts.org/units/Nanomolar,3172358,=,1,1,=,,IC50,nM,,2717.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2717.0
,,19010826,[],CHEMBL4345423,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARylation using histone as substrate measured after 45 mins in presence of biotinylated-NAD+ by ELISA,A,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1CN(c2cc(F)c3c(c2)N(C)C(=O)C32CCN(c3nc4c(c(=O)[nH]3)CCCN4C)CC2)C[C@H](C)O1,,,CHEMBL4342498,J Med Chem,2020,,CHEMBL4449082,,CHEMBL4449082,5.91,0,http://www.openphacts.org/units/Nanomolar,3172391,=,1,1,=,,IC50,nM,,1240.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1240.0
,,19010827,[],CHEMBL4345423,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARylation using histone as substrate measured after 45 mins in presence of biotinylated-NAD+ by ELISA,A,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)c1ccc(-c2nnc(/C=C/c3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,,,CHEMBL4342498,J Med Chem,2020,,CHEMBL2325503,,CHEMBL2325503,,1,http://www.openphacts.org/units/Nanomolar,3172392,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100000.0
,,19052915,[],CHEMBL4355645,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1ccc(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)cc1)NO,,,CHEMBL4354803,Bioorg Med Chem,2019,"{'bei': '15.87', 'le': '0.29', 'lle': '5.47', 'sei': '7.25'}",CHEMBL4078014,,CHEMBL4078014,8.60,1,http://www.openphacts.org/units/Nanomolar,3178833,=,1,1,=,,IC50,nM,,2.53,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.53
,,19052954,[],CHEMBL4355645,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4354803,Bioorg Med Chem,2019,"{'bei': '19.68', 'le': '0.36', 'lle': '6.20', 'sei': '9.90'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.55,1,http://www.openphacts.org/units/Nanomolar,3178863,=,1,1,=,,IC50,nM,,2.81,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.81
,,19151933,[],CHEMBL4380328,Inhibition of recombinant human PARP2 using histone as substrate after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(C(F)(F)F)c(-c2nc3c(c(N4CCOCC4)n2)CCN(C(=O)c2cc(Cc4n[nH]c(=O)c5ccccc45)ccc2F)C3)cn1,,,CHEMBL4376860,J Med Chem,2020,"{'bei': '12.78', 'le': '0.24', 'lle': '4.30', 'sei': '5.89'}",CHEMBL4470724,,CHEMBL4470724,8.44,0,http://www.openphacts.org/units/Nanomolar,3196357,=,1,1,=,,IC50,nM,,3.631,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,8.44
,,19151934,[],CHEMBL4380328,Inhibition of recombinant human PARP2 using histone as substrate after 1 hr in presence of biotinylated NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4376860,J Med Chem,2020,"{'bei': '20.71', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,1,http://www.openphacts.org/units/Nanomolar,3196354,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,9.0
,,19185478,[],CHEMBL4388151,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARylation using histone as substrate measured after 45 mins in presence of biotinylated-NAD+ by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1,,,CHEMBL4387706,J Med Chem,2019,"{'bei': '16.60', 'le': '0.31', 'lle': '3.67', 'sei': '9.20'}",CHEMBL4454483,,CHEMBL4454483,5.65,0,http://www.openphacts.org/units/Nanomolar,3202350,=,1,1,=,,IC50,nM,,2230.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2230.0
,,19185479,[],CHEMBL4388151,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARylation using histone as substrate measured after 45 mins in presence of biotinylated-NAD+ by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)c1ccc(-c2nnc(/C=C/c3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)nc1,,,CHEMBL4387706,J Med Chem,2019,,CHEMBL2325503,,CHEMBL2325503,,0,http://www.openphacts.org/units/Nanomolar,3202352,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100000.0
,,19185480,[],CHEMBL4388151,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARylation using histone as substrate measured after 45 mins in presence of biotinylated-NAD+ by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(N2CCC3(CC2)CN(CCO)c2cc(F)cc(F)c23)nc2c1CCCC2,,,CHEMBL4387706,J Med Chem,2019,"{'bei': '13.36', 'le': '0.25', 'lle': '3.29', 'sei': '7.68'}",CHEMBL4448872,,CHEMBL4448872,5.57,0,http://www.openphacts.org/units/Nanomolar,3202400,=,1,1,=,,IC50,nM,,2717.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2717.0
,,19447160,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCNCc1ccc(-c2nc3cncc4c3n2CCNC4=O)cc1,,,CHEMBL4431370,Bioorg Med Chem,2016,"{'bei': '24.91', 'le': '0.46', 'lle': '6.05', 'sei': '11.14'}",CHEMBL4460350,,CHEMBL4460350,8.00,0,http://www.openphacts.org/units/Nanomolar,3249086,=,1,1,=,,IC50,nM,,9.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9.9
,Not Determined,19447161,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2nc3cncc4c3n2CCNC4=O)cc1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4592544,,CHEMBL4592544,,0,,3249085,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,19447162,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2nc3cncc4c3n2CCNC4=O)cc1,,,CHEMBL4431370,Bioorg Med Chem,2016,"{'bei': '26.49', 'le': '0.48', 'lle': '6.58', 'sei': '11.33'}",CHEMBL4458889,,CHEMBL4458889,8.14,0,http://www.openphacts.org/units/Nanomolar,3249084,=,1,1,=,,IC50,nM,,7.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.2
,Not Determined,19447163,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(-c3nc4cncc5c4n3CCNC5=O)cc2)CC1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4570886,,CHEMBL4570886,,0,,3249083,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,19447164,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(-c3ccc(N4CCNCC4)cc3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,"{'bei': '23.71', 'le': '0.43', 'lle': '7.01', 'sei': '11.00'}",CHEMBL4522170,,CHEMBL4522170,8.26,0,http://www.openphacts.org/units/Nanomolar,3249082,=,1,1,=,,IC50,nM,,5.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.5
,Not Determined,19447165,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(-c3ccccc3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4458372,,CHEMBL4458372,,0,,3249081,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447166,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(C3CCN(C(=O)c4ccc(Cl)cc4)CC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4468323,,CHEMBL4468323,,0,,3249080,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447167,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(C3CCN(C(=O)c4cccc(Cl)c4)CC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4436157,,CHEMBL4436157,,0,,3249079,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447168,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(C3CCN(C(=O)c4ccccc4Cl)CC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4532640,,CHEMBL4532640,,0,,3249078,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447169,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(C3CCN(C(=O)c4ccccc4)CC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4578024,,CHEMBL4578024,,0,,3249077,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447170,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(C3CCN(C(=O)C4CC4)CC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4586369,,CHEMBL4586369,,0,,3249076,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447171,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(c2nc3cncc4c3n2CCNC4=O)CC1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4579910,,CHEMBL4579910,,0,,3249075,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447172,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(C3CCN(Cc4ccccc4)CC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4515565,,CHEMBL4515565,,0,,3249074,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,19447173,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN1CCC(c2nc3cncc4c3n2CCNC4=O)CC1,,,CHEMBL4431370,Bioorg Med Chem,2016,"{'bei': '24.78', 'le': '0.46', 'lle': '6.10', 'sei': '12.87'}",CHEMBL4435879,,CHEMBL4435879,8.11,0,http://www.openphacts.org/units/Nanomolar,3249073,=,1,1,=,,IC50,nM,,7.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.7
,Not Determined,19447174,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCN1CCC(c2nc3cncc4c3n2CCNC4=O)CC1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4454541,,CHEMBL4454541,,0,,3249072,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447175,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCC(c2nc3cncc4c3n2CCNC4=O)CC1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4463611,,CHEMBL4463611,,0,,3249071,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447176,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCC(c2nc3cncc4c3n2CCNC4=O)CC1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4590570,,CHEMBL4590570,,0,,3249070,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447177,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.O=C1NCCn2c(C3CCNCC3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4447860,,CHEMBL4595613,,0,,3249069,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447195,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCc1ccc(-c2nc3cncc4c3n2CCNC4=O)cc1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4454690,,CHEMBL4454690,,0,,3249087,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447196,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NCc1ccc(-c2nc3cncc4c3n2CCNC4=O)cc1,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4459573,,CHEMBL4459573,,0,,3249088,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447197,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(-c3ccc(CN4CCCC4)cc3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4545981,,CHEMBL4545981,,0,,3249089,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,19447198,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2c(-c3ccc(CN4CCCCC4)cc3)nc3cncc1c32,,,CHEMBL4431370,Bioorg Med Chem,2016,,CHEMBL4563153,,CHEMBL4563153,,0,,3249090,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,19447199,[],CHEMBL4432791,Inhibition of PARP-2 (unknown origin) after 1 hr in presence of NAD+/biotinylated NAD+/slDNA by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL4431370,Bioorg Med Chem,2016,"{'bei': '36.37', 'le': '0.67', 'lle': '7.63', 'sei': '10.60'}",CHEMBL506871,VELIPARIB,CHEMBL506871,8.89,0,http://www.openphacts.org/units/Nanomolar,3249091,=,1,1,=,,IC50,nM,,1.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.3
,,19483603,[],CHEMBL4481031,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL4480392,Eur J Med Chem,2019,"{'bei': '27.08', 'le': '0.49', 'lle': '6.09', 'sei': '11.90'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,8.68,1,http://www.openphacts.org/units/Nanomolar,3258234,=,1,1,=,,IC50,nM,,2.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.1
,,19483605,[],CHEMBL4481028,Inhibition of human recombinant PARP2 by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCN(CC2CC2)C1)c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F,,,CHEMBL4480392,Eur J Med Chem,2019,"{'bei': '16.42', 'le': '0.31', 'lle': '5.08', 'sei': '8.22'}",CHEMBL4533690,,CHEMBL4533690,7.17,0,http://www.openphacts.org/units/Nanomolar,3258232,=,1,1,=,,IC50,nM,,67.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,67.8
,,19483607,[],CHEMBL4481026,Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[Si](C)(C)OCCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL4480392,Eur J Med Chem,2019,"{'bei': '13.97', 'le': None, 'lle': None, 'sei': None}",CHEMBL4569417,,CHEMBL4569417,7.95,0,http://www.openphacts.org/units/Nanomolar,3258231,=,1,1,=,,IC50,nM,,11.33,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11.33
,,19483614,[],CHEMBL4481019,Inhibition of recombinant human PARP2 using histone as substrate after 1 hr in presence of NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC1CN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)Cc2nnc(C(F)(F)F)n21,,,CHEMBL4480392,Eur J Med Chem,2019,"{'bei': '19.85', 'le': '0.38', 'lle': '6.18', 'sei': '9.98'}",CHEMBL3907010,,CHEMBL3907010,9.66,1,http://www.openphacts.org/units/Nanomolar,3258229,=,1,1,=,,IC50,nM,,0.22,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.22
,,19483625,[],CHEMBL4481011,Inhibition of PARP2 (unknown origin) by biotinylated NAD+-based luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2cc3cc(F)cc(C(N)=O)c3o2)cc1,,,CHEMBL4480392,Eur J Med Chem,2019,"{'bei': '29.23', 'le': '0.54', 'lle': '5.66', 'sei': '12.78'}",CHEMBL4584534,,CHEMBL4584534,8.72,0,http://www.openphacts.org/units/Nanomolar,3258224,=,1,1,=,,IC50,nM,,1.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.9
,,20652043,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(SCCN2CCN(c3ccccn3)CC2)nc2ccccc12,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '17.04', 'le': '0.33', 'lle': '4.03', 'sei': '9.61'}",CHEMBL4460557,,CHEMBL4460557,6.26,0,http://www.openphacts.org/units/Nanomolar,3476410,=,1,1,=,,IC50,nM,,549.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,549.0
,,20652044,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(SCCN2CCN(CCCOc3ccc(-c4ccccc4)cc3)CC2)nc2ccccc12,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '12.92', 'le': '0.25', 'lle': '1.70', 'sei': '10.52'}",CHEMBL4642139,,CHEMBL4642139,6.47,0,http://www.openphacts.org/units/Nanomolar,3476411,=,1,1,=,,IC50,nM,,340.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,340.0
,,20652045,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(SCCN2CCN(CCCc3nc(-c4ccccc4)no3)CC2)nc2ccccc12,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '13.49', 'le': '0.26', 'lle': '3.11', 'sei': '7.06'}",CHEMBL4648016,,CHEMBL4648016,6.43,0,http://www.openphacts.org/units/Nanomolar,3476412,=,1,1,=,,IC50,nM,,370.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,370.0
,,20652046,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CC2(CCN(C(=O)CN3CCN(CCSc4nc5ccccc5c(=O)[nH]4)CC3)CC2)Oc2ccccc21,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '11.79', 'le': '0.23', 'lle': '3.80', 'sei': '6.54'}",CHEMBL4632484,,CHEMBL4632484,6.46,0,http://www.openphacts.org/units/Nanomolar,3476413,=,1,1,=,,IC50,nM,,347.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,347.0
,,20652047,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1CCN(CCSc2nc3ccccc3c(=O)[nH]2)CC1,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '14.17', 'le': '0.27', 'lle': '3.05', 'sei': '7.66'}",CHEMBL4641894,,CHEMBL4641894,6.02,0,http://www.openphacts.org/units/Nanomolar,3476414,=,1,1,=,,IC50,nM,,963.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,963.0
,,20652048,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c(SCCN2CCN(CCSc3nc4ccccc4c(=O)[nH]3)CC2)nc2ccccc12,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '15.01', 'le': '0.30', 'lle': '4.76', 'sei': '7.58'}",CHEMBL4638701,,CHEMBL4638701,7.42,0,http://www.openphacts.org/units/Nanomolar,3476415,=,1,1,=,,IC50,nM,,37.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,37.8
,,20652049,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1NC2(CCN(C(=O)CCSc3nc4ccccc4c(=O)[nH]3)CC2)Nc2cc3ccccc3cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613304,ACS Med Chem Lett,2020,,CHEMBL4641161,,CHEMBL4641161,,0,http://www.openphacts.org/units/Nanomolar,3476416,=,1,1,=,,IC50,nM,,132000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,132000.0
,,20652050,[],CHEMBL4616004,Inhibition of full length human N-terminal His-tagged PARP2 expressed in baculovirus infected Sf9 cells using histone H3.3 as substrate incubated for 20 mins followed by [32P[-NAD+ addition and further incubated for 1 hr by liquid scintillation counter,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,,,CHEMBL4613304,ACS Med Chem Lett,2020,"{'bei': '26.52', 'le': '0.49', 'lle': '5.65', 'sei': '12.01'}",CHEMBL372303,PJ34,CHEMBL372303,7.83,0,http://www.openphacts.org/units/Nanomolar,3476417,=,1,1,=,,IC50,nM,,14.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,14.7
,,20662582,[],CHEMBL4618657,Inhibition of ARTD2 (unknown origin) measured after 30 mins in presence of NAD+ by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(-c2nnc([C@H]3C[C@H](NC(=O)c4ccccn4)C3)n2-c2ccccc2F)nc1,,,CHEMBL4616677,J Med Chem,2020,,CHEMBL4633637,,CHEMBL4633637,,0,http://www.openphacts.org/units/Nanomolar,3478964,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,20662583,[],CHEMBL4618657,Inhibition of ARTD2 (unknown origin) measured after 30 mins in presence of NAD+ by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2c(c1)[nH]c(=O)n2[C@H]1C[C@H](c2nnc(-c3ccncn3)n2-c2ccccc2Cl)C1,,,CHEMBL4616677,J Med Chem,2020,,CHEMBL4095003,,CHEMBL4095003,,0,http://www.openphacts.org/units/Nanomolar,3478980,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432613,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Nc1cc(F)cc2c(=O)[nH]c(CCCN3CCN(c4ccc(F)cc4)CC3)cc12,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4781887,,CHEMBL4781887,8.02,0,http://www.openphacts.org/units/Nanomolar,3515132,=,1,1,=,,IC50,nM,,9.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432614,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN(CCCc3cc4c(N)cc(F)cc4c(=O)[nH]3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4748390,,CHEMBL4748390,8.41,0,http://www.openphacts.org/units/Nanomolar,3515133,=,1,1,=,,IC50,nM,,3.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432615,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN(CCCc3cc4c(N)cccc4c(=O)[nH]3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4787850,,CHEMBL4787850,8.14,0,http://www.openphacts.org/units/Nanomolar,3515134,=,1,1,=,,IC50,nM,,7.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432616,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)c1ccc(N2CCN(CCCc3cc4c(N)cc(F)cc4c(=O)[nH]3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4800042,,CHEMBL4800042,8.34,0,http://www.openphacts.org/units/Nanomolar,3515135,=,1,1,=,,IC50,nM,,4.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432617,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)c1ccc(N2CCN(CCCc3cc4c(N)cc(F)cc4c(=O)[nH]3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4786854,,CHEMBL4786854,7.97,0,http://www.openphacts.org/units/Nanomolar,3515136,=,1,1,=,,IC50,nM,,10.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432618,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5c(N)cc(F)cc5c(=O)[nH]4)CC3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4755076,,CHEMBL4755076,8.89,0,http://www.openphacts.org/units/Nanomolar,3515137,=,1,1,=,,IC50,nM,,1.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432619,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@@H]3C=C(c4cc5c(N)cc(F)cc5c(=O)[nH]4)CC3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4777158,,CHEMBL4777158,6.70,0,http://www.openphacts.org/units/Nanomolar,3515138,=,1,1,=,,IC50,nM,,200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,200.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432620,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5c(N)cccc5c(=O)[nH]4)CC3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4747106,,CHEMBL4747106,8.82,0,http://www.openphacts.org/units/Nanomolar,3515139,=,1,1,=,,IC50,nM,,1.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432621,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@@H]3C=C(c4cc5c(N)cccc5c(=O)[nH]4)CC3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4741921,,CHEMBL4741921,6.78,0,http://www.openphacts.org/units/Nanomolar,3515140,=,1,1,=,,IC50,nM,,167.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,167.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432622,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5c(N)cc(F)cc5c(=O)[nH]4)CC3)CC2)c(F)c1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4753410,,CHEMBL4753410,8.59,0,http://www.openphacts.org/units/Nanomolar,3515141,=,1,1,=,,IC50,nM,,2.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432623,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@@H]3C=C(c4cc5c(N)cc(F)cc5c(=O)[nH]4)CC3)CC2)c(F)c1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4776507,,CHEMBL4776507,7.24,0,http://www.openphacts.org/units/Nanomolar,3515142,=,1,1,=,,IC50,nM,,58.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,58.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432624,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5ncc(F)cc5c(=O)[nH]4)CC3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4789581,,CHEMBL4789581,7.57,0,http://www.openphacts.org/units/Nanomolar,3515143,=,1,1,=,,IC50,nM,,26.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,26.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432625,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5ncccc5c(=O)[nH]4)CC3)CC2)nc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4746309,,CHEMBL4746309,7.78,0,http://www.openphacts.org/units/Nanomolar,3515144,=,1,1,=,,IC50,nM,,16.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,16.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432626,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5ncccc5c(=O)[nH]4)CC3)CC2)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL4776820,,CHEMBL4776820,8.09,0,http://www.openphacts.org/units/Nanomolar,3515145,=,1,1,=,,IC50,nM,,8.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,8.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432627,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL3137320,TALAZOPARIB,CHEMBL3137320,9.22,0,http://www.openphacts.org/units/Nanomolar,3515146,=,1,1,=,,IC50,nM,,0.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432628,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL521686,OLAPARIB,CHEMBL521686,9.30,1,http://www.openphacts.org/units/Nanomolar,3515147,=,1,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22432629,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4676663,Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells using histone mixture (H2A and H2B) and biotinylated NAD+ as substrate in presence of activated DNA incubated for 60 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL4673259,Bioorg Med Chem,2020,,CHEMBL1173055,RUCAPARIB,CHEMBL1173055,9.10,0,http://www.openphacts.org/units/Nanomolar,3515148,=,1,1,=,,IC50,nM,,0.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439299,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2ccc3c(Cl)cc(C(N)=O)n3n2)cc1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '18.71', 'le': '0.37', 'lle': '3.33', 'sei': '9.67'}",CHEMBL4754497,,CHEMBL4754497,6.15,0,http://www.openphacts.org/units/Nanomolar,3516593,=,1,1,=,,IC50,nM,,704.62,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,704.62
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439300,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2ccc3c(Cl)cc(C(N)=O)n3n2)cc1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '18.91', 'le': '0.37', 'lle': '3.48', 'sei': '8.22'}",CHEMBL4778202,,CHEMBL4778202,5.95,0,http://www.openphacts.org/units/Nanomolar,3516594,=,1,1,=,,IC50,nM,,1118.31,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1118.31
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439301,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)Cc1ccc(-c2ccc3c(Cl)cc(C(N)=O)n3n2)cc1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '15.85', 'le': '0.31', 'lle': '2.06', 'sei': '8.89'}",CHEMBL4745626,,CHEMBL4745626,5.66,0,http://www.openphacts.org/units/Nanomolar,3516595,=,1,1,=,,IC50,nM,,2202.99,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2202.99
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439302,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(CN4CCCC4)cc3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '16.77', 'le': '0.33', 'lle': '2.60', 'sei': '9.35'}",CHEMBL4756008,,CHEMBL4756008,5.95,0,http://www.openphacts.org/units/Nanomolar,3516596,=,1,1,=,,IC50,nM,,1118.78,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1118.78
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439303,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(Cc2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)cc2)CC1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '14.44', 'le': '0.28', 'lle': '2.67', 'sei': '8.90'}",CHEMBL4746131,,CHEMBL4746131,5.95,0,http://www.openphacts.org/units/Nanomolar,3516597,=,1,1,=,,IC50,nM,,1126.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1126.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439304,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(CN4CCNCC4)cc3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '15.23', 'le': '0.30', 'lle': '3.47', 'sei': '7.45'}",CHEMBL4779263,,CHEMBL4779263,5.63,0,http://www.openphacts.org/units/Nanomolar,3516598,=,1,1,=,,IC50,nM,,2325.82,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2325.82
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439305,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(CN4CCN(C5CC5)CC4)cc3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '14.64', 'le': '0.28', 'lle': '2.97', 'sei': '8.97'}",CHEMBL4760246,,CHEMBL4760246,6.00,0,http://www.openphacts.org/units/Nanomolar,3516599,=,1,1,=,,IC50,nM,,997.49,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,997.49
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439306,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCN(Cc2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)cc2)CC1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '14.18', 'le': '0.28', 'lle': '2.56', 'sei': '8.73'}",CHEMBL4746094,,CHEMBL4746094,5.84,0,http://www.openphacts.org/units/Nanomolar,3516600,=,1,1,=,,IC50,nM,,1444.72,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1444.72
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439307,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(CN4CCN(c5ccc(C(F)(F)F)cc5)CC4)cc3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '12.36', 'le': '0.24', 'lle': '1.26', 'sei': '9.50'}",CHEMBL4761828,,CHEMBL4761828,6.35,0,http://www.openphacts.org/units/Nanomolar,3516601,=,1,1,=,,IC50,nM,,445.06,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,445.06
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439308,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(C(=O)c2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)cc2)C1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '14.46', 'le': '0.28', 'lle': '3.16', 'sei': '6.41'}",CHEMBL4750148,,CHEMBL4750148,5.77,0,http://www.openphacts.org/units/Nanomolar,3516602,=,1,1,=,,IC50,nM,,1714.13,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1714.13
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439309,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(C(=O)c2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)cc2)CC1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '12.95', 'le': '0.25', 'lle': '2.35', 'sei': '5.94'}",CHEMBL4786867,,CHEMBL4786867,5.35,0,http://www.openphacts.org/units/Nanomolar,3516603,=,1,1,=,,IC50,nM,,4508.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4508.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439310,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(C(=O)c2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)c(F)c2)C1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '13.91', 'le': '0.27', 'lle': '3.05', 'sei': '6.45'}",CHEMBL4759867,,CHEMBL4759867,5.80,0,http://www.openphacts.org/units/Nanomolar,3516604,=,1,1,=,,IC50,nM,,1594.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1594.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439311,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(C(=O)c2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)c(F)c2)CC1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '13.42', 'le': '0.26', 'lle': '2.64', 'sei': '6.43'}",CHEMBL4785360,,CHEMBL4785360,5.78,0,http://www.openphacts.org/units/Nanomolar,3516605,=,1,1,=,,IC50,nM,,1642.75,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1642.75
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439312,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '15.63', 'le': '0.30', 'lle': '4.20', 'sei': '6.47'}",CHEMBL4785312,,CHEMBL4785312,6.00,0,http://www.openphacts.org/units/Nanomolar,3516606,=,1,1,=,,IC50,nM,,1005.03,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1005.03
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439313,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(C(=O)N4CCN(C(=O)C5CC5)CC4)cc3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '13.18', 'le': '0.25', 'lle': '3.51', 'sei': '5.90'}",CHEMBL4758319,,CHEMBL4758319,5.96,0,http://www.openphacts.org/units/Nanomolar,3516607,=,1,1,=,,IC50,nM,,1104.91,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1104.91
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439314,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC(=O)N1CCN(C(=O)c2ccc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)cc2)CC1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '12.81', 'le': '0.25', 'lle': '2.92', 'sei': '5.94'}",CHEMBL4760782,,CHEMBL4760782,6.00,0,http://www.openphacts.org/units/Nanomolar,3516608,=,1,1,=,,IC50,nM,,1010.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1010.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439315,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(C(=O)N4CCN(C(=O)C5CC5)CC4)cc3F)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '11.99', 'le': '0.23', 'lle': '3.04', 'sei': '5.58'}",CHEMBL4752536,,CHEMBL4752536,5.63,0,http://www.openphacts.org/units/Nanomolar,3516609,=,1,1,=,,IC50,nM,,2324.48,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2324.48
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439316,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2ccc(-c3ccc(F)c(C(=O)N4CCN(C(=O)C5CC5)CC4)c3)nn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '12.16', 'le': '0.24', 'lle': '3.13', 'sei': '5.66'}",CHEMBL4751128,,CHEMBL4751128,5.72,0,http://www.openphacts.org/units/Nanomolar,3516610,=,1,1,=,,IC50,nM,,1923.75,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1923.75
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439317,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2cc(-c3cc4c(s3)CCNC4)cnn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '20.07', 'le': '0.41', 'lle': '4.22', 'sei': '9.22'}",CHEMBL4758651,,CHEMBL4758651,6.68,0,http://www.openphacts.org/units/Nanomolar,3516611,=,1,1,=,,IC50,nM,,209.38,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,209.38
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439318,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2cc(-c3cc4c(s3)CNCC4)cnn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '21.56', 'le': '0.45', 'lle': '4.72', 'sei': '9.91'}",CHEMBL4744702,,CHEMBL4744702,7.17,0,http://www.openphacts.org/units/Nanomolar,3516612,=,1,1,=,,IC50,nM,,66.81,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,66.81
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439319,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2cc(-c3cc4c(s3)CCNC4C3CC3)cnn12,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '15.88', 'le': '0.32', 'lle': '2.51', 'sei': '8.18'}",CHEMBL4741306,,CHEMBL4741306,5.92,0,http://www.openphacts.org/units/Nanomolar,3516613,=,1,1,=,,IC50,nM,,1198.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1198.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439320,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC1NCCc2sc(-c3cnn4c(C(N)=O)cc(Cl)c4c3)cc21,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '14.30', 'le': '0.29', 'lle': '1.51', 'sei': '7.68'}",CHEMBL4758514,,CHEMBL4758514,5.56,0,http://www.openphacts.org/units/Nanomolar,3516614,=,1,1,=,,IC50,nM,,2756.47,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2756.47
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439321,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C1NCCc2sc(-c3cnn4c(C(N)=O)cc(Cl)c4c3)cc21,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '15.66', 'le': '0.32', 'lle': '2.04', 'sei': '8.41'}",CHEMBL4762579,,CHEMBL4762579,6.09,0,http://www.openphacts.org/units/Nanomolar,3516615,=,1,1,=,,IC50,nM,,811.39,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,811.39
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439322,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC1NCCc2cc(-c3cnn4c(C(N)=O)cc(Cl)c4c3)sc21,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '16.20', 'le': '0.33', 'lle': '2.25', 'sei': '8.70'}",CHEMBL4741696,,CHEMBL4741696,6.30,0,http://www.openphacts.org/units/Nanomolar,3516616,=,1,1,=,,IC50,nM,,501.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,501.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439323,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C1NCCc2cc(-c3cnn4c(C(N)=O)cc(Cl)c4c3)sc21,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '15.43', 'le': '0.32', 'lle': '1.95', 'sei': '8.29'}",CHEMBL4740356,,CHEMBL4740356,6.00,0,http://www.openphacts.org/units/Nanomolar,3516617,=,1,1,=,,IC50,nM,,999.67,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,999.67
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439324,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCc2sc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)cc2C1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '18.57', 'le': '0.38', 'lle': '3.64', 'sei': '10.12'}",CHEMBL4756907,,CHEMBL4756907,6.44,0,http://www.openphacts.org/units/Nanomolar,3516618,=,1,1,=,,IC50,nM,,363.35,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,363.35
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439325,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCc2cc(-c3ccc4c(Cl)cc(C(N)=O)n4n3)sc2C1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '18.50', 'le': '0.38', 'lle': '3.62', 'sei': '10.09'}",CHEMBL4744208,,CHEMBL4744208,6.42,0,http://www.openphacts.org/units/Nanomolar,3516619,=,1,1,=,,IC50,nM,,382.13,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,382.13
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22439326,[],CHEMBL4678141,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4673325,Bioorg Med Chem Lett,2021,"{'bei': '20.09', 'le': '0.37', 'lle': '6.38', 'sei': '10.11'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.73,0,http://www.openphacts.org/units/Nanomolar,3516620,=,1,1,=,,IC50,nM,,1.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.87
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22440996,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '21.63', 'le': '0.40', 'lle': '7.05', 'sei': '10.88'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.40,1,http://www.openphacts.org/units/Nanomolar,3516958,=,1,1,=,,IC50,nM,,0.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22440997,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '30.32', 'le': '0.56', 'lle': '6.97', 'sei': '14.95'}",CHEMBL4112930,PAMIPARIB,CHEMBL4112930,9.05,0,http://www.openphacts.org/units/Nanomolar,3516956,=,1,1,=,,IC50,nM,,0.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.9
,Not Determined,22440998,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)[C@@H]3CCCN3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4749094,,CHEMBL4749094,,0,,3516954,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22440999,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)C(=O)N1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3905040,,CHEMBL3905040,,0,,3516953,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441000,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(N)C(=O)N1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '28.91', 'le': '0.53', 'lle': '8.31', 'sei': '8.69'}",CHEMBL3970252,,CHEMBL3970252,9.00,1,http://www.openphacts.org/units/Nanomolar,3516952,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
,Not Determined,22441001,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC1(C(=O)N2CC3=NNC(=O)c4cc(F)cc5[nH]c(c3c45)C2)CC1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4748572,,CHEMBL4748572,,0,,3516951,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441002,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(S(=O)(=O)C3CC3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4749300,,CHEMBL4749300,,0,,3516950,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441003,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)N1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3906623,,CHEMBL3906623,,0,,3516949,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441004,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C(C(=O)N2CC3=NNC(=O)c4cc(F)cc5[nH]c(c3c45)C2)C1(C)C,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4788782,,CHEMBL4788782,,0,,3516948,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441005,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)C3(O)CC3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4784831,,CHEMBL4784831,,0,,3516947,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441006,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)C3(c4ccccc4)CC3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4753364,,CHEMBL4753364,,0,,3516946,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441007,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C(=O)N2CC3=NNC(=O)c4cc(F)cc5[nH]c(c3c45)C2)CC1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4784468,,CHEMBL4784468,,0,,3516945,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441008,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)C3CC3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3983859,,CHEMBL3983859,,0,,3516944,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441009,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CN(C(=O)C3CC3)Cc3[nH]c4cccc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3922789,,CHEMBL3922789,,0,,3516943,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441010,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCN1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3905389,,CHEMBL3905389,,0,,3516942,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441011,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3931972,,CHEMBL3931972,,0,,3516941,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441012,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '33.90', 'le': '0.62', 'lle': '7.26', 'sei': '15.04'}",CHEMBL3907535,,CHEMBL3907535,9.10,1,http://www.openphacts.org/units/Nanomolar,3516940,=,1,1,=,,IC50,nM,,0.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.8
,Not Determined,22441013,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3917078,,CHEMBL3917078,,0,,3516939,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441014,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3908123,,CHEMBL3908123,,0,,3516938,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441015,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3908092,,CHEMBL3908092,,0,,3516937,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441016,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CNCc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3931542,,CHEMBL3931542,,0,,3516936,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441017,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CNCc3[nH]c4cccc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3970120,,CHEMBL3970120,,0,,3516935,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441018,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNCCn1c2c3c4c(cccc41)C(=O)NN=C3CC(C)(C)C2,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4776661,,CHEMBL4776661,,0,,3516934,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441019,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CC2CO2)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '24.82', 'le': '0.46', 'lle': '5.22', 'sei': '13.03'}",CHEMBL3940569,,CHEMBL3940569,7.68,1,http://www.openphacts.org/units/Nanomolar,3516933,=,1,1,=,,IC50,nM,,21.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,21.0
,Not Determined,22441020,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CCO)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3910594,,CHEMBL3910594,,0,,3516932,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441021,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CCN2CCOCC2)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3952984,,CHEMBL3952984,,0,,3516931,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441022,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CCN2CCCCC2)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '26.61', 'le': '0.49', 'lle': '6.15', 'sei': '19.54'}",CHEMBL3984980,,CHEMBL3984980,9.70,1,http://www.openphacts.org/units/Nanomolar,3516930,=,1,1,=,,IC50,nM,,0.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.2
,Not Determined,22441023,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CCN2CCCC2)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3947623,,CHEMBL3947623,,0,,3516929,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441024,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4c3c2c(n4CCN(Cc2ccccc2)Cc2ccccc2)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3976904,,CHEMBL3976904,,0,,3516928,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441025,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1c2c3c4c(cccc41)C(=O)NN=C3CC(C)(C)C2,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '27.02', 'le': '0.50', 'lle': '6.12', 'sei': '19.19'}",CHEMBL3926240,,CHEMBL3926240,9.52,1,http://www.openphacts.org/units/Nanomolar,3516927,=,1,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441026,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1c2c3c4c(cc(F)cc41)C(=O)NN=C3CC(C)(C)C2,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '27.81', 'le': '0.52', 'lle': '6.76', 'sei': '19.19'}",CHEMBL3929889,,CHEMBL3929889,9.52,0,http://www.openphacts.org/units/Nanomolar,3516926,=,1,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441027,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1c2c3c4c(cccc41)C(=O)NN=C3CC(C)(C)C2,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '29.35', 'le': '0.54', 'lle': '6.90', 'sei': '19.19'}",CHEMBL3975917,,CHEMBL3975917,9.52,0,http://www.openphacts.org/units/Nanomolar,3516925,=,1,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
,Not Determined,22441028,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3c2c2c1cccc2n3CCN1CCOCC1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3894393,,CHEMBL3894393,,0,,3516924,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441029,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3c2c2c1cccc2n3CCN1CCCCC1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3969049,,CHEMBL3969049,,0,,3516923,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441030,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3c2c2c1cccc2n3CCN1CCCC1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3898162,,CHEMBL3898162,,0,,3516922,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441031,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3c2c2c1cccc2n3CCN(Cc1ccccc1)Cc1ccccc1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3945909,,CHEMBL3945909,,0,,3516921,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441032,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1c2c3c4c(cccc41)C(=O)NN=C3CCC2,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3983247,,CHEMBL3983247,,0,,3516920,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441033,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCn1c2c3c4c(cccc41)C(=O)NN=C3CCC2,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3954603,,CHEMBL3954603,,0,,3516919,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441034,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2c3c4c(cccc41)C(=O)NN=C3CC(C)(C)C2,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3906567,,CHEMBL3906567,,0,,3516918,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441035,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2c3c4c(cccc41)C(=O)NN=C3CCC2,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3895581,,CHEMBL3895581,,0,,3516917,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441036,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1O,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3901638,,CHEMBL3901638,,0,,3516916,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441037,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1=O,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3961684,,CHEMBL3961684,,0,,3516915,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441038,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C(=O)C2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1=O,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL4778454,,CHEMBL4778454,,0,,3516914,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441039,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCCc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '35.58', 'le': '0.66', 'lle': '6.67', 'sei': '15.99'}",CHEMBL3962648,,CHEMBL3962648,9.15,0,http://www.openphacts.org/units/Nanomolar,3516913,=,1,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441040,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCCc3[nH]c4cccc1c4c32,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '37.44', 'le': '0.68', 'lle': '6.62', 'sei': '15.65'}",CHEMBL3969742,,CHEMBL3969742,8.96,1,http://www.openphacts.org/units/Nanomolar,3516912,=,1,1,=,,IC50,nM,,1.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.1
,Not Determined,22441041,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(C2CC3=NNC(=O)c4cc(F)cc5[nH]c(c3c45)C2)cc1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3916191,,CHEMBL3916191,,0,,3516911,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441042,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CC(c3ccccc3)Cc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '27.38', 'le': '0.50', 'lle': '5.26', 'sei': '15.27'}",CHEMBL3900548,,CHEMBL3900548,8.74,0,http://www.openphacts.org/units/Nanomolar,3516910,=,1,1,=,,IC50,nM,,1.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441043,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '32.09', 'le': '0.60', 'lle': '6.18', 'sei': '15.99'}",CHEMBL3925115,,CHEMBL3925115,9.15,0,http://www.openphacts.org/units/Nanomolar,3516909,=,1,1,=,,IC50,nM,,0.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.7
,Not Determined,22441044,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCc2[nH]c3cc(F)cc4c3c2C1=NNC4=O,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3914932,,CHEMBL3914932,,0,,3516908,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441045,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3c(F)ccc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3901034,,CHEMBL3901034,,0,,3516907,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,Not Determined,22441046,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3911687,,CHEMBL3911687,,0,,3516906,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441047,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC2=NNC(=O)c3cccc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '36.41', 'le': '0.66', 'lle': '6.63', 'sei': '16.11'}",CHEMBL3972156,,CHEMBL3972156,9.22,1,http://www.openphacts.org/units/Nanomolar,3516905,=,1,1,=,,IC50,nM,,0.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441048,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC2=NNC(=O)c3cc(F)cc4[nH]c(c2c34)C1,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '34.54', 'le': '0.64', 'lle': '6.55', 'sei': '15.52'}",CHEMBL3910080,,CHEMBL3910080,8.89,0,http://www.openphacts.org/units/Nanomolar,3516904,=,1,1,=,,IC50,nM,,1.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.3
,Not Determined,22441049,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3[nH]c4c(F)ccc1c4c32,,,CHEMBL4673340,J Med Chem,2020,,CHEMBL3983342,,CHEMBL3983342,,0,,3516903,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441050,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3[nH]c4cc(F)cc1c4c32,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '37.40', 'le': '0.69', 'lle': '7.01', 'sei': '15.89'}",CHEMBL3929705,,CHEMBL3929705,9.10,1,http://www.openphacts.org/units/Nanomolar,3516902,=,1,1,=,,IC50,nM,,0.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22441051,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4678540,Inhibition of PARP-2 (unknown origin) pre-incubated for 30 mins before addition of activated DNA and NAD by chemiluminescent assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NN=C2CCCc3[nH]c4cccc1c4c32,,,CHEMBL4673340,J Med Chem,2020,"{'bei': '38.72', 'le': '0.70', 'lle': '6.77', 'sei': '15.23'}",CHEMBL3891329,,CHEMBL3891329,8.72,1,http://www.openphacts.org/units/Nanomolar,3516901,=,1,1,=,,IC50,nM,,1.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22915915,[],CHEMBL4735510,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cc(C(=O)N3CCN(c4nc(-c5cnc(NC(=O)CN6CCOCC6)cc5C(F)(F)F)nc(N5CCOCC5)n4)CC3)oc12,,,CHEMBL4732120,Eur J Med Chem,2021,"{'bei': '11.33', 'le': '0.22', 'lle': '6.34', 'sei': '4.43'}",CHEMBL4761383,,CHEMBL4761383,8.21,0,http://www.openphacts.org/units/Nanomolar,3557912,=,1,1,=,,IC50,nM,,6.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.2
,,22954465,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4767401,Inhibition of human recombinant N-terminal GST-tagged PARP-2 expressed in Baculovirus infected Sf9 cells assessed as reduction in NAD+-dependent ADP ribosylation using histone mixture (H2A and H2B) as substrate in presence of activated DNA incubated for 30 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(/C=N/NC(N)=S)c(Br)c(Br)c1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4765243,J Med Chem,2019,,CHEMBL4797458,,CHEMBL4797458,,0,http://www.openphacts.org/units/Nanomolar,3564444,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1000.0
,,22954466,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4767401,Inhibition of human recombinant N-terminal GST-tagged PARP-2 expressed in Baculovirus infected Sf9 cells assessed as reduction in NAD+-dependent ADP ribosylation using histone mixture (H2A and H2B) as substrate in presence of activated DNA incubated for 30 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(/C=N/NC(N)=S)c(Br)c(Br)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4765243,J Med Chem,2019,,CHEMBL4799284,,CHEMBL4799284,,0,http://www.openphacts.org/units/Nanomolar,3564445,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1000.0
,,22954467,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4767401,Inhibition of human recombinant N-terminal GST-tagged PARP-2 expressed in Baculovirus infected Sf9 cells assessed as reduction in NAD+-dependent ADP ribosylation using histone mixture (H2A and H2B) as substrate in presence of activated DNA incubated for 30 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(/C=N/NC(=S)NCCCN2CCOCC2)c(Br)c(Br)c1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4765243,J Med Chem,2019,,CHEMBL4786454,,CHEMBL4786454,,0,http://www.openphacts.org/units/Nanomolar,3564429,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1000.0
,,22954468,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4767401,Inhibition of human recombinant N-terminal GST-tagged PARP-2 expressed in Baculovirus infected Sf9 cells assessed as reduction in NAD+-dependent ADP ribosylation using histone mixture (H2A and H2B) as substrate in presence of activated DNA incubated for 30 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1ccc(NC(=S)N/N=C/c2cc(OC)c(OC)c(Br)c2Br)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4765243,J Med Chem,2019,,CHEMBL4797518,,CHEMBL4797518,,0,http://www.openphacts.org/units/Nanomolar,3564433,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1000.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22954469,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4767401,Inhibition of human recombinant N-terminal GST-tagged PARP-2 expressed in Baculovirus infected Sf9 cells assessed as reduction in NAD+-dependent ADP ribosylation using histone mixture (H2A and H2B) as substrate in presence of activated DNA incubated for 30 mins by chemiluminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4765243,J Med Chem,2019,,CHEMBL521686,OLAPARIB,CHEMBL521686,,0,http://www.openphacts.org/units/Nanomolar,3564412,<,1,1,<,,IC50,nM,,3910.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.91
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23183462,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4817105,Inhibition of PARP2 (unknown origin) using biotin-NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(CN2CCN(C(=O)c3cc4cccc(C(N)=O)c4o3)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,,,CHEMBL4813994,Eur J Med Chem,2021,"{'bei': '14.72', 'le': '0.28', 'lle': '6.36', 'sei': '5.32'}",CHEMBL4865059,,CHEMBL4865059,9.04,0,http://www.openphacts.org/units/Nanomolar,3604843,=,1,1,=,,IC50,nM,,0.92,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.92
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23183463,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4817105,Inhibition of PARP2 (unknown origin) using biotin-NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5s4)CC3)oc12,,,CHEMBL4813994,Eur J Med Chem,2021,"{'bei': '14.88', 'le': '0.28', 'lle': '6.55', 'sei': '5.25'}",CHEMBL4871210,,CHEMBL4871210,8.92,0,http://www.openphacts.org/units/Nanomolar,3604844,=,1,1,=,,IC50,nM,,1.19,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.19
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23183464,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4817105,Inhibition of PARP2 (unknown origin) using biotin-NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cc(C(=O)N3CCN(Cc4cc5nc(-c6cnc(N)nc6)nc(N6CCOCC6)c5o4)CC3)oc12,,,CHEMBL4813994,Eur J Med Chem,2021,"{'bei': '15.20', 'le': '0.28', 'lle': '6.97', 'sei': '4.85'}",CHEMBL4868231,,CHEMBL4868231,8.87,0,http://www.openphacts.org/units/Nanomolar,3604845,=,1,1,=,,IC50,nM,,1.34,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.34
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23183465,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL4817105,Inhibition of PARP2 (unknown origin) using biotin-NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(CN2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,,,CHEMBL4813994,Eur J Med Chem,2021,"{'bei': '12.80', 'le': '0.24', 'lle': '5.25', 'sei': '5.68'}",CHEMBL4858564,,CHEMBL4858564,9.05,0,http://www.openphacts.org/units/Nanomolar,3604858,=,1,1,=,,IC50,nM,,0.89,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.89
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310791,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.26', 'le': '0.17', 'lle': '-0.14', 'sei': '2.74'}",CHEMBL63354,AMENTOFLAVONE,CHEMBL63354,4.99,0,http://www.openphacts.org/units/Nanomolar,3627880,=,1,1,=,,IC50,nM,,10300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310792,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2cccc(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.55', 'le': '0.17', 'lle': '-0.44', 'sei': '3.09'}",CHEMBL4864275,,CHEMBL4864275,4.99,0,http://www.openphacts.org/units/Nanomolar,3627881,=,1,1,=,,IC50,nM,,10300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310793,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2cccc(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '8.41', 'le': '0.15', 'lle': '-0.60', 'sei': '2.49'}",CHEMBL4847220,,CHEMBL4847220,4.53,0,http://www.openphacts.org/units/Nanomolar,3627882,=,1,1,=,,IC50,nM,,29500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,29.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310794,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2cccc(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(C(F)(F)F)cc5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '7.97', 'le': '0.15', 'lle': '-2.16', 'sei': '3.24'}",CHEMBL4877975,,CHEMBL4877975,4.58,0,http://www.openphacts.org/units/Nanomolar,3627883,=,1,1,=,,IC50,nM,,26400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,26.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310795,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2cccc(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(F)cc5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.67', 'le': '0.18', 'lle': '-0.79', 'sei': '3.59'}",CHEMBL4864125,,CHEMBL4864125,5.07,0,http://www.openphacts.org/units/Nanomolar,3627884,=,1,1,=,,IC50,nM,,8500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,8.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310796,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cccc(-c5cc(=O)c6c(O)cc(O)cc6o5)c4)c3o2)cc1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.42', 'le': '0.17', 'lle': '-1.13', 'sei': '3.47'}",CHEMBL4868946,,CHEMBL4868946,4.90,0,http://www.openphacts.org/units/Nanomolar,3627885,=,1,1,=,,IC50,nM,,12500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,12.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310797,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cccc(-c5cc(=O)c6c(O)cc(O)cc6o5)c4)c3o2)cc1C,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.16', 'le': '0.17', 'lle': '-1.44', 'sei': '3.46'}",CHEMBL4860646,,CHEMBL4860646,4.90,0,http://www.openphacts.org/units/Nanomolar,3627886,=,1,1,=,,IC50,nM,,12700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,12.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310798,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2cccc(-c3c(O)cc(O)c4c(=O)cc(-c5cccs5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.67', 'le': '0.18', 'lle': '-0.83', 'sei': '3.51'}",CHEMBL4850879,,CHEMBL4850879,4.96,0,http://www.openphacts.org/units/Nanomolar,3627887,=,1,1,=,,IC50,nM,,11100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,11.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310799,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2cccc(-c3c(O)cc(O)c4c(=O)cc(-c5ccco5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.73', 'le': '0.18', 'lle': '-0.49', 'sei': '3.13'}",CHEMBL4872638,,CHEMBL4872638,4.83,0,http://www.openphacts.org/units/Nanomolar,3627888,=,1,1,=,,IC50,nM,,14700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,14.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310800,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '20.53', 'le': '0.38', 'lle': '6.57', 'sei': '10.33'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.92,0,http://www.openphacts.org/units/Nanomolar,3627889,=,1,1,=,,IC50,nM,,1.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.0012
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310801,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C1CC1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.84', 'le': '0.24', 'lle': '2.97', 'sei': '4.89'}",CHEMBL4868456,,CHEMBL4868456,5.60,0,http://www.openphacts.org/units/Nanomolar,3627890,=,1,1,=,,IC50,nM,,2500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310802,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C1CCC1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.40', 'le': '0.23', 'lle': '2.57', 'sei': '4.88'}",CHEMBL4869388,,CHEMBL4869388,5.58,0,http://www.openphacts.org/units/Nanomolar,3627891,=,1,1,=,,IC50,nM,,2600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310803,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C1CCCCC1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.78', 'le': '0.22', 'lle': '1.84', 'sei': '4.93'}",CHEMBL4866335,,CHEMBL4866335,5.64,0,http://www.openphacts.org/units/Nanomolar,3627892,=,1,1,=,,IC50,nM,,2300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310804,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(=O)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.95', 'le': '0.24', 'lle': '2.80', 'sei': '4.96'}",CHEMBL4870649,,CHEMBL4870649,5.68,0,http://www.openphacts.org/units/Nanomolar,3627893,=,1,1,=,,IC50,nM,,2100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310805,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '13.46', 'le': '0.25', 'lle': '3.28', 'sei': '4.83'}",CHEMBL4863798,,CHEMBL4863798,5.52,0,http://www.openphacts.org/units/Nanomolar,3627894,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310806,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccccc1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.72', 'le': '0.22', 'lle': '2.01', 'sei': '4.84'}",CHEMBL4851728,,CHEMBL4851728,5.54,0,http://www.openphacts.org/units/Nanomolar,3627895,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310807,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)N2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)cc1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.15', 'le': '0.21', 'lle': '2.06', 'sei': '4.53'}",CHEMBL4854910,,CHEMBL4854910,5.60,0,http://www.openphacts.org/units/Nanomolar,3627896,=,1,1,=,,IC50,nM,,2500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310808,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cccc(C(F)(F)F)c1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.25', 'le': '0.19', 'lle': '0.99', 'sei': '4.84'}",CHEMBL4847485,,CHEMBL4847485,5.54,0,http://www.openphacts.org/units/Nanomolar,3627897,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310809,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccc(Cl)cc1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.89', 'le': '0.21', 'lle': '1.33', 'sei': '4.83'}",CHEMBL4852964,,CHEMBL4852964,5.52,0,http://www.openphacts.org/units/Nanomolar,3627898,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310810,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cccnc1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.30', 'le': '0.23', 'lle': '2.89', 'sei': '4.57'}",CHEMBL4848834,,CHEMBL4848834,5.82,0,http://www.openphacts.org/units/Nanomolar,3627899,=,1,1,=,,IC50,nM,,1500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310811,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccncc1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.36', 'le': '0.23', 'lle': '2.92', 'sei': '4.60'}",CHEMBL4867555,,CHEMBL4867555,5.85,0,http://www.openphacts.org/units/Nanomolar,3627900,=,1,1,=,,IC50,nM,,1400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310812,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccccn1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.43', 'le': '0.23', 'lle': '2.96', 'sei': '4.62'}",CHEMBL4849380,,CHEMBL4849380,5.89,0,http://www.openphacts.org/units/Nanomolar,3627901,=,1,1,=,,IC50,nM,,1300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310813,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cccs1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.45', 'le': '0.24', 'lle': '2.36', 'sei': '5.21'}",CHEMBL4847227,,CHEMBL4847227,5.96,0,http://www.openphacts.org/units/Nanomolar,3627902,=,1,1,=,,IC50,nM,,1100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310814,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1ccco1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '13.18', 'le': '0.24', 'lle': '2.97', 'sei': '4.78'}",CHEMBL4853039,,CHEMBL4853039,6.10,0,http://www.openphacts.org/units/Nanomolar,3627903,=,1,1,=,,IC50,nM,,800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310815,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(OCc1ccccc1)N1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.30', 'le': '0.21', 'lle': '1.65', 'sei': '4.59'}",CHEMBL4850517,,CHEMBL4850517,5.68,0,http://www.openphacts.org/units/Nanomolar,3627904,=,1,1,=,,IC50,nM,,2100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310816,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)cc(COC(=O)N2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)c1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.74', 'le': '0.20', 'lle': '1.05', 'sei': '4.61'}",CHEMBL4853266,,CHEMBL4853266,5.70,0,http://www.openphacts.org/units/Nanomolar,3627905,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310817,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(CC4CC4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '13.11', 'le': '0.24', 'lle': '2.44', 'sei': '5.69'}",CHEMBL4861814,,CHEMBL4861814,5.54,0,http://www.openphacts.org/units/Nanomolar,3627906,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310818,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(CC4CCCCC4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.83', 'le': '0.22', 'lle': '1.22', 'sei': '5.64'}",CHEMBL4864330,,CHEMBL4864330,5.50,0,http://www.openphacts.org/units/Nanomolar,3627907,=,1,1,=,,IC50,nM,,3200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310819,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCN1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.39', 'le': '0.23', 'lle': '1.69', 'sei': '5.58'}",CHEMBL4877994,,CHEMBL4877994,5.43,0,http://www.openphacts.org/units/Nanomolar,3627908,=,1,1,=,,IC50,nM,,3700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310820,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CN2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)cc1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.16', 'le': '0.22', 'lle': '1.54', 'sei': '5.90'}",CHEMBL4876352,,CHEMBL4876352,5.75,0,http://www.openphacts.org/units/Nanomolar,3627909,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310821,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccc(Cl)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.65', 'le': '0.22', 'lle': '1.19', 'sei': '5.90'}",CHEMBL4854276,,CHEMBL4854276,5.75,0,http://www.openphacts.org/units/Nanomolar,3627910,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310822,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CN2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)cc1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.67', 'le': '0.22', 'lle': '1.80', 'sei': '5.35'}",CHEMBL4865730,,CHEMBL4865730,5.70,0,http://www.openphacts.org/units/Nanomolar,3627911,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310823,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(CN2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)cc(OC)c1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.13', 'le': '0.21', 'lle': '1.86', 'sei': '4.98'}",CHEMBL4863696,,CHEMBL4863696,5.77,0,http://www.openphacts.org/units/Nanomolar,3627912,=,1,1,=,,IC50,nM,,1700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310824,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CN2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)c(OC)c1OC,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.79', 'le': '0.20', 'lle': '2.00', 'sei': '4.73'}",CHEMBL4862002,,CHEMBL4862002,5.92,0,http://www.openphacts.org/units/Nanomolar,3627913,=,1,1,=,,IC50,nM,,1200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310825,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.87', 'le': '0.21', 'lle': '0.81', 'sei': '5.88'}",CHEMBL4876971,,CHEMBL4876971,5.72,0,http://www.openphacts.org/units/Nanomolar,3627914,=,1,1,=,,IC50,nM,,1900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310826,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccc(F)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.96', 'le': '0.22', 'lle': '1.67', 'sei': '5.85'}",CHEMBL4875196,,CHEMBL4875196,5.70,0,http://www.openphacts.org/units/Nanomolar,3627915,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310827,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(CC4CCCO4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.38', 'le': '0.23', 'lle': '2.73', 'sei': '5.25'}",CHEMBL4874308,,CHEMBL4874308,5.60,0,http://www.openphacts.org/units/Nanomolar,3627916,=,1,1,=,,IC50,nM,,2500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310828,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4cccs4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '13.01', 'le': '0.25', 'lle': '2.09', 'sei': '6.21'}",CHEMBL4868405,,CHEMBL4868405,6.05,0,http://www.openphacts.org/units/Nanomolar,3627917,=,1,1,=,,IC50,nM,,900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310829,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccco4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '13.12', 'le': '0.24', 'lle': '2.40', 'sei': '5.33'}",CHEMBL4876922,,CHEMBL4876922,5.89,0,http://www.openphacts.org/units/Nanomolar,3627918,=,1,1,=,,IC50,nM,,1300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310830,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccncc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.97', 'le': '0.24', 'lle': '2.67', 'sei': '5.40'}",CHEMBL4856808,,CHEMBL4856808,5.96,0,http://www.openphacts.org/units/Nanomolar,3627919,=,1,1,=,,IC50,nM,,1100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310831,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccsc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.95', 'le': '0.23', 'lle': '1.59', 'sei': '5.70'}",CHEMBL4850338,,CHEMBL4850338,5.55,0,http://www.openphacts.org/units/Nanomolar,3627920,=,1,1,=,,IC50,nM,,2800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310832,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(Cc4ccoc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.45', 'le': '0.23', 'lle': '2.10', 'sei': '5.05'}",CHEMBL4861133,,CHEMBL4861133,5.58,0,http://www.openphacts.org/units/Nanomolar,3627921,=,1,1,=,,IC50,nM,,2600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310833,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4ccccc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.77', 'le': '0.23', 'lle': '1.78', 'sei': '5.83'}",CHEMBL4855360,,CHEMBL4855360,5.68,0,http://www.openphacts.org/units/Nanomolar,3627922,=,1,1,=,,IC50,nM,,2100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310834,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4ccccc4O)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.38', 'le': '0.23', 'lle': '2.10', 'sei': '4.85'}",CHEMBL4848408,,CHEMBL4848408,5.70,0,http://www.openphacts.org/units/Nanomolar,3627923,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310835,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4ccc(O)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.03', 'le': '0.22', 'lle': '1.94', 'sei': '4.71'}",CHEMBL4862834,,CHEMBL4862834,5.54,0,http://www.openphacts.org/units/Nanomolar,3627924,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310836,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(N2CCN(Cc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)CC2)cc1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.11', 'le': '0.22', 'lle': '1.34', 'sei': '5.70'}",CHEMBL4846968,,CHEMBL4846968,5.55,0,http://www.openphacts.org/units/Nanomolar,3627925,=,1,1,=,,IC50,nM,,2800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310837,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4ccc(Cl)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.34', 'le': '0.22', 'lle': '0.88', 'sei': '5.58'}",CHEMBL4854158,,CHEMBL4854158,5.43,0,http://www.openphacts.org/units/Nanomolar,3627926,=,1,1,=,,IC50,nM,,3700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310838,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4ccc(C(F)(F)F)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.84', 'le': '0.20', 'lle': '0.63', 'sei': '5.70'}",CHEMBL4865987,,CHEMBL4865987,5.55,0,http://www.openphacts.org/units/Nanomolar,3627927,=,1,1,=,,IC50,nM,,2800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310839,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4ccc(F)cc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.97', 'le': '0.22', 'lle': '1.50', 'sei': '5.69'}",CHEMBL4862496,,CHEMBL4862496,5.54,0,http://www.openphacts.org/units/Nanomolar,3627928,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310840,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCN(c4cncnc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.87', 'le': '0.24', 'lle': '3.05', 'sei': '4.66'}",CHEMBL4873634,,CHEMBL4873634,5.75,0,http://www.openphacts.org/units/Nanomolar,3627929,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310841,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)C1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.16', 'le': '0.23', 'lle': '2.21', 'sei': '4.30'}",CHEMBL4872760,,CHEMBL4872760,5.17,0,http://www.openphacts.org/units/Nanomolar,3627930,=,1,1,=,,IC50,nM,,6700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,6.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310842,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)C1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.95', 'le': '0.22', 'lle': '1.90', 'sei': '4.36'}",CHEMBL4855558,,CHEMBL4855558,5.25,0,http://www.openphacts.org/units/Nanomolar,3627931,=,1,1,=,,IC50,nM,,5600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,5.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310843,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCC(CO)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '13.38', 'le': '0.25', 'lle': '2.54', 'sei': '4.65'}",CHEMBL1836301,,CHEMBL1836301,5.32,0,http://www.openphacts.org/units/Nanomolar,3627932,=,1,1,=,,IC50,nM,,4800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310844,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CCC(c4ccccc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '12.17', 'le': '0.22', 'lle': '0.44', 'sei': '5.73'}",CHEMBL4863900,,CHEMBL4863900,5.40,0,http://www.openphacts.org/units/Nanomolar,3627933,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310845,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cccc(F)c1F)C1CCN(Cc2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)CC1,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '10.54', 'le': '0.20', 'lle': '0.40', 'sei': '4.81'}",CHEMBL4857076,,CHEMBL4857076,5.35,0,http://www.openphacts.org/units/Nanomolar,3627934,=,1,1,=,,IC50,nM,,4500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310846,[],CHEMBL4843991,Inhibition of recombinant human full-length PARP-2 using biotinylated substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)cc2)oc2c(CN3CC=C(c4ccccc4)CC3)c(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '11.56', 'le': '0.21', 'lle': '0.23', 'sei': '5.42'}",CHEMBL4875472,,CHEMBL4875472,5.10,0,http://www.openphacts.org/units/Nanomolar,3627935,=,1,1,=,,IC50,nM,,7900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,7.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23310997,[],CHEMBL4844059,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '9.26', 'le': '0.17', 'lle': '-0.14', 'sei': '2.74'}",CHEMBL63354,AMENTOFLAVONE,CHEMBL63354,4.99,0,http://www.openphacts.org/units/Nanomolar,3627880,=,1,1,=,,IC50,nM,,10300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.3
,,23310998,[],CHEMBL4844059,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(/C=N/NC(N)=S)c(Br)c(Br)c1OC,Potential transcription error,"Values appear to be an order of magnitude different from previously reported, so units may be incorrect",CHEMBL4842357,J Med Chem,2021,,CHEMBL4799284,,CHEMBL4799284,,1,http://www.openphacts.org/units/Nanomolar,3627937,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23311000,[],CHEMBL4844059,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cccc1/C=C1\C(=O)NC(=O)c2ccccc21,,,CHEMBL4842357,J Med Chem,2021,"{'bei': '17.43', 'le': '0.32', 'lle': '2.56', 'sei': '8.61'}",CHEMBL4303397,,CHEMBL4303397,4.40,0,http://www.openphacts.org/units/Nanomolar,3627939,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,40.0
,,24345386,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5030392,Inhibition of PARP2 (unknown origin) incubated for 30 mins in presence of NAD,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(-c2nnc([C@H]3C[C@H](NC(=O)c4ccccn4)C3)n2-c2ccccc2F)nc1,,,CHEMBL5029189,J Med Chem,2021,,CHEMBL4633637,,CHEMBL4633637,,1,http://www.openphacts.org/units/Nanomolar,3771709,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,24345387,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5030392,Inhibition of PARP2 (unknown origin) incubated for 30 mins in presence of NAD,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(-c2nnc([C@H]3C[C@H](NC(=O)c4cccc5nccnc45)C3)n2-c2ccccc2F)nc1,,,CHEMBL5029189,J Med Chem,2021,,CHEMBL5090849,,CHEMBL5090849,,0,http://www.openphacts.org/units/Nanomolar,3771732,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507582,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.31', 'le': '0.34', 'lle': '5.95', 'sei': '8.32'}",CHEMBL5093696,,CHEMBL5093696,7.26,0,http://www.openphacts.org/units/Nanomolar,3837322,=,1,1,=,,IC50,nM,,55.38,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,55.38
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507583,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '19.15', 'le': '0.36', 'lle': '6.28', 'sei': '8.71'}",CHEMBL5081921,,CHEMBL5081921,7.59,0,http://www.openphacts.org/units/Nanomolar,3837323,=,1,1,=,,IC50,nM,,25.58,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,25.58
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507584,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC(F)(F)F,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.50', 'le': '0.34', 'lle': '5.78', 'sei': '10.68'}",CHEMBL5073596,,CHEMBL5073596,8.37,0,http://www.openphacts.org/units/Nanomolar,3837324,=,1,1,=,,IC50,nM,,4.25,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.25
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507585,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC(F)(F)F,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.62', 'le': '0.32', 'lle': '5.36', 'sei': '10.14'}",CHEMBL5094072,,CHEMBL5094072,7.95,0,http://www.openphacts.org/units/Nanomolar,3837325,=,1,1,=,,IC50,nM,,11.19,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11.19
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507586,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.60', 'le': '0.35', 'lle': '5.73', 'sei': '10.40'}",CHEMBL5087953,,CHEMBL5087953,8.16,0,http://www.openphacts.org/units/Nanomolar,3837326,=,1,1,=,,IC50,nM,,6.98,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.98
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507587,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.23', 'le': '0.34', 'lle': '5.56', 'sei': '10.19'}",CHEMBL5088800,,CHEMBL5088800,7.99,0,http://www.openphacts.org/units/Nanomolar,3837327,=,1,1,=,,IC50,nM,,10.17,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.17
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507588,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '19.51', 'le': '0.37', 'lle': '6.15', 'sei': '11.26'}",CHEMBL5073404,,CHEMBL5073404,8.83,0,http://www.openphacts.org/units/Nanomolar,3837328,=,1,1,=,,IC50,nM,,1.49,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.49
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507589,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.98', 'le': '0.34', 'lle': '5.46', 'sei': '10.38'}",CHEMBL5081000,,CHEMBL5081000,8.14,0,http://www.openphacts.org/units/Nanomolar,3837329,=,1,1,=,,IC50,nM,,7.31,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.31
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507590,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.44', 'le': '0.34', 'lle': '5.88', 'sei': '10.59'}",CHEMBL5080640,,CHEMBL5080640,8.31,0,http://www.openphacts.org/units/Nanomolar,3837330,=,1,1,=,,IC50,nM,,4.93,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.93
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507591,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.05', 'le': '0.34', 'lle': '5.70', 'sei': '10.37'}",CHEMBL5083291,,CHEMBL5083291,8.13,0,http://www.openphacts.org/units/Nanomolar,3837331,=,1,1,=,,IC50,nM,,7.41,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.41
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507592,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C/C=C/CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.05', 'le': '0.34', 'lle': '5.53', 'sei': '10.37'}",CHEMBL5080395,,CHEMBL5080395,8.13,0,http://www.openphacts.org/units/Nanomolar,3837332,=,1,1,=,,IC50,nM,,7.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507593,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C/C=C/CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.37', 'le': '0.32', 'lle': '5.23', 'sei': '9.98'}",CHEMBL5087572,,CHEMBL5087572,7.83,0,http://www.openphacts.org/units/Nanomolar,3837333,=,1,1,=,,IC50,nM,,14.95,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,14.95
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507594,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.48', 'le': '0.33', 'lle': '5.13', 'sei': '10.36'}",CHEMBL5089572,,CHEMBL5089572,8.12,0,http://www.openphacts.org/units/Nanomolar,3837334,=,1,1,=,,IC50,nM,,7.56,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.56
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507595,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.99', 'le': '0.32', 'lle': '4.90', 'sei': '10.07'}",CHEMBL5088510,,CHEMBL5088510,7.89,0,http://www.openphacts.org/units/Nanomolar,3837335,=,1,1,=,,IC50,nM,,12.79,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,12.79
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507596,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(=O)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '19.71', 'le': '0.37', 'lle': '6.98', 'sei': '9.63'}",CHEMBL5080271,,CHEMBL5080271,9.19,0,http://www.openphacts.org/units/Nanomolar,3837336,=,1,1,=,,IC50,nM,,0.64,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.64
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507597,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(=O)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.50', 'le': '0.35', 'lle': '6.42', 'sei': '9.04'}",CHEMBL5093731,,CHEMBL5093731,8.63,0,http://www.openphacts.org/units/Nanomolar,3837337,=,1,1,=,,IC50,nM,,2.34,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.34
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507598,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '19.90', 'le': '0.37', 'lle': '6.30', 'sei': '10.01'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.65,0,http://www.openphacts.org/units/Nanomolar,3837338,=,1,1,=,,IC50,nM,,2.26,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.26
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507599,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.22', 'le': '0.34', 'lle': '5.78', 'sei': '8.58'}",CHEMBL5092897,,CHEMBL5092897,7.48,0,http://www.openphacts.org/units/Nanomolar,3837339,=,1,1,=,,IC50,nM,,33.29,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,33.29
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507600,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.55', 'le': '0.35', 'lle': '5.91', 'sei': '8.73'}",CHEMBL5087831,,CHEMBL5087831,7.61,0,http://www.openphacts.org/units/Nanomolar,3837340,=,1,1,=,,IC50,nM,,24.35,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,24.35
,,24507601,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C,,,CHEMBL5053536,J Med Chem,2021,,CHEMBL5091323,,CHEMBL5091323,,0,http://www.openphacts.org/units/Nanomolar,3837341,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
,,24507602,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C,,,CHEMBL5053536,J Med Chem,2021,,CHEMBL5080224,,CHEMBL5080224,,0,http://www.openphacts.org/units/Nanomolar,3837342,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507603,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.41', 'le': '0.33', 'lle': '5.21', 'sei': '9.74'}",CHEMBL5089136,,CHEMBL5089136,7.64,0,http://www.openphacts.org/units/Nanomolar,3837343,=,1,1,=,,IC50,nM,,23.11,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,23.11
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507604,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.81', 'le': '0.33', 'lle': '5.38', 'sei': '9.96'}",CHEMBL5083752,,CHEMBL5083752,7.81,0,http://www.openphacts.org/units/Nanomolar,3837344,=,1,1,=,,IC50,nM,,15.46,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,15.46
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507605,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC(F)(F)F,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '18.09', 'le': '0.35', 'lle': '5.93', 'sei': '11.36'}",CHEMBL5072662,,CHEMBL5072662,8.91,0,http://www.openphacts.org/units/Nanomolar,3837345,=,1,1,=,,IC50,nM,,1.24,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.24
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507606,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC(F)(F)F,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '14.66', 'le': '0.28', 'lle': '4.24', 'sei': '9.20'}",CHEMBL5079003,,CHEMBL5079003,7.22,0,http://www.openphacts.org/units/Nanomolar,3837346,=,1,1,=,,IC50,nM,,60.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,60.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507607,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1CC,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.12', 'le': '0.30', 'lle': '4.48', 'sei': '9.30'}",CHEMBL5088094,,CHEMBL5088094,7.29,0,http://www.openphacts.org/units/Nanomolar,3837347,=,1,1,=,,IC50,nM,,50.65,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.65
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507608,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1CC,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.18', 'le': '0.30', 'lle': '4.50', 'sei': '9.34'}",CHEMBL5090532,,CHEMBL5090532,7.32,0,http://www.openphacts.org/units/Nanomolar,3837348,=,1,1,=,,IC50,nM,,47.54,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,47.54
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507609,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(C)C,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.44', 'le': '0.31', 'lle': '4.62', 'sei': '9.49'}",CHEMBL5074757,,CHEMBL5074757,7.44,0,http://www.openphacts.org/units/Nanomolar,3837349,=,1,1,=,,IC50,nM,,36.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,36.4
,,24507610,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(C)C,,,CHEMBL5053536,J Med Chem,2021,,CHEMBL5088329,,CHEMBL5088329,,0,http://www.openphacts.org/units/Nanomolar,3837350,>,1,1,>,,IC50,nM,,100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507611,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.80', 'le': '0.31', 'lle': '4.99', 'sei': '9.96'}",CHEMBL5083950,,CHEMBL5083950,7.81,0,http://www.openphacts.org/units/Nanomolar,3837351,=,1,1,=,,IC50,nM,,15.63,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,15.63
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507612,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '15.86', 'le': '0.30', 'lle': '4.55', 'sei': '9.40'}",CHEMBL5087801,,CHEMBL5087801,7.37,0,http://www.openphacts.org/units/Nanomolar,3837352,=,1,1,=,,IC50,nM,,42.82,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,42.82
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507613,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(C)=O,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.75', 'le': '0.31', 'lle': '5.62', 'sei': '7.94'}",CHEMBL5071826,,CHEMBL5071826,7.58,0,http://www.openphacts.org/units/Nanomolar,3837353,=,1,1,=,,IC50,nM,,26.39,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,26.39
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507614,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(C)=O,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.36', 'le': '0.33', 'lle': '5.89', 'sei': '8.23'}",CHEMBL5086078,,CHEMBL5086078,7.86,0,http://www.openphacts.org/units/Nanomolar,3837354,=,1,1,=,,IC50,nM,,13.97,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,13.97
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507615,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(=O)C(F)(F)F,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.06', 'le': '0.31', 'lle': '5.64', 'sei': '8.52'}",CHEMBL5079913,,CHEMBL5079913,8.14,0,http://www.openphacts.org/units/Nanomolar,3837355,=,1,1,=,,IC50,nM,,7.31,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.31
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507616,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(=O)C(F)(F)F,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '15.68', 'le': '0.30', 'lle': '5.44', 'sei': '8.31'}",CHEMBL5077121,,CHEMBL5077121,7.94,0,http://www.openphacts.org/units/Nanomolar,3837356,=,1,1,=,,IC50,nM,,11.51,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11.51
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507617,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@H]1CC,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.86', 'le': '0.32', 'lle': '5.51', 'sei': '8.24'}",CHEMBL5084022,,CHEMBL5084022,7.86,0,http://www.openphacts.org/units/Nanomolar,3837357,=,1,1,=,,IC50,nM,,13.68,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,13.68
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507618,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=O)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)C[C@@H]1CC,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '17.49', 'le': '0.33', 'lle': '5.81', 'sei': '8.55'}",CHEMBL5088601,,CHEMBL5088601,8.16,0,http://www.openphacts.org/units/Nanomolar,3837358,=,1,1,=,,IC50,nM,,6.91,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.91
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507619,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(=O)C1CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.93', 'le': '0.32', 'lle': '5.75', 'sei': '8.48'}",CHEMBL5075095,,CHEMBL5075095,8.10,0,http://www.openphacts.org/units/Nanomolar,3837359,=,1,1,=,,IC50,nM,,7.96,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.96
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24507620,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5054879,Inhibition of recombinant human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1C(=O)C1CC1,,,CHEMBL5053536,J Med Chem,2021,"{'bei': '16.69', 'le': '0.31', 'lle': '5.64', 'sei': '8.36'}",CHEMBL5094748,,CHEMBL5094748,7.99,0,http://www.openphacts.org/units/Nanomolar,3837360,=,1,1,=,,IC50,nM,,10.34,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,10.34
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24508684,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.75', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '45.0'}]",CHEMBL5055126,Inhibition of recombinant PARP2 (unknown origin) incubated for 45 mins in presence of biotinylated-NAD+ by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1C(=O)N(C)c2cnc(N(C)c3ccc(-c4nc5c(C(N)=O)cccc5[nH]4)cc3OC)nc2N1C1CCCC1,,,CHEMBL5053549,J Med Chem,2021,"{'bei': '15.01', 'le': '0.28', 'lle': '3.93', 'sei': '6.23'}",CHEMBL5084388,,CHEMBL5084388,8.33,0,http://www.openphacts.org/units/Nanomolar,3837566,=,1,1,=,,IC50,nM,,4.7,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.7
,,24517909,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(OCc2cccc(Br)c2)cc1,,,CHEMBL5055677,Bioorg Med Chem,2021,,CHEMBL4293771,,CHEMBL4293771,,0,http://www.openphacts.org/units/Nanomolar,3839075,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24517910,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2sccc2c2cc(OCc3ccccc3)ccc12,,,CHEMBL5055677,Bioorg Med Chem,2021,"{'bei': '13.21', 'le': '0.25', 'lle': '-0.26', 'sei': '9.65'}",CHEMBL5076823,,CHEMBL5076823,4.06,0,http://www.openphacts.org/units/Nanomolar,3839076,=,1,1,=,,IC50,nM,,87000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,87.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24517911,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2sccc2c2cc(O)ccc12,,,CHEMBL5055677,Bioorg Med Chem,2021,"{'bei': '27.25', 'le': '0.54', 'lle': '3.47', 'sei': '11.15'}",CHEMBL5077731,,CHEMBL5077731,5.92,0,http://www.openphacts.org/units/Nanomolar,3839077,=,1,1,=,,IC50,nM,,1200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24517912,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2sccc2c2cc(OCc3cccc(Br)c3)ccc12,,,CHEMBL5055677,Bioorg Med Chem,2021,"{'bei': '10.93', 'le': '0.25', 'lle': '-0.86', 'sei': '10.03'}",CHEMBL5078132,,CHEMBL5078132,4.22,0,http://www.openphacts.org/units/Nanomolar,3839078,=,1,1,=,,IC50,nM,,60000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,60.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24517913,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)Oc1ccc2c(=O)[nH]c3sccc3c2c1,,,CHEMBL5055677,Bioorg Med Chem,2021,"{'bei': '18.21', 'le': '0.36', 'lle': '1.19', 'sei': '11.22'}",CHEMBL5083566,,CHEMBL5083566,4.72,0,http://www.openphacts.org/units/Nanomolar,3839079,=,1,1,=,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24517914,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2c(=O)[nH]c3sccc3c2c1,,,CHEMBL5055677,Bioorg Med Chem,2021,"{'bei': '24.84', 'le': '0.49', 'lle': '2.99', 'sei': '13.65'}",CHEMBL5084343,,CHEMBL5084343,5.75,0,http://www.openphacts.org/units/Nanomolar,3839080,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.8
,,24517915,[],CHEMBL5057861,Inhibition of PARP2 (1 to 583 residues) (unknown origin) expressed in Escherichia coli using NAD+ as substrate by fluorescence based assay,B,,,BAO_0000190,BAO_0000019,assay format,CCOc1ccc2c(=O)[nH]c3sccc3c2c1,,,CHEMBL5055677,Bioorg Med Chem,2021,,CHEMBL5091585,,CHEMBL5091585,,0,http://www.openphacts.org/units/Nanomolar,3839081,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24704386,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'min', 'standard_value': '65.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'min', 'value': '65.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'min', 'standard_value': '70.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'min', 'value': '70.0'}]",CHEMBL5108301,Inhibition of N-terminal His-tagged full length human PARP2 expressed in Escherichia coli BL21 (DE3) preincubated with 6-a-NAD+ for 5 to 10 mins followed by enzyme addition and measured after 60 mins using NAD+ as substrate byHRP based chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cccc2c(=O)[nH]c(CSc3ncccn3)nc12,,,CHEMBL5107944,RSC Med Chem,2021,"{'bei': '21.44', 'le': '0.42', 'lle': '3.79', 'sei': '8.52'}",CHEMBL5187963,,CHEMBL5187963,6.10,0,http://www.openphacts.org/units/Nanomolar,3852280,=,1,1,=,,IC50,nM,,800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24704387,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'min', 'standard_value': '65.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'min', 'value': '65.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'min', 'standard_value': '70.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'min', 'value': '70.0'}]",CHEMBL5108301,Inhibition of N-terminal His-tagged full length human PARP2 expressed in Escherichia coli BL21 (DE3) preincubated with 6-a-NAD+ for 5 to 10 mins followed by enzyme addition and measured after 60 mins using NAD+ as substrate byHRP based chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(Br)cc2c(=O)[nH]c(CSc3ncccn3)nc12,,,CHEMBL5107944,RSC Med Chem,2021,"{'bei': '15.69', 'le': '0.37', 'lle': '2.62', 'sei': '7.97'}",CHEMBL5181770,,CHEMBL5181770,5.70,0,http://www.openphacts.org/units/Nanomolar,3852282,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24754827,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL5120795,J Med Chem,2022,"{'bei': '22.23', 'le': '0.45', 'lle': '3.28', 'sei': '15.09'}",CHEMBL1086580,,CHEMBL1086580,6.94,1,http://www.openphacts.org/units/Nanomolar,3862130,=,1,1,=,,IC50,nM,,114.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.114
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24754828,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1N1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1,,,CHEMBL5120795,J Med Chem,2022,"{'bei': '16.60', 'le': '0.31', 'lle': '3.67', 'sei': '9.20'}",CHEMBL4454483,,CHEMBL4454483,5.65,1,http://www.openphacts.org/units/Nanomolar,3862133,=,1,1,=,,IC50,nM,,2230.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.23
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24754829,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(N2CCC3(CC2)CN(CCO)c2cc(F)cc(F)c23)nc2c1CCCC2,,,CHEMBL5120795,J Med Chem,2022,"{'bei': '13.36', 'le': '0.25', 'lle': '3.29', 'sei': '7.68'}",CHEMBL4448872,,CHEMBL4448872,5.57,1,http://www.openphacts.org/units/Nanomolar,3862134,=,1,1,=,,IC50,nM,,2717.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.717
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24754830,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2cc(F)c3c(c2)N(C)C(=O)C32CCN(c3nc4c(c(=O)[nH]3)CCCN4C)CC2)C[C@H](C)O1,,,CHEMBL5120795,J Med Chem,2022,"{'bei': '11.57', 'le': '0.22', 'lle': '3.49', 'sei': '6.95'}",CHEMBL4449082,,CHEMBL4449082,5.91,1,http://www.openphacts.org/units/Nanomolar,3862135,=,1,1,=,,IC50,nM,,1240.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.24
,,24754831,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(NCCc2ccc(O)cc2)c2nncn2n1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL3238252,,CHEMBL3238252,,1,http://www.openphacts.org/units/Nanomolar,3862132,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,24754832,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL562310,,CHEMBL562310,,1,http://www.openphacts.org/units/Nanomolar,3862140,>,1,1,>,,IC50,nM,,18750.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,18.75
,ND,24754833,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2c(=O)[nH]ccc12)[C@H]1CCCNC1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL5190651,,CHEMBL5190651,,0,,3862131,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24754834,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2nc(O)c3ccccc3n2)cc1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL336718,,CHEMBL336718,,0,,3862136,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24754835,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cn3ccnc3c(=O)[nH]2)cc1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL5190218,,CHEMBL5190218,,0,,3862137,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24754836,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c(SCCCN3C(=O)c4cccc5cccc(c45)C3=O)nnc2-c2ccncc2)cc1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL4303453,,CHEMBL4303453,,0,,3862139,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24754837,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL1552719,,CHEMBL1552719,,0,,3862141,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24754838,[],CHEMBL5122239,Inhibition of PAPR2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)C3CCCNC43)CC2)nc1,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL5206816,,CHEMBL5206816,,0,,3862150,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24754852,[],CHEMBL5122251,Inhibition of PARP2 (unknown origin) by fluorescence based multimode plate reader method,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(=O)[nH]c(-c3ccc(C(C)(C)O)cc3)cn12,,,CHEMBL5120795,J Med Chem,2022,,CHEMBL5199558,,CHEMBL5199558,,0,,3862129,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,,24760515,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCCCC2)cc1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5178227,,CHEMBL5178227,,0,http://www.openphacts.org/units/Nanomolar,3863128,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760516,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCCC2)cc1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5206305,,CHEMBL5206305,,0,http://www.openphacts.org/units/Nanomolar,3863129,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24760517,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCC2)cc1,,,CHEMBL5120855,Eur J Med Chem,2022,"{'bei': '21.53', 'le': '0.40', 'lle': '2.46', 'sei': '8.45'}",CHEMBL5186967,,CHEMBL5186967,4.42,0,http://www.openphacts.org/units/Nanomolar,3863130,=,1,1,=,,IC50,nM,,38000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,38.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24760518,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CC2)cc1,,,CHEMBL5120855,Eur J Med Chem,2022,"{'bei': '22.36', 'le': '0.42', 'lle': '2.71', 'sei': '8.17'}",CHEMBL5198692,,CHEMBL5198692,4.28,0,http://www.openphacts.org/units/Nanomolar,3863131,=,1,1,=,,IC50,nM,,53000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,53.0
,,24760519,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCc2cncs2)cc1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5185078,,CHEMBL5185078,,0,http://www.openphacts.org/units/Nanomolar,3863132,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760520,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OCC2CCCCC2)ccc1C(N)=O,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5185276,,CHEMBL5185276,,0,http://www.openphacts.org/units/Nanomolar,3863133,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760521,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OCc2cccc(Br)c2)ccc1C(N)=O,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5198615,,CHEMBL5198615,,0,http://www.openphacts.org/units/Nanomolar,3863134,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760522,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OCc2cccc3ccccc23)ccc1C(N)=O,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5176918,,CHEMBL5176918,,0,http://www.openphacts.org/units/Nanomolar,3863135,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760523,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OCc2ccccc2F)ccc1C(N)=O,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5194963,,CHEMBL5194963,,0,http://www.openphacts.org/units/Nanomolar,3863136,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760524,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCCCC2)cc1F,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5198984,,CHEMBL5198984,,0,http://www.openphacts.org/units/Nanomolar,3863137,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760525,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCC2)cc1F,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5183715,,CHEMBL5183715,,0,http://www.openphacts.org/units/Nanomolar,3863138,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760526,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCc2cccc(Br)c2)cc1F,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5186481,,CHEMBL5186481,,0,http://www.openphacts.org/units/Nanomolar,3863139,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760527,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1COc1ccc(C(N)=O)c(F)c1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5174106,,CHEMBL5174106,,0,http://www.openphacts.org/units/Nanomolar,3863140,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760528,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCCCC2)cc1OCc1ccccn1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5173129,,CHEMBL5173129,,0,http://www.openphacts.org/units/Nanomolar,3863141,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760529,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(OCC2CCC2)cc1OCCN1CCNCC1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5179164,,CHEMBL5179164,,0,http://www.openphacts.org/units/Nanomolar,3863142,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760530,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCC3CCCCC3)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5181947,,CHEMBL5181947,,0,http://www.openphacts.org/units/Nanomolar,3863143,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760531,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCC3CCCC3)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5192839,,CHEMBL5192839,,0,http://www.openphacts.org/units/Nanomolar,3863144,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760532,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCC3CCC3)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5187187,,CHEMBL5187187,,0,http://www.openphacts.org/units/Nanomolar,3863145,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760533,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCC3CC3)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5181107,,CHEMBL5181107,,0,http://www.openphacts.org/units/Nanomolar,3863146,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760534,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCc3cccc(Br)c3)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5171357,,CHEMBL5171357,,0,http://www.openphacts.org/units/Nanomolar,3863147,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760535,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCc3ccccc3F)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5200358,,CHEMBL5200358,,0,http://www.openphacts.org/units/Nanomolar,3863148,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760536,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.1667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '10.0'}]",CHEMBL5123563,Inhibition of human PARP2 using NAD+ as substrate incubated for 10 mins by fluorescence based analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH][nH]c(=O)c2cc(OCc3ccsc3)ccc12,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL5200521,,CHEMBL5200521,,0,http://www.openphacts.org/units/Nanomolar,3863149,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,24760622,[],CHEMBL5123582,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(Oc2ccc(C(N)=O)cc2)cc1,,,CHEMBL5120855,Eur J Med Chem,2022,,CHEMBL1438938,,CHEMBL1438938,,1,http://www.openphacts.org/units/Nanomolar,3863127,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24761011,[],CHEMBL5123672,Inhibition of PAPR-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(NC(=O)c2ccc(NC(=O)N3CCN(C(=O)c4cc(Cc5n[nH]c(=O)c6ccccc56)ccc4F)CC3)cc2)cc1,,,CHEMBL5120857,Eur J Med Chem,2022,"{'bei': '14.06', 'le': '0.26', 'lle': '4.02', 'sei': '6.52'}",CHEMBL5176874,,CHEMBL5176874,8.92,0,http://www.openphacts.org/units/Nanomolar,3863178,=,1,1,=,,IC50,nM,,1.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.2
,,24763893,[],CHEMBL5124467,Inhibition of PARP2 (unknown origin) expressed in Escherichia coli Rosette2 (DE3),B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(Oc2ccc(C(N)=O)cc2)cc1,,,CHEMBL5120882,J Med Chem,2022,,CHEMBL1438938,,CHEMBL1438938,,1,http://www.openphacts.org/units/Nanomolar,3863903,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24763916,[],CHEMBL5124482,Inhibition of N-terminal his-tagged human PARP2 expressed in Escherichia coli Rosette2 (DE3),B,,,BAO_0000190,BAO_0000019,assay format,N#Cc1ccc(Oc2ccc(C(N)=O)cc2)cc1,,,CHEMBL5120882,J Med Chem,2022,"{'bei': '19.18', 'le': '0.35', 'lle': '2.12', 'sei': '6.00'}",CHEMBL5184823,,CHEMBL5184823,4.57,0,http://www.openphacts.org/units/Nanomolar,3863904,=,1,1,=,,IC50,nM,,27000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,27.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24763917,[],CHEMBL5124482,Inhibition of N-terminal his-tagged human PARP2 expressed in Escherichia coli Rosette2 (DE3),B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1ccc(Oc2cccc(C(N)=O)c2)cc1,,,CHEMBL5120882,J Med Chem,2022,"{'bei': '22.51', 'le': '0.41', 'lle': '4.09', 'sei': '6.05'}",CHEMBL4126054,,CHEMBL4126054,5.77,0,http://www.openphacts.org/units/Nanomolar,3863905,=,1,1,=,,IC50,nM,,1700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.7
,,24763954,[],CHEMBL5124491,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC#Cc1ccc2c(=O)[nH]c(CSc3ncccn3)nc2c1C,,,CHEMBL5120882,J Med Chem,2022,,CHEMBL5191676,,CHEMBL5191676,,0,http://www.openphacts.org/units/Nanomolar,3863922,>,1,1,>,,IC50,nM,,30000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,30.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24763955,[],CHEMBL5124491,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(=O)[nH]c(CSc3ncccn3)nc12,,,CHEMBL5120882,J Med Chem,2022,"{'bei': '16.87', 'le': '0.33', 'lle': '2.49', 'sei': '6.70'}",CHEMBL5187963,,CHEMBL5187963,4.80,0,http://www.openphacts.org/units/Nanomolar,3863923,=,1,1,=,,IC50,nM,,16000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,16.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24763956,[],CHEMBL5124491,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(=O)[nH]c(CSc3ncccn3)nc2c1C,,,CHEMBL5120882,J Med Chem,2022,"{'bei': '15.95', 'le': '0.31', 'lle': '2.14', 'sei': '6.65'}",CHEMBL5186007,,CHEMBL5186007,4.76,0,http://www.openphacts.org/units/Nanomolar,3863924,=,1,1,=,,IC50,nM,,17400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,17.4
,,24763957,[],CHEMBL5124491,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC#Cc1ccc2c(=O)[nH]c(CSc3ccc(C(=O)O)cc3)nc2c1C,,,CHEMBL5120882,J Med Chem,2022,,CHEMBL5207717,,CHEMBL5207717,,0,http://www.openphacts.org/units/Nanomolar,3863925,>,1,1,>,,IC50,nM,,30000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,30.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24763958,[],CHEMBL5124491,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](COCCC(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1)Nc1cn[nH]c(=O)c1C(F)(F)F,,,CHEMBL5120882,J Med Chem,2022,"{'bei': '14.84', 'le': '0.29', 'lle': '5.62', 'sei': '6.68'}",CHEMBL5095043,ATAMPARIB,CHEMBL5095043,7.77,0,http://www.openphacts.org/units/Nanomolar,3863935,=,1,1,=,,IC50,nM,,17.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.017
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24772101,[],CHEMBL5126729,Inhibition of human recombinant PARP2 by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5126500,Eur J Med Chem,2021,"{'bei': '22.92', 'le': '0.42', 'lle': '4.43', 'sei': '13.02'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,7.41,0,http://www.openphacts.org/units/Nanomolar,3865281,=,1,1,=,,IC50,nM,,38.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,38.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24775564,[],CHEMBL5127794,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,,,CHEMBL5126523,Eur J Med Chem,2022,"{'bei': '23.66', 'le': '0.44', 'lle': '6.37', 'sei': '10.17'}",CHEMBL3137320,TALAZOPARIB,CHEMBL3137320,9.00,0,http://www.openphacts.org/units/Nanomolar,3866180,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24775565,[],CHEMBL5127794,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5126523,Eur J Med Chem,2022,"{'bei': '27.29', 'le': '0.50', 'lle': '5.84', 'sei': '15.50'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,8.82,0,http://www.openphacts.org/units/Nanomolar,3866181,=,1,1,=,,IC50,nM,,1.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24775566,[],CHEMBL5127794,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL5126523,Eur J Med Chem,2022,"{'bei': '27.08', 'le': '0.49', 'lle': '6.09', 'sei': '11.90'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,8.68,1,http://www.openphacts.org/units/Nanomolar,3866182,=,1,1,=,,IC50,nM,,2.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24775567,[],CHEMBL5127794,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5126523,Eur J Med Chem,2022,"{'bei': '20.71', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,1,http://www.openphacts.org/units/Nanomolar,3866183,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790244,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '28.76', 'le': '0.53', 'lle': '6.32', 'sei': '16.34'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,9.30,1,http://www.openphacts.org/units/Nanomolar,3869728,=,1,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790245,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '21.76', 'le': '0.40', 'lle': '3.85', 'sei': '16.52'}",CHEMBL5208255,,CHEMBL5208255,7.95,0,http://www.openphacts.org/units/Nanomolar,3869739,=,1,1,=,,IC50,nM,,11.21,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11.21
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790246,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN(Cc2ccc(-c3[nH]c4cc(F)cc5c4c3CCNC5=O)cc2)CC1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '19.49', 'le': '0.36', 'lle': '5.27', 'sei': '11.97'}",CHEMBL5183006,,CHEMBL5183006,8.19,0,http://www.openphacts.org/units/Nanomolar,3869742,=,1,1,=,,IC50,nM,,6.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790247,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2c(-c3ccc(CN4CCN(CCO)CC4)cc3)[nH]c3cc(F)cc1c23,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '19.35', 'le': '0.36', 'lle': '5.81', 'sei': '11.42'}",CHEMBL5174694,,CHEMBL5174694,8.18,0,http://www.openphacts.org/units/Nanomolar,3869745,=,1,1,=,,IC50,nM,,6.68,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.68
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790248,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(Cc2ccc(-c3[nH]c4cc(F)cc5c4c3CCNC5=O)cc2)CCN1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '21.75', 'le': '0.40', 'lle': '5.49', 'sei': '14.19'}",CHEMBL5203682,,CHEMBL5203682,8.54,0,http://www.openphacts.org/units/Nanomolar,3869751,=,1,1,=,,IC50,nM,,2.91,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.91
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790249,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(Cc2ccc(-c3[nH]c4cc(F)cc5c4c3CCNC5=O)cc2)CC1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '21.34', 'le': '0.39', 'lle': '5.20', 'sei': '11.30'}",CHEMBL5182785,,CHEMBL5182785,8.38,0,http://www.openphacts.org/units/Nanomolar,3869753,=,1,1,=,,IC50,nM,,4.21,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.21
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790250,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NC1CCN(Cc2ccc(-c3[nH]c4cc(F)cc5c4c3CCNC5=O)cc2)CC1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '16.43', 'le': '0.31', 'lle': '3.34', 'sei': '9.36'}",CHEMBL5193574,,CHEMBL5193574,8.10,0,http://www.openphacts.org/units/Nanomolar,3869757,=,1,1,=,,IC50,nM,,8.04,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,8.04
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790251,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2c(-c3ccc(CN4CCN(c5ncccn5)CC4)cc3)[nH]c3cc(F)cc1c23,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '18.06', 'le': '0.33', 'lle': '4.87', 'sei': '10.68'}",CHEMBL5170407,,CHEMBL5170407,8.24,0,http://www.openphacts.org/units/Nanomolar,3869758,=,1,1,=,,IC50,nM,,5.71,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.71
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24790252,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5132147,Inhibition of human PARP2 using NAD+ as substrate incubated for 1 hr by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(Cc2cccc(-c3[nH]c4cc(F)cc5c4c3CCNC5=O)c2)CC1,,,CHEMBL5131383,Eur J Med Chem,2022,"{'bei': '18.37', 'le': '0.34', 'lle': '4.03', 'sei': '9.72'}",CHEMBL5197357,,CHEMBL5197357,7.21,0,http://www.openphacts.org/units/Nanomolar,3869771,=,1,1,=,,IC50,nM,,61.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,61.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24814803,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL5138214,Inhibition of PARP2 (unknown origin) incubated for 60 mins by microplate assay kit method,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)Nc1nc2ccc(-c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)cc2[nH]1.Cl,,,CHEMBL5136991,Eur J Med Chem,2022,"{'bei': '15.96', 'le': '0.29', 'lle': '2.54', 'sei': '6.47'}",CHEMBL5184668,,CHEMBL5222013,7.30,0,http://www.openphacts.org/units/Nanomolar,3874702,=,1,1,=,,IC50,nM,,50.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,50.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867293,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '18.92', 'le': '0.35', 'lle': '5.87', 'sei': '9.52'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.22,0,http://www.openphacts.org/units/Nanomolar,3885698,=,1,1,=,,IC50,nM,,6.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.006
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867294,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '20.92', 'le': '0.38', 'lle': '3.78', 'sei': '11.88'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,6.76,0,http://www.openphacts.org/units/Nanomolar,3885699,=,1,1,=,,IC50,nM,,172.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.172
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867295,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '17.93', 'le': '0.33', 'lle': '3.15', 'sei': '7.88'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,5.75,0,http://www.openphacts.org/units/Nanomolar,3885700,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867296,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '19.78', 'le': '0.37', 'lle': '4.89', 'sei': '8.50'}",CHEMBL3137320,TALAZOPARIB,CHEMBL3137320,7.52,0,http://www.openphacts.org/units/Nanomolar,3885701,=,1,1,=,,IC50,nM,,30.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.03
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867297,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '27.21', 'le': '0.50', 'lle': '5.39', 'sei': '7.93'}",CHEMBL506871,VELIPARIB,CHEMBL506871,6.65,0,http://www.openphacts.org/units/Nanomolar,3885702,=,1,1,=,,IC50,nM,,225.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.225
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867298,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '13.10', 'le': '0.25', 'lle': '2.26', 'sei': '7.77'}",CHEMBL3606021,,CHEMBL3606021,5.18,0,http://www.openphacts.org/units/Nanomolar,3885703,=,1,1,=,,IC50,nM,,6600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,6.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867299,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CCCN2CC=C(c3ccc(F)cc3)CC2)nc2c(Cl)cccc12,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '11.81', 'le': '0.23', 'lle': '0.26', 'sei': '9.59'}",CHEMBL251030,,CHEMBL251030,4.70,0,http://www.openphacts.org/units/Nanomolar,3885704,=,1,1,=,,IC50,nM,,20000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,20.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867300,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CCCN2CCN(c3ccc(F)cc3F)CC2)nc2c(Cl)cccc12,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '11.12', 'le': '0.22', 'lle': '1.05', 'sei': '8.92'}",CHEMBL5190481,,CHEMBL5190481,4.66,0,http://www.openphacts.org/units/Nanomolar,3885705,=,1,1,=,,IC50,nM,,22000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,22.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867301,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(CCCc3nc4c(Cl)cccc4c(=O)[nH]3)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '13.46', 'le': '0.26', 'lle': '3.03', 'sei': '7.71'}",CHEMBL5193246,,CHEMBL5193246,5.40,0,http://www.openphacts.org/units/Nanomolar,3885706,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867302,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(Cc3ccc4c(c3)[nH]c(=O)c3ccccc34)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '16.06', 'le': '0.29', 'lle': '3.17', 'sei': '10.88'}",CHEMBL5191396,,CHEMBL5191396,6.22,0,http://www.openphacts.org/units/Nanomolar,3885707,=,1,1,=,,IC50,nM,,600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867303,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(Cc3ccc4c(c3)[nH]c(=O)c3cccnc34)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '12.98', 'le': '0.24', 'lle': '2.60', 'sei': '7.20'}",CHEMBL5197824,,CHEMBL5197824,5.04,0,http://www.openphacts.org/units/Nanomolar,3885708,=,1,1,=,,IC50,nM,,9100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,9.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867304,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(Cc3ccc4c(c3)[nH]c(=O)c3ncccc34)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '11.72', 'le': '0.21', 'lle': '2.11', 'sei': '6.50'}",CHEMBL5176615,,CHEMBL5176615,4.55,0,http://www.openphacts.org/units/Nanomolar,3885709,=,1,1,=,,IC50,nM,,28000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,28.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867305,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(Cc3ccc4c5c(c(=O)[nH]c4c3)CCCC5)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '16.12', 'le': '0.30', 'lle': '3.54', 'sei': '11.04'}",CHEMBL5177596,,CHEMBL5177596,6.31,0,http://www.openphacts.org/units/Nanomolar,3885710,=,1,1,=,,IC50,nM,,490.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.49
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867306,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(Cc3ccc4c5c(c(=O)[nH]c4c3)COCC5)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '13.17', 'le': '0.24', 'lle': '3.22', 'sei': '7.80'}",CHEMBL5178594,,CHEMBL5178594,5.18,0,http://www.openphacts.org/units/Nanomolar,3885711,=,1,1,=,,IC50,nM,,6600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,6.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867307,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cnc(N2CCN(Cc3ccc4c5c(c(=O)[nH]c4c3)CCCN5)CC2)n1C,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '15.18', 'le': '0.28', 'lle': '3.71', 'sei': '8.61'}",CHEMBL5209181,,CHEMBL5209181,5.96,0,http://www.openphacts.org/units/Nanomolar,3885712,=,1,1,=,,IC50,nM,,1100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867308,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4ncc(C)n4C)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '14.71', 'le': '0.27', 'lle': '2.93', 'sei': '9.41'}",CHEMBL5181905,,CHEMBL5181905,5.38,0,http://www.openphacts.org/units/Nanomolar,3885713,=,1,1,=,,IC50,nM,,4200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.2
,,24867309,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4ccc(F)cc4F)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,,CHEMBL5196187,,CHEMBL5196187,,0,http://www.openphacts.org/units/Nanomolar,3885714,>,1,1,>,,IC50,nM,,26000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,26.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867310,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4ccc(C(=O)NC)cc4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '13.37', 'le': '0.25', 'lle': '2.64', 'sei': '7.90'}",CHEMBL5200723,,CHEMBL5200723,5.41,0,http://www.openphacts.org/units/Nanomolar,3885715,=,1,1,=,,IC50,nM,,3900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867311,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4cnc(C(=O)NC)cn4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '12.86', 'le': '0.24', 'lle': '3.67', 'sei': '5.55'}",CHEMBL5195580,,CHEMBL5195580,5.23,0,http://www.openphacts.org/units/Nanomolar,3885716,=,1,1,=,,IC50,nM,,5900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,5.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867312,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4cnc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '13.83', 'le': '0.26', 'lle': '4.06', 'sei': '5.96'}",CHEMBL5183769,,CHEMBL5183769,5.62,0,http://www.openphacts.org/units/Nanomolar,3885717,=,1,1,=,,IC50,nM,,2400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867313,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4ccc(C(=O)NC)nn4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '12.62', 'le': '0.23', 'lle': '3.57', 'sei': '5.45'}",CHEMBL5202060,,CHEMBL5202060,5.13,0,http://www.openphacts.org/units/Nanomolar,3885718,=,1,1,=,,IC50,nM,,7400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,7.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867314,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ccc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '14.69', 'le': '0.27', 'lle': '3.79', 'sei': '7.33'}",CHEMBL5197101,,CHEMBL5197101,5.96,0,http://www.openphacts.org/units/Nanomolar,3885719,=,1,1,=,,IC50,nM,,1100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867315,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1nc2ccc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '13.06', 'le': '0.24', 'lle': '3.75', 'sei': '5.64'}",CHEMBL5188853,,CHEMBL5188853,5.31,0,http://www.openphacts.org/units/Nanomolar,3885720,=,1,1,=,,IC50,nM,,4900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867316,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2cnc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '14.19', 'le': '0.26', 'lle': '4.21', 'sei': '6.12'}",CHEMBL4874589,,CHEMBL4874589,5.77,0,http://www.openphacts.org/units/Nanomolar,3885721,=,1,1,=,,IC50,nM,,1700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24867317,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5152029,Inhibition of human recombinant N-terminal Avi-6His-TEV tagged PARP2 full length expressed in pFastBac expression system incubated for 4 hrs by fluorescence anisotropy binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150005,J Med Chem,2021,"{'bei': '14.40', 'le': '0.27', 'lle': '4.29', 'sei': '6.21'}",CHEMBL5095220,SARUPARIB,CHEMBL5095220,5.85,0,http://www.openphacts.org/units/Nanomolar,3885722,=,1,1,=,,IC50,nM,,1400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870080,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(OC(F)F)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '16.40', 'le': '0.31', 'lle': '4.01', 'sei': '9.16'}",CHEMBL5191912,,CHEMBL5191912,6.81,0,http://www.openphacts.org/units/Nanomolar,3886461,=,1,1,=,,IC50,nM,,154.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,154.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870081,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(C)(C)O)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '15.57', 'le': '0.29', 'lle': '3.92', 'sei': '7.44'}",CHEMBL5180063,,CHEMBL5180063,6.35,0,http://www.openphacts.org/units/Nanomolar,3886462,=,1,1,=,,IC50,nM,,450.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,450.0
,ND,24870082,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(N)C(F)(F)F)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5208807,,CHEMBL5208807,,0,,3886463,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870083,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4cnc5cn[nH]c5c4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '21.27', 'le': '0.39', 'lle': '6.20', 'sei': '8.83'}",CHEMBL5190645,,CHEMBL5190645,8.28,0,http://www.openphacts.org/units/Nanomolar,3886464,=,1,1,=,,IC50,nM,,5.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870084,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5[nH]ncc5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '19.61', 'le': '0.36', 'lle': '5.56', 'sei': '8.14'}",CHEMBL5185522,,CHEMBL5185522,7.64,0,http://www.openphacts.org/units/Nanomolar,3886465,=,1,1,=,,IC50,nM,,23.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,23.0
,ND,24870085,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5cn[nH]c5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5176160,,CHEMBL5176160,,0,,3886466,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870086,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5cc[nH]c5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '19.76', 'le': '0.36', 'lle': '5.00', 'sei': '9.49'}",CHEMBL5205419,,CHEMBL5205419,7.68,0,http://www.openphacts.org/units/Nanomolar,3886467,=,1,1,=,,IC50,nM,,21.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,21.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870087,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5oc(=O)[nH]c5c4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.41', 'le': '0.32', 'lle': '4.82', 'sei': '7.19'}",CHEMBL5196723,,CHEMBL5196723,7.06,0,http://www.openphacts.org/units/Nanomolar,3886468,=,1,1,=,,IC50,nM,,87.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,87.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870088,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5nc(C(F)(F)F)[nH]c5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '15.79', 'le': '0.30', 'lle': '4.12', 'sei': '7.70'}",CHEMBL5185548,,CHEMBL5185548,7.22,0,http://www.openphacts.org/units/Nanomolar,3886469,=,1,1,=,,IC50,nM,,60.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,60.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870089,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4cc5c(cn4)NC(=O)CC5)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.73', 'le': '0.33', 'lle': '5.33', 'sei': '7.88'}",CHEMBL5201927,,CHEMBL5201927,7.42,0,http://www.openphacts.org/units/Nanomolar,3886470,=,1,1,=,,IC50,nM,,38.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,38.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870090,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4cc5cccc(C(=O)NC)c5cn4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '14.94', 'le': '0.27', 'lle': '4.10', 'sei': '7.24'}",CHEMBL5187899,,CHEMBL5187899,6.82,0,http://www.openphacts.org/units/Nanomolar,3886471,=,1,1,=,,IC50,nM,,151.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,151.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870091,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)c5nccn45)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '13.48', 'le': '0.25', 'lle': '4.20', 'sei': '6.09'}",CHEMBL5179448,,CHEMBL5179448,6.01,0,http://www.openphacts.org/units/Nanomolar,3886472,=,1,1,=,,IC50,nM,,982.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,982.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870092,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCn4c(cnc4C(=O)NC)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '21.01', 'le': '0.39', 'lle': '6.64', 'sei': '8.03'}",CHEMBL5198072,,CHEMBL5198072,7.70,0,http://www.openphacts.org/units/Nanomolar,3886473,=,1,1,=,,IC50,nM,,20.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,20.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870093,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCc4nc(C(=O)NC)ccc4C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '16.73', 'le': '0.31', 'lle': '4.51', 'sei': '6.94'}",CHEMBL5176626,,CHEMBL5176626,6.31,0,http://www.openphacts.org/units/Nanomolar,3886474,=,1,1,=,,IC50,nM,,485.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,485.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870094,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCc4cc(/C=C/C(=O)NC)ccc4C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '18.34', 'le': '0.34', 'lle': '4.58', 'sei': '9.45'}",CHEMBL5206717,,CHEMBL5206717,7.38,0,http://www.openphacts.org/units/Nanomolar,3886475,=,1,1,=,,IC50,nM,,41.53,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,41.53
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870095,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4CN(c5ccc(C(=O)NC)nc5)CC4C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.91', 'le': '0.33', 'lle': '5.93', 'sei': '8.22'}",CHEMBL5180001,,CHEMBL5180001,7.75,0,http://www.openphacts.org/units/Nanomolar,3886476,=,1,1,=,,IC50,nM,,18.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,18.0
,ND,24870096,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4CCC(C3)N4c3ccc(C(=O)NC)nc3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5205409,,CHEMBL5205409,,0,,3886477,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24870097,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4CC(C3)N4c3ccc(C(=O)NC)nc3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5191816,,CHEMBL5191816,,0,,3886478,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870098,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3C[C@@H]4C[C@H]3CN4c3ccc(C(=O)NC)nc3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '15.46', 'le': '0.28', 'lle': '4.77', 'sei': '6.87'}",CHEMBL5179279,,CHEMBL5179279,6.47,0,http://www.openphacts.org/units/Nanomolar,3886479,=,1,1,=,,IC50,nM,,340.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,340.0
,ND,24870099,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4(CCN(c5ccc(C(=O)NC)nc5)CC4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5185063,,CHEMBL5185063,,0,,3886480,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870100,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4(C3)CN(c3ccc(C(=O)NC)nc3)C4)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '19.23', 'le': '0.35', 'lle': '6.49', 'sei': '8.54'}",CHEMBL5193674,,CHEMBL5193674,8.05,0,http://www.openphacts.org/units/Nanomolar,3886481,=,1,1,=,,IC50,nM,,9.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870101,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCC(Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.63', 'le': '0.33', 'lle': '5.24', 'sei': '6.96'}",CHEMBL5178741,,CHEMBL5178741,7.17,0,http://www.openphacts.org/units/Nanomolar,3886482,=,1,1,=,,IC50,nM,,68.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,68.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870102,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC(Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.11', 'le': '0.32', 'lle': '5.18', 'sei': '6.52'}",CHEMBL5173989,,CHEMBL5173989,6.72,0,http://www.openphacts.org/units/Nanomolar,3886483,=,1,1,=,,IC50,nM,,192.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,192.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870103,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCC(Nc4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.59', 'le': '0.33', 'lle': '5.08', 'sei': '7.18'}",CHEMBL5202261,,CHEMBL5202261,7.40,0,http://www.openphacts.org/units/Nanomolar,3886484,=,1,1,=,,IC50,nM,,40.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,40.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870104,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC[C@@H](Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '16.92', 'le': '0.31', 'lle': '4.95', 'sei': '6.68'}",CHEMBL5179882,,CHEMBL5179882,6.88,0,http://www.openphacts.org/units/Nanomolar,3886485,=,1,1,=,,IC50,nM,,133.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,133.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870105,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC[C@H](Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '16.88', 'le': '0.31', 'lle': '4.93', 'sei': '6.66'}",CHEMBL5195834,,CHEMBL5195834,6.86,0,http://www.openphacts.org/units/Nanomolar,3886486,=,1,1,=,,IC50,nM,,137.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,137.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870106,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '20.66', 'le': '0.38', 'lle': '6.84', 'sei': '8.91'}",CHEMBL5095220,SARUPARIB,CHEMBL5095220,8.40,0,http://www.openphacts.org/units/Nanomolar,3886487,=,1,1,=,,IC50,nM,,4.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870107,[],CHEMBL5152893,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '23.02', 'le': '0.43', 'lle': '7.65', 'sei': '11.58'}",CHEMBL521686,OLAPARIB,CHEMBL521686,10.00,0,http://www.openphacts.org/units/Nanomolar,3886488,=,1,1,=,,IC50,nM,,0.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870136,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(OC(F)F)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '12.52', 'le': '0.24', 'lle': '2.40', 'sei': '6.99'}",CHEMBL5191912,,CHEMBL5191912,5.20,0,http://www.openphacts.org/units/Nanomolar,3886461,=,1,1,=,,IC50,nM,,6303.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6303.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870137,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(C)(C)O)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '11.91', 'le': '0.22', 'lle': '2.42', 'sei': '5.69'}",CHEMBL5180063,,CHEMBL5180063,4.85,0,http://www.openphacts.org/units/Nanomolar,3886462,=,1,1,=,,IC50,nM,,13990.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,13990.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870138,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(N)C(F)(F)F)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '11.04', 'le': '0.21', 'lle': '2.17', 'sei': '5.41'}",CHEMBL5208807,,CHEMBL5208807,4.93,0,http://www.openphacts.org/units/Nanomolar,3886463,=,1,1,=,,IC50,nM,,11790.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,11790.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870139,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4cnc5cn[nH]c5c4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.14', 'le': '0.31', 'lle': '4.60', 'sei': '7.12'}",CHEMBL5190645,,CHEMBL5190645,6.68,0,http://www.openphacts.org/units/Nanomolar,3886464,=,1,1,=,,IC50,nM,,210.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,210.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870140,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5[nH]ncc5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '15.23', 'le': '0.28', 'lle': '3.85', 'sei': '6.32'}",CHEMBL5185522,,CHEMBL5185522,5.93,0,http://www.openphacts.org/units/Nanomolar,3886465,=,1,1,=,,IC50,nM,,1174.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1174.0
,ND,24870141,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5cn[nH]c5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5176160,,CHEMBL5176160,,0,,3886466,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870142,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5cc[nH]c5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '17.87', 'le': '0.33', 'lle': '4.26', 'sei': '8.58'}",CHEMBL5205419,,CHEMBL5205419,6.94,0,http://www.openphacts.org/units/Nanomolar,3886467,=,1,1,=,,IC50,nM,,114.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,114.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870143,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5oc(=O)[nH]c5c4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '14.80', 'le': '0.27', 'lle': '3.76', 'sei': '6.11'}",CHEMBL5196723,,CHEMBL5196723,6.00,0,http://www.openphacts.org/units/Nanomolar,3886468,=,1,1,=,,IC50,nM,,993.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,993.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870144,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc5nc(C(F)(F)F)[nH]c5n4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '12.80', 'le': '0.24', 'lle': '2.75', 'sei': '6.24'}",CHEMBL5185548,,CHEMBL5185548,5.86,0,http://www.openphacts.org/units/Nanomolar,3886469,=,1,1,=,,IC50,nM,,1397.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1397.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870145,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4cc5c(cn4)NC(=O)CC5)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '16.19', 'le': '0.30', 'lle': '4.69', 'sei': '7.19'}",CHEMBL5201927,,CHEMBL5201927,6.78,0,http://www.openphacts.org/units/Nanomolar,3886470,=,1,1,=,,IC50,nM,,167.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,167.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870146,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4cc5cccc(C(=O)NC)c5cn4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '12.10', 'le': '0.22', 'lle': '2.81', 'sei': '5.87'}",CHEMBL5187899,,CHEMBL5187899,5.53,0,http://www.openphacts.org/units/Nanomolar,3886471,=,1,1,=,,IC50,nM,,2976.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2976.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870147,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)c5nccn45)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '13.03', 'le': '0.24', 'lle': '4.00', 'sei': '5.89'}",CHEMBL5179448,,CHEMBL5179448,5.81,0,http://www.openphacts.org/units/Nanomolar,3886472,=,1,1,=,,IC50,nM,,1558.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1558.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870148,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCn4c(cnc4C(=O)NC)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '15.53', 'le': '0.29', 'lle': '4.63', 'sei': '5.93'}",CHEMBL5198072,,CHEMBL5198072,5.69,0,http://www.openphacts.org/units/Nanomolar,3886473,=,1,1,=,,IC50,nM,,2036.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2036.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870149,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCc4nc(C(=O)NC)ccc4C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '14.29', 'le': '0.26', 'lle': '3.59', 'sei': '5.93'}",CHEMBL5176626,,CHEMBL5176626,5.39,0,http://www.openphacts.org/units/Nanomolar,3886474,=,1,1,=,,IC50,nM,,4039.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4039.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870150,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCc4cc(/C=C/C(=O)NC)ccc4C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '14.74', 'le': '0.27', 'lle': '3.13', 'sei': '7.60'}",CHEMBL5206717,,CHEMBL5206717,5.93,0,http://www.openphacts.org/units/Nanomolar,3886475,=,1,1,=,,IC50,nM,,1163.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1163.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870151,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4CN(c5ccc(C(=O)NC)nc5)CC4C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '14.26', 'le': '0.26', 'lle': '4.36', 'sei': '6.55'}",CHEMBL5180001,,CHEMBL5180001,6.17,0,http://www.openphacts.org/units/Nanomolar,3886476,=,1,1,=,,IC50,nM,,677.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,677.5
,ND,24870152,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4CCC(C3)N4c3ccc(C(=O)NC)nc3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5205409,,CHEMBL5205409,,0,,3886477,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
,ND,24870153,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4CC(C3)N4c3ccc(C(=O)NC)nc3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5191816,,CHEMBL5191816,,0,,3886478,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870154,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3C[C@@H]4C[C@H]3CN4c3ccc(C(=O)NC)nc3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '10.57', 'le': '0.19', 'lle': '2.72', 'sei': '4.70'}",CHEMBL5179279,,CHEMBL5179279,4.42,0,http://www.openphacts.org/units/Nanomolar,3886479,=,1,1,=,,IC50,nM,,37656.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,37656.0
,ND,24870155,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4(CCN(c5ccc(C(=O)NC)nc5)CC4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,,CHEMBL5185063,,CHEMBL5185063,,0,,3886480,,1,0,,,IC50,,,,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,,,,
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870156,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC4(C3)CN(c3ccc(C(=O)NC)nc3)C4)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '14.52', 'le': '0.27', 'lle': '4.52', 'sei': '6.45'}",CHEMBL5193674,,CHEMBL5193674,6.08,0,http://www.openphacts.org/units/Nanomolar,3886481,=,1,1,=,,IC50,nM,,839.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,839.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870157,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCC(Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '12.36', 'le': '0.23', 'lle': '3.10', 'sei': '4.88'}",CHEMBL5178741,,CHEMBL5178741,5.03,0,http://www.openphacts.org/units/Nanomolar,3886482,=,1,1,=,,IC50,nM,,9440.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9440.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870158,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC(Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '12.54', 'le': '0.23', 'lle': '3.38', 'sei': '4.78'}",CHEMBL5173989,,CHEMBL5173989,4.92,0,http://www.openphacts.org/units/Nanomolar,3886483,=,1,1,=,,IC50,nM,,12027.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,12027.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870159,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCC(Nc4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '13.12', 'le': '0.24', 'lle': '3.20', 'sei': '5.35'}",CHEMBL5202261,,CHEMBL5202261,5.51,0,http://www.openphacts.org/units/Nanomolar,3886484,=,1,1,=,,IC50,nM,,3054.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3054.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870160,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC[C@@H](Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '13.58', 'le': '0.25', 'lle': '3.59', 'sei': '5.36'}",CHEMBL5179882,,CHEMBL5179882,5.52,0,http://www.openphacts.org/units/Nanomolar,3886485,=,1,1,=,,IC50,nM,,3005.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3005.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870161,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CC[C@H](Nc4ccc(C(=O)NC)nc4)C3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '13.23', 'le': '0.24', 'lle': '3.45', 'sei': '5.22'}",CHEMBL5195834,,CHEMBL5195834,5.38,0,http://www.openphacts.org/units/Nanomolar,3886486,=,1,1,=,,IC50,nM,,4171.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4171.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870162,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '16.29', 'le': '0.30', 'lle': '5.06', 'sei': '7.03'}",CHEMBL5095220,SARUPARIB,CHEMBL5095220,6.62,0,http://www.openphacts.org/units/Nanomolar,3886487,=,1,1,=,,IC50,nM,,239.6,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,239.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24870163,[],CHEMBL5152895,Inhibition of PARP-2 (unknown origin) binding to DNA assessed as DNA trapping activity,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5150037,Bioorg Med Chem Lett,2022,"{'bei': '19.64', 'le': '0.36', 'lle': '6.18', 'sei': '9.88'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.53,0,http://www.openphacts.org/units/Nanomolar,3886488,=,1,1,=,,IC50,nM,,2.93,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.93
"{'action_type': 'DEGRADER', 'description': 'Binds to or antagonizes a receptor, leading to its degradation', 'parent_type': 'NEGATIVE MODULATOR'}",,24917561,[],CHEMBL5165113,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5154873,Eur J Med Chem,2022,"{'bei': '20.70', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,0,http://www.openphacts.org/units/Nanomolar,3894531,=,1,1,=,,IC50,nM,,1.01,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.01
"{'action_type': 'DEGRADER', 'description': 'Binds to or antagonizes a receptor, leading to its degradation', 'parent_type': 'NEGATIVE MODULATOR'}",,24917562,[],CHEMBL5165113,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(COc1ccc2c(c1)CCCN2C(=O)CCl)NCCCCCCCCCC(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,,,CHEMBL5154873,Eur J Med Chem,2022,"{'bei': '11.85', 'le': '0.23', 'lle': '3.72', 'sei': '6.55'}",CHEMBL5182405,,CHEMBL5182405,9.49,0,http://www.openphacts.org/units/Nanomolar,3894557,=,1,1,=,,IC50,nM,,0.32,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.32
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24919330,[],CHEMBL5165747,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5154882,J Med Chem,2022,"{'bei': '29.06', 'le': '0.53', 'lle': '6.42', 'sei': '16.51'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,9.40,0,http://www.openphacts.org/units/Nanomolar,3894890,=,1,1,=,,IC50,nM,,0.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24919332,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.01667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '1.0'}]",CHEMBL5165749,Inhibition of PARP2 (unknown origin) using NAD as substrate incubated for 1 min,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,,,CHEMBL5154882,J Med Chem,2022,"{'bei': '25.50', 'le': '0.47', 'lle': '7.07', 'sei': '10.96'}",CHEMBL3137320,TALAZOPARIB,CHEMBL3137320,9.70,0,http://www.openphacts.org/units/Nanomolar,3894891,=,1,1,=,,IC50,nM,,0.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24959176,[],CHEMBL5215262,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCN(CC2CC2)C1)c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F,,,CHEMBL5214889,Eur J Med Chem,2021,"{'bei': '16.42', 'le': '0.31', 'lle': '5.08', 'sei': '8.22'}",CHEMBL4533690,,CHEMBL4533690,7.17,1,http://www.openphacts.org/units/Nanomolar,3898810,=,1,1,=,,IC50,nM,,67.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,67.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24984335,[],CHEMBL5227213,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5226297,J Med Chem,2021,"{'bei': '20.71', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,1,http://www.openphacts.org/units/Nanomolar,3905856,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24984523,[],CHEMBL5227340,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nc(-c2ccc(C(F)(F)F)cc2)nc2c1CSCC2,,,CHEMBL5226302,J Med Chem,2021,"{'bei': '22.23', 'le': '0.45', 'lle': '3.28', 'sei': '15.09'}",CHEMBL1086580,,CHEMBL1086580,6.94,1,http://www.openphacts.org/units/Nanomolar,3905963,=,1,1,=,,IC50,nM,,114.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,114.0
,,24984524,[],CHEMBL5227340,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@@H]3[C@H](C2=O)[C@@H]2C=C[C@H]3C2)cc1,,,CHEMBL5226302,J Med Chem,2021,,CHEMBL562310,,CHEMBL562310,,0,http://www.openphacts.org/units/Nanomolar,3905962,>,1,1,>,,IC50,nM,,18750.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,18.75
,,24984544,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.01667', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '1.0'}]",CHEMBL5227345,Inhibition of PARP2 (unknown origin) using NAD as substrate incubated for 1 min,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c(=O)[nH]c(-c3ccc(C)cc3)cc12,,,CHEMBL5226302,J Med Chem,2021,,CHEMBL3763870,,CHEMBL3763870,,0,http://www.openphacts.org/units/Nanomolar,3905957,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
,,24984545,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.01667', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '1.0'}]",CHEMBL5227345,Inhibition of PARP2 (unknown origin) using NAD as substrate incubated for 1 min,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,,,CHEMBL5226302,J Med Chem,2021,,CHEMBL2419706,,CHEMBL2419706,,1,http://www.openphacts.org/units/Nanomolar,3905959,>,1,1,>,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24984885,[],CHEMBL5227485,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5226304,Eur J Med Chem,2021,"{'bei': '28.76', 'le': '0.53', 'lle': '6.32', 'sei': '16.34'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,9.30,1,http://www.openphacts.org/units/Nanomolar,3906040,=,1,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24986892,[],CHEMBL5228290,Inhibition of N-terminal GST-tagged human recombinant PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 insect cells by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2c(=O)[nH]c(-c3ccc(C(C)(C)O)cc3)cn12,,,CHEMBL5226325,J Med Chem,2021,"{'bei': '23.73', 'le': '0.44', 'lle': '3.87', 'sei': '11.65'}",CHEMBL5199558,,CHEMBL5199558,6.70,0,http://www.openphacts.org/units/Nanomolar,3906625,=,1,1,=,,IC50,nM,,200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24993455,[],CHEMBL5230811,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2cc3cc(F)cc(C(N)=O)c3o2)cc1.Cl,,,CHEMBL5230098,Eur J Med Chem,2020,"{'bei': '29.23', 'le': '0.54', 'lle': '5.66', 'sei': '12.78'}",CHEMBL5286956,,CHEMBL4584534,8.72,0,http://www.openphacts.org/units/Nanomolar,3908521,=,1,1,=,,IC50,nM,,1.9,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25023522,[],CHEMBL5240107,Inhibition of human recombinant PARP2 by ELISA method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCN(CC2CC2)C1)c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F,,,CHEMBL5236633,J Med Chem,2022,"{'bei': '16.42', 'le': '0.31', 'lle': '5.08', 'sei': '8.22'}",CHEMBL4533690,,CHEMBL4533690,7.17,1,http://www.openphacts.org/units/Nanomolar,3916913,=,1,1,=,,IC50,nM,,67.8,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,67.8
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25023540,[],CHEMBL5240115,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,,,CHEMBL5236633,J Med Chem,2022,"{'bei': '9.26', 'le': '0.17', 'lle': '-0.14', 'sei': '2.74'}",CHEMBL63354,AMENTOFLAVONE,CHEMBL63354,4.99,1,http://www.openphacts.org/units/Nanomolar,3916921,=,1,1,=,,IC50,nM,,10300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25073013,[],CHEMBL5253409,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34,,,CHEMBL5252527,J Med Chem,2016,"{'bei': '33.38', 'le': '0.62', 'lle': '7.88', 'sei': '16.46'}",CHEMBL4112930,PAMIPARIB,CHEMBL4112930,9.96,0,http://www.openphacts.org/units/Nanomolar,3930118,=,1,1,=,,IC50,nM,,0.11,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.11
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25073014,[],CHEMBL5253409,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2[nH]c3c4c(c5c(c3c12)C(=O)N(CN1CCN(C)CC1)C5=O)CCC4,,,CHEMBL5252527,J Med Chem,2016,"{'bei': '19.65', 'le': '0.36', 'lle': '5.60', 'sei': '11.94'}",CHEMBL4297461,CEP-9722,CHEMBL4297461,8.22,0,http://www.openphacts.org/units/Nanomolar,3930110,=,1,1,=,,IC50,nM,,6.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25073020,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5253415,Inhibition of human PARP-2 using histone as substrate incubated for 16 hrs by ELISA assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[Si](C)(C)OCCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5252527,J Med Chem,2016,"{'bei': '15.63', 'le': None, 'lle': None, 'sei': None}",CHEMBL4569417,,CHEMBL4569417,8.89,0,http://www.openphacts.org/units/Nanomolar,3930114,=,1,1,=,,IC50,nM,,1.29,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.29
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25073028,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5253422,Inhibition of human PARP-2 incubated for 18 to 20 hrs by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cccc1/C=C1\C(=O)NC(=O)c2ccccc21,,,CHEMBL5252527,J Med Chem,2016,"{'bei': '21.40', 'le': '0.39', 'lle': '3.56', 'sei': '10.56'}",CHEMBL4303397,,CHEMBL4303397,5.40,0,http://www.openphacts.org/units/Nanomolar,3930116,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4000.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25445667,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5317574,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells expression system incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](CN1CC(C(=O)N2CCN(c3ncc(C(F)(F)F)cn3)CC2)C1)Nc1cn[nH]c(=O)c1C(F)(F)F,,,CHEMBL5316291,J Med Chem,2023,"{'bei': '11.72', 'le': '0.23', 'lle': '4.58', 'sei': '5.68'}",CHEMBL5395820,,CHEMBL5395820,6.26,0,http://www.openphacts.org/units/Nanomolar,3957577,=,1,1,=,,IC50,nM,,546.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,546.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25445668,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5317574,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583 residues) expressed in baculovirus infected Sf9 cells expression system incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](COCCC(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1)Nc1cn[nH]c(=O)c1C(F)(F)F,,,CHEMBL5316291,J Med Chem,2023,"{'bei': '14.84', 'le': '0.29', 'lle': '5.62', 'sei': '6.68'}",CHEMBL5095043,ATAMPARIB,CHEMBL5095043,7.77,1,http://www.openphacts.org/units/Nanomolar,3957580,=,1,1,=,,IC50,nM,,17.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,17.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447865,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '28.52', 'le': '0.57', 'lle': '3.15', 'sei': '17.88'}",CHEMBL4296925,,CHEMBL4296925,5.40,0,http://www.openphacts.org/units/Nanomolar,3957919,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447866,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,c1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '30.11', 'le': '0.60', 'lle': '3.34', 'sei': '17.48'}",CHEMBL5396332,,CHEMBL5396332,5.28,0,http://www.openphacts.org/units/Nanomolar,3957920,=,1,1,=,,IC50,nM,,5300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,5.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447867,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2sc3nncn3c2c1,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '30.78', 'le': '0.61', 'lle': '3.57', 'sei': '19.29'}",CHEMBL5398835,,CHEMBL5398835,5.82,0,http://www.openphacts.org/units/Nanomolar,3957921,=,1,1,=,,IC50,nM,,1500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447868,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cccc2c1sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '26.85', 'le': '0.53', 'lle': '2.83', 'sei': '16.83'}",CHEMBL5427075,,CHEMBL5427075,5.08,0,http://www.openphacts.org/units/Nanomolar,3957922,=,1,1,=,,IC50,nM,,8300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,8.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447869,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '26.61', 'le': '0.53', 'lle': '2.90', 'sei': '17.92'}",CHEMBL5395131,,CHEMBL5395131,5.41,0,http://www.openphacts.org/units/Nanomolar,3957923,=,1,1,=,,IC50,nM,,3900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,3.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447870,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '24.61', 'le': '0.49', 'lle': '2.28', 'sei': '17.71'}",CHEMBL5439304,,CHEMBL5439304,5.35,0,http://www.openphacts.org/units/Nanomolar,3957924,=,1,1,=,,IC50,nM,,4500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447871,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Clc1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '26.80', 'le': '0.59', 'lle': '3.02', 'sei': '18.61'}",CHEMBL5395721,,CHEMBL5395721,5.62,0,http://www.openphacts.org/units/Nanomolar,3957925,=,1,1,=,,IC50,nM,,2400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447872,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(C)c2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '28.96', 'le': '0.57', 'lle': '3.33', 'sei': '19.50'}",CHEMBL5402584,,CHEMBL5402584,5.89,0,http://www.openphacts.org/units/Nanomolar,3957926,=,1,1,=,,IC50,nM,,1300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447873,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(F)c2c1sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '24.91', 'le': '0.50', 'lle': '2.77', 'sei': '17.10'}",CHEMBL5427721,,CHEMBL5427721,5.16,0,http://www.openphacts.org/units/Nanomolar,3957927,=,1,1,=,,IC50,nM,,6900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,6.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447874,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2sc3nncn3c2c1,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '25.96', 'le': '0.52', 'lle': '3.38', 'sei': '13.52'}",CHEMBL5402663,,CHEMBL5402663,5.33,0,http://www.openphacts.org/units/Nanomolar,3957928,=,1,1,=,,IC50,nM,,4700.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,4.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447875,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '24.63', 'le': '0.49', 'lle': '3.11', 'sei': '12.82'}",CHEMBL5398837,,CHEMBL5398837,5.06,0,http://www.openphacts.org/units/Nanomolar,3957929,=,1,1,=,,IC50,nM,,8800.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,8.8
,,25447876,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc2c1sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,,CHEMBL5434061,,CHEMBL5434061,,0,http://www.openphacts.org/units/Nanomolar,3957930,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447877,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc2sc3nncn3c12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '27.66', 'le': '0.55', 'lle': '3.73', 'sei': '14.40'}",CHEMBL5433172,,CHEMBL5433172,5.68,0,http://www.openphacts.org/units/Nanomolar,3957931,=,1,1,=,,IC50,nM,,2100.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447878,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '21.41', 'le': '0.43', 'lle': '3.08', 'sei': '10.35'}",CHEMBL5416085,,CHEMBL5416085,5.04,0,http://www.openphacts.org/units/Nanomolar,3957932,=,1,1,=,,IC50,nM,,9200.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,9.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447879,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1cc(OC)c2sc3nncn3c2c1,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '19.97', 'le': '0.40', 'lle': '2.74', 'sei': '9.66'}",CHEMBL5430541,,CHEMBL5430541,4.70,0,http://www.openphacts.org/units/Nanomolar,3957933,=,1,1,=,,IC50,nM,,20000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,20.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447880,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Oc1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '38.47', 'le': '0.77', 'lle': '5.71', 'sei': '14.59'}",CHEMBL5406267,,CHEMBL5406267,7.36,0,http://www.openphacts.org/units/Nanomolar,3957934,=,1,1,=,,IC50,nM,,44.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.044
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447881,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Oc1cccc2c1sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '23.73', 'le': '0.48', 'lle': '2.89', 'sei': '9.00'}",CHEMBL5400133,,CHEMBL5400133,4.54,0,http://www.openphacts.org/units/Nanomolar,3957935,=,1,1,=,,IC50,nM,,29000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,29.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447882,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Oc1ccc(O)c2c1sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '31.95', 'le': '0.65', 'lle': '5.26', 'sei': '9.37'}",CHEMBL5421878,,CHEMBL5421878,6.62,0,http://www.openphacts.org/units/Nanomolar,3957936,=,1,1,=,,IC50,nM,,240.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.24
,,25447883,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nnc(O)n12,,,CHEMBL5316303,J Med Chem,2023,,CHEMBL5403002,,CHEMBL5403002,,0,http://www.openphacts.org/units/Nanomolar,3957937,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
,,25447884,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nnc(S)n12,,,CHEMBL5316303,J Med Chem,2023,,CHEMBL5394776,,CHEMBL5394776,,0,http://www.openphacts.org/units/Nanomolar,3957938,>,1,1,>,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447885,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nnc(N)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '28.38', 'le': '0.57', 'lle': '3.97', 'sei': '10.31'}",CHEMBL5431108,,CHEMBL5431108,5.80,0,http://www.openphacts.org/units/Nanomolar,3957939,=,1,1,=,,IC50,nM,,1600.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,1.6
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447886,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,CSc1nnc2sc3cc(C)ccc3n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '20.91', 'le': '0.45', 'lle': '1.95', 'sei': '16.30'}",CHEMBL2136900,,CHEMBL2136900,4.92,0,http://www.openphacts.org/units/Nanomolar,3957940,=,1,1,=,,IC50,nM,,12000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,12.0
,,25447887,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nnc(SCc3ccc(Cl)cc3)n12,,,CHEMBL5316303,J Med Chem,2023,,CHEMBL5394260,,CHEMBL5394260,,0,http://www.openphacts.org/units/Nanomolar,3957941,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,100.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447888,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nnc(/N=C\c3ccc(Cl)cc3)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '16.94', 'le': '0.34', 'lle': '0.88', 'sei': '13.01'}",CHEMBL5412860,,CHEMBL5412860,5.54,0,http://www.openphacts.org/units/Nanomolar,3957942,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,2.9
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447889,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2c(c1)sc1nnc(NCc3ccc(Cl)cc3)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '12.64', 'le': '0.26', 'lle': '-0.37', 'sei': '9.84'}",CHEMBL5412151,,CHEMBL5412151,4.16,0,http://www.openphacts.org/units/Nanomolar,3957943,=,1,1,=,,IC50,nM,,70000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,70.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447890,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nnc(S)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '17.66', 'le': '0.38', 'lle': '2.47', 'sei': '9.70'}",CHEMBL5394162,,CHEMBL5394162,4.72,0,http://www.openphacts.org/units/Nanomolar,3957944,=,1,1,=,,IC50,nM,,19000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,19.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447891,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nnc(N)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '19.98', 'le': '0.40', 'lle': '3.46', 'sei': '6.70'}",CHEMBL5404785,,CHEMBL5404785,5.00,0,http://www.openphacts.org/units/Nanomolar,3957945,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,10.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447892,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nnc(SC)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '18.04', 'le': '0.39', 'lle': '2.40', 'sei': '10.43'}",CHEMBL5429120,,CHEMBL5429120,5.08,0,http://www.openphacts.org/units/Nanomolar,3957946,=,1,1,=,,IC50,nM,,8400.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,8.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447893,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nnc(NC(=O)c3ccc(Cl)cc3)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '11.20', 'le': '0.23', 'lle': '0.49', 'sei': '5.60'}",CHEMBL5399492,,CHEMBL5399492,4.36,0,http://www.openphacts.org/units/Nanomolar,3957947,=,1,1,=,,IC50,nM,,44000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,44.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447894,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nnc(NC(=O)C(C)(C)C)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '15.78', 'le': '0.31', 'lle': '2.33', 'sei': '6.79'}",CHEMBL5409536,,CHEMBL5409536,5.28,0,http://www.openphacts.org/units/Nanomolar,3957948,=,1,1,=,,IC50,nM,,5300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,5.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447895,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC)c2c1sc1nnc(NC(C)=O)n12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '13.73', 'le': '0.27', 'lle': '2.09', 'sei': '5.16'}",CHEMBL5416726,,CHEMBL5416726,4.01,0,http://www.openphacts.org/units/Nanomolar,3957949,=,1,1,=,,IC50,nM,,97000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,97.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25447896,[],CHEMBL5318187,Inhibition of N-terminal MBP tagged/C-terminal PARP2 (unknown origin) expressed in Escherichia coli in presence of NAD+,B,,,BAO_0000190,BAO_0000019,assay format,Oc1ccc2c(c1)sc1nncn12,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '38.91', 'le': '0.78', 'lle': '5.79', 'sei': '14.76'}",CHEMBL5406267,,CHEMBL5406267,7.44,0,http://www.openphacts.org/units/Nanomolar,3957934,=,1,1,=,,IC50,nM,,36.31,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,pIC50,,UO_0000065,,7.44
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25448100,[],CHEMBL5318221,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc2c3c(cccc13)N=C(CN1Cc3ccccc3C1)N2,,,CHEMBL5316303,J Med Chem,2023,"{'bei': '27.41', 'le': '0.50', 'lle': '6.31', 'sei': '11.85'}",CHEMBL3644587,2X-121,CHEMBL3644587,8.70,0,http://www.openphacts.org/units/Nanomolar,3957950,=,1,1,=,,IC50,nM,,2.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25470849,[],CHEMBL5324555,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1-c1nc2c(C(N)=O)cccc2[nH]1,,,CHEMBL5321287,J Med Chem,2023,"{'bei': '13.73', 'le': '0.25', 'lle': '1.98', 'sei': '5.44'}",CHEMBL5437375,,CHEMBL5437375,7.11,0,http://www.openphacts.org/units/Nanomolar,3961973,=,1,1,=,,IC50,nM,,78.4,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,78.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25500475,[],CHEMBL5331994,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5331057,Eur J Med Chem,2022,"{'bei': '20.71', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,1,http://www.openphacts.org/units/Nanomolar,3967645,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25563717,[],CHEMBL5349316,Inhibition of human PARP-2 by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccccc1OCc1cccc(NC(=O)c2ccc(Cl)cc2)c1,,,CHEMBL5346921,Eur J Med Chem,2023,"{'bei': '21.95', 'le': '0.42', 'lle': '4.09', 'sei': '10.27'}",CHEMBL5427365,,CHEMBL5427365,8.36,0,http://www.openphacts.org/units/Nanomolar,3979519,=,1,1,=,,IC50,nM,,4.36,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,4.36
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25563718,[],CHEMBL5349316,Inhibition of human PARP-2 by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccccc1OCc1cccc(NC(=O)c2ccc(Br)cc2)c1,,,CHEMBL5346921,Eur J Med Chem,2023,"{'bei': '20.29', 'le': '0.44', 'lle': '4.25', 'sei': '10.60'}",CHEMBL5416841,,CHEMBL5416841,8.63,0,http://www.openphacts.org/units/Nanomolar,3979522,=,1,1,=,,IC50,nM,,2.34,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.34
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25563719,[],CHEMBL5349316,Inhibition of human PARP-2 by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5346921,Eur J Med Chem,2023,"{'bei': '18.68', 'le': '0.35', 'lle': '5.77', 'sei': '9.40'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.12,0,http://www.openphacts.org/units/Nanomolar,3979529,=,1,1,=,,IC50,nM,,7.64,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,7.64
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25633941,[],CHEMBL5366428,Inhibition of PARP2 (unknown origin) using histone as substrate by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCn2c(nnc2-c2ccc(Br)o2)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5365431,J Med Chem,2023,,CHEMBL5402698,,CHEMBL5402698,,0,http://www.openphacts.org/units/Nanomolar,3993499,=,1,1,=,,IC50,nM,,0.001,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.001
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25633942,[],CHEMBL5366428,Inhibition of PARP2 (unknown origin) using histone as substrate by ELISA,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5365431,J Med Chem,2023,"{'bei': '20.20', 'le': '0.37', 'lle': '6.42', 'sei': '10.16'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.78,1,http://www.openphacts.org/units/Nanomolar,3993519,=,1,1,=,,IC50,nM,,1.68,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.68
,,25647314,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '60.0'}]",CHEMBL5369702,"Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus-infected Sf9 cells using histone as substrate incubated for 60 mins in presence of activated DNA, NAD+, NAD+-biotin by luminescence based analysis",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(CC2=NOB(O)c3ccccc32)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5365528,J Med Chem,2023,,CHEMBL5435592,,CHEMBL5435592,,0,http://www.openphacts.org/units/Nanomolar,3995659,>,1,1,>,,IC50,nM,,1000.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1000.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25647315,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '60.0'}]",CHEMBL5369702,"Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus-infected Sf9 cells using histone as substrate incubated for 60 mins in presence of activated DNA, NAD+, NAD+-biotin by luminescence based analysis",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(CC2=NNB(O)c3ccccc32)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5365528,J Med Chem,2023,"{'bei': '15.94', 'le': None, 'lle': None, 'sei': None}",CHEMBL5440473,,CHEMBL5440473,6.92,0,http://www.openphacts.org/units/Nanomolar,3995660,=,1,1,=,,IC50,nM,,120.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,uM,UO_0000065,,0.12
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25647316,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '60.0'}]",CHEMBL5369702,"Inhibition of N-terminal GST-tagged human PARP2 (2 to 583 residues) expressed in baculovirus-infected Sf9 cells using histone as substrate incubated for 60 mins in presence of activated DNA, NAD+, NAD+-biotin by luminescence based analysis",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5365528,J Med Chem,2023,"{'bei': '22.75', 'le': '0.42', 'lle': '7.54', 'sei': '11.45'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.89,0,http://www.openphacts.org/units/Nanomolar,3995661,=,1,1,=,,IC50,nM,,0.13,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.13
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662125,[],CHEMBL5373879,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.71', 'le': '0.38', 'lle': '6.65', 'sei': '10.42'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.00,1,http://www.openphacts.org/units/Nanomolar,3998522,=,1,1,=,,IC50,nM,,1.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662126,[],CHEMBL5373879,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '28.76', 'le': '0.53', 'lle': '6.32', 'sei': '16.34'}",CHEMBL1173055,RUCAPARIB,CHEMBL1173055,9.30,1,http://www.openphacts.org/units/Nanomolar,3998523,=,1,1,=,,IC50,nM,,0.5,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.5
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662127,[],CHEMBL5373879,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '27.08', 'le': '0.49', 'lle': '6.09', 'sei': '11.90'}",CHEMBL1094636,NIRAPARIB,CHEMBL1094636,8.68,1,http://www.openphacts.org/units/Nanomolar,3998524,=,1,1,=,,IC50,nM,,2.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662128,[],CHEMBL5373879,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '25.04', 'le': '0.46', 'lle': '6.89', 'sei': '10.76'}",CHEMBL3137320,TALAZOPARIB,CHEMBL3137320,9.52,0,http://www.openphacts.org/units/Nanomolar,3998525,=,1,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662129,[],CHEMBL5373879,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '31.92', 'le': '0.59', 'lle': '7.44', 'sei': '15.74'}",CHEMBL4112930,PAMIPARIB,CHEMBL4112930,9.52,0,http://www.openphacts.org/units/Nanomolar,3998526,=,1,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662130,[],CHEMBL5373879,Inhibition of PARP2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCn2c(nnc2-c2ccc(Br)o2)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5370623,J Med Chem,2023,,CHEMBL5402698,,CHEMBL5402698,,0,http://www.openphacts.org/units/Nanomolar,3998530,<,1,1,<,,IC50,nM,,0.001,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.001
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662135,[],CHEMBL5373882,Inhibition of PARP2 (unknown origin) by ELISA assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)Cc2nnc(-c3nccs3)n21,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.99', 'le': '0.36', 'lle': '5.93', 'sei': '8.68'}",CHEMBL5420649,,CHEMBL5420649,9.52,0,http://www.openphacts.org/units/Nanomolar,3998529,=,1,1,=,,IC50,nM,,0.3,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662172,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '22.01', 'le': '0.41', 'lle': '8.28', 'sei': '8.37'}",CHEMBL5428859,,CHEMBL5428859,8.73,0,http://www.openphacts.org/units/Nanomolar,3998487,=,1,1,=,,IC50,nM,,1.88,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.88
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662173,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.10', 'le': '0.38', 'lle': '7.46', 'sei': '8.64'}",CHEMBL5408420,,CHEMBL5408420,8.25,0,http://www.openphacts.org/units/Nanomolar,3998488,=,1,1,=,,IC50,nM,,5.62,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,5.62
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662174,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '21.00', 'le': '0.39', 'lle': '7.73', 'sei': '9.34'}",CHEMBL5413070,,CHEMBL5413070,8.91,0,http://www.openphacts.org/units/Nanomolar,3998489,=,1,1,=,,IC50,nM,,1.22,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.22
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662175,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC(F)(F)F,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.24', 'le': '0.35', 'lle': '7.01', 'sei': '9.14'}",CHEMBL5421933,,CHEMBL5421933,8.73,0,http://www.openphacts.org/units/Nanomolar,3998490,=,1,1,=,,IC50,nM,,1.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.87
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662176,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.29', 'le': '0.36', 'lle': '6.89', 'sei': '8.86'}",CHEMBL5427496,,CHEMBL5427496,8.46,0,http://www.openphacts.org/units/Nanomolar,3998491,=,1,1,=,,IC50,nM,,3.48,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.48
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662177,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.99', 'le': '0.37', 'lle': '7.19', 'sei': '9.18'}",CHEMBL5428217,,CHEMBL5428217,8.76,0,http://www.openphacts.org/units/Nanomolar,3998492,=,1,1,=,,IC50,nM,,1.72,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.72
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662178,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.57', 'le': '0.39', 'lle': '7.35', 'sei': '9.75'}",CHEMBL5394020,,CHEMBL5394020,9.31,0,http://www.openphacts.org/units/Nanomolar,3998493,=,1,1,=,,IC50,nM,,0.49,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.49
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662179,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.82', 'le': '0.39', 'lle': '7.60', 'sei': '9.87'}",CHEMBL5432851,,CHEMBL5432851,9.42,0,http://www.openphacts.org/units/Nanomolar,3998494,=,1,1,=,,IC50,nM,,0.38,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.38
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662180,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC(C)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.68', 'le': '0.39', 'lle': '7.40', 'sei': '9.80'}",CHEMBL5432860,,CHEMBL5432860,9.36,0,http://www.openphacts.org/units/Nanomolar,3998495,=,1,1,=,,IC50,nM,,0.44,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.44
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662181,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCCCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.35', 'le': '0.36', 'lle': '6.68', 'sei': '9.45'}",CHEMBL5437947,,CHEMBL5437947,9.03,0,http://www.openphacts.org/units/Nanomolar,3998496,=,1,1,=,,IC50,nM,,0.94,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.94
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662182,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.37', 'le': '0.36', 'lle': '6.83', 'sei': '9.46'}",CHEMBL5406001,,CHEMBL5406001,9.04,0,http://www.openphacts.org/units/Nanomolar,3998497,=,1,1,=,,IC50,nM,,0.92,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.92
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662183,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC(C)CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.03', 'le': '0.36', 'lle': '6.67', 'sei': '9.30'}",CHEMBL5404171,,CHEMBL5404171,8.88,0,http://www.openphacts.org/units/Nanomolar,3998498,=,1,1,=,,IC50,nM,,1.32,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.32
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662184,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC(CC)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.51', 'le': '0.37', 'lle': '6.75', 'sei': '9.53'}",CHEMBL5406119,,CHEMBL5406119,9.10,0,http://www.openphacts.org/units/Nanomolar,3998499,=,1,1,=,,IC50,nM,,0.79,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.79
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662185,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.32', 'le': '0.38', 'lle': '7.27', 'sei': '9.93'}",CHEMBL5419831,,CHEMBL5419831,9.48,0,http://www.openphacts.org/units/Nanomolar,3998500,=,1,1,=,,IC50,nM,,0.33,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.33
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662186,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)C(C)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.71', 'le': '0.35', 'lle': '6.52', 'sei': '9.14'}",CHEMBL5434732,,CHEMBL5434732,8.73,0,http://www.openphacts.org/units/Nanomolar,3998501,=,1,1,=,,IC50,nM,,1.86,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,1.86
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662187,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,C=CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.96', 'le': '0.39', 'lle': '7.80', 'sei': '9.58'}",CHEMBL5395127,,CHEMBL5395127,9.15,0,http://www.openphacts.org/units/Nanomolar,3998502,=,1,1,=,,IC50,nM,,0.71,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.71
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662188,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)=CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.58', 'le': '0.35', 'lle': '6.50', 'sei': '9.04'}",CHEMBL5400153,,CHEMBL5400153,8.63,0,http://www.openphacts.org/units/Nanomolar,3998503,=,1,1,=,,IC50,nM,,2.35,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.35
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662189,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,C#CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.65', 'le': '0.36', 'lle': '7.74', 'sei': '8.94'}",CHEMBL5399361,,CHEMBL5399361,8.54,0,http://www.openphacts.org/units/Nanomolar,3998504,=,1,1,=,,IC50,nM,,2.92,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.92
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662190,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)CCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '17.48', 'le': '0.33', 'lle': '7.45', 'sei': '8.28'}",CHEMBL5393999,,CHEMBL5393999,8.17,0,http://www.openphacts.org/units/Nanomolar,3998505,=,1,1,=,,IC50,nM,,6.75,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.75
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662191,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,COCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.98', 'le': '0.38', 'lle': '8.27', 'sei': '8.67'}",CHEMBL5419161,,CHEMBL5419161,9.08,0,http://www.openphacts.org/units/Nanomolar,3998506,=,1,1,=,,IC50,nM,,0.83,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.83
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662192,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)CN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.30', 'le': '0.34', 'lle': '8.24', 'sei': '7.04'}",CHEMBL5421189,,CHEMBL5421189,8.57,0,http://www.openphacts.org/units/Nanomolar,3998507,=,1,1,=,,IC50,nM,,2.67,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.67
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662193,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CCCO,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.04', 'le': '0.34', 'lle': '7.66', 'sei': '7.09'}",CHEMBL5414994,,CHEMBL5414994,8.20,0,http://www.openphacts.org/units/Nanomolar,3998508,=,1,1,=,,IC50,nM,,6.31,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,6.31
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662194,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.05', 'le': '0.36', 'lle': '7.01', 'sei': '8.99'}",CHEMBL5419639,,CHEMBL5419639,8.58,0,http://www.openphacts.org/units/Nanomolar,3998509,=,1,1,=,,IC50,nM,,2.63,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.63
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662195,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CCC1CC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.66', 'le': '0.35', 'lle': '6.71', 'sei': '9.08'}",CHEMBL5437813,,CHEMBL5437813,8.67,0,http://www.openphacts.org/units/Nanomolar,3998510,=,1,1,=,,IC50,nM,,2.15,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.15
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662196,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F)N1CCN(C2CCCC2)C(=O)C1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.53', 'le': '0.38', 'lle': '7.44', 'sei': '9.99'}",CHEMBL5439635,,CHEMBL5439635,9.54,0,http://www.openphacts.org/units/Nanomolar,3998511,=,1,1,=,,IC50,nM,,0.29,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.29
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662197,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CCCC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.90', 'le': '0.39', 'lle': '7.65', 'sei': '10.47'}",CHEMBL5397373,,CHEMBL5397373,10.00,0,http://www.openphacts.org/units/Nanomolar,3998512,=,1,1,=,,IC50,nM,,0.1,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.1
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662198,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C1CCCC1)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.61', 'le': '0.37', 'lle': '6.92', 'sei': '10.11'}",CHEMBL5423934,,CHEMBL5423934,9.66,0,http://www.openphacts.org/units/Nanomolar,3998513,=,1,1,=,,IC50,nM,,0.22,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.22
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662199,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F)N1CCN(C2CCCCC2)C(=O)C1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.81', 'le': '0.37', 'lle': '6.99', 'sei': '9.93'}",CHEMBL5416806,,CHEMBL5416806,9.48,0,http://www.openphacts.org/units/Nanomolar,3998514,=,1,1,=,,IC50,nM,,0.33,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.33
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662200,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1CC1CCCCC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.53', 'le': '0.36', 'lle': '6.88', 'sei': '10.08'}",CHEMBL5421335,,CHEMBL5421335,9.62,0,http://www.openphacts.org/units/Nanomolar,3998515,=,1,1,=,,IC50,nM,,0.24,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.24
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662201,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C1CCCCC1)N1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.92', 'le': '0.35', 'lle': '6.46', 'sei': '10.04'}",CHEMBL5423161,,CHEMBL5423161,9.59,0,http://www.openphacts.org/units/Nanomolar,3998516,=,1,1,=,,IC50,nM,,0.26,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.26
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662202,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C1CN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CCN1Cc1ccccc1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.73', 'le': '0.35', 'lle': '6.75', 'sei': '9.54'}",CHEMBL5418896,,CHEMBL5418896,9.11,0,http://www.openphacts.org/units/Nanomolar,3998517,=,1,1,=,,IC50,nM,,0.77,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.77
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662203,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F)N1CCN(c2ccccc2)C(=O)C1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.49', 'le': '0.36', 'lle': '6.84', 'sei': '9.64'}",CHEMBL5423072,,CHEMBL5423072,9.21,0,http://www.openphacts.org/units/Nanomolar,3998518,=,1,1,=,,IC50,nM,,0.62,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.62
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662204,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F)N1CC(=O)N2CCCC2C1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.41', 'le': '0.34', 'lle': '6.72', 'sei': '8.42'}",CHEMBL5434897,,CHEMBL5434897,8.04,0,http://www.openphacts.org/units/Nanomolar,3998519,=,1,1,=,,IC50,nM,,9.2,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,9.2
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662205,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cn2c(=O)[nH]c(=O)c3ccccc32)ccc1F)N1CC(=O)N2CCCCC2C1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '18.80', 'le': '0.35', 'lle': '6.76', 'sei': '8.87'}",CHEMBL5414478,,CHEMBL5414478,8.47,0,http://www.openphacts.org/units/Nanomolar,3998520,=,1,1,=,,IC50,nM,,3.41,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,3.41
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662206,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,CCC(CC)N1CCN(C(=O)c2cc(Cn3c(=O)[n-]c(=O)c4ccccc43)ccc2F)CC1=O.[Na+],,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.42', 'le': '0.36', 'lle': '6.71', 'sei': '9.49'}",CHEMBL5403305,,CHEMBL5406119,9.06,0,http://www.openphacts.org/units/Nanomolar,3998521,=,1,1,=,,IC50,nM,,0.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.87
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662207,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5373884,Inhibition of human recombinant PARP2 expressed in Escherichia coli BL21(DE3) incubated for 1 hr by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.00', 'le': '0.37', 'lle': '6.34', 'sei': '10.06'}",CHEMBL521686,OLAPARIB,CHEMBL521686,8.69,0,http://www.openphacts.org/units/Nanomolar,3998522,=,1,1,=,,IC50,nM,,2.05,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,2.05
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662291,[],CHEMBL5373890,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583(end) residues) expressed in Sf9 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCC(CC)N1CCN(C(=O)c2cc(Cn3c(=O)[n-]c(=O)c4ccccc43)ccc2F)CC1=O.[Na+],,,CHEMBL5370623,J Med Chem,2023,"{'bei': '19.42', 'le': '0.36', 'lle': '6.71', 'sei': '9.49'}",CHEMBL5403305,,CHEMBL5406119,9.06,0,http://www.openphacts.org/units/Nanomolar,3998521,=,1,1,=,,IC50,nM,,0.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.87
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25662292,[],CHEMBL5373890,Inhibition of human recombinant N-terminal GST-tagged PARP2 (2 to 583(end) residues) expressed in Sf9 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,,,CHEMBL5370623,J Med Chem,2023,"{'bei': '20.85', 'le': '0.39', 'lle': '6.71', 'sei': '10.49'}",CHEMBL521686,OLAPARIB,CHEMBL521686,9.06,0,http://www.openphacts.org/units/Nanomolar,3998522,=,1,1,=,,IC50,nM,,0.87,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,0.87
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679119,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(CCCN2CCC(c3ccccc3)CC2)nc2cccc(Cl)c12,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '16.24', 'le': '0.31', 'lle': '1.81', 'sei': '12.66'}",CHEMBL5427976,,CHEMBL5427976,6.20,0,http://www.openphacts.org/units/Nanomolar,4002087,=,1,1,=,,IC50,nM,,630.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,630.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679120,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(=O)[nH]c(CCCN3CCC(c4ccc(F)cc4)CC3)nc12,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '17.86', 'le': '0.33', 'lle': '2.60', 'sei': '13.83'}",CHEMBL5401937,,CHEMBL5401937,6.78,0,http://www.openphacts.org/units/Nanomolar,4002086,=,1,1,=,,IC50,nM,,167.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,167.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679121,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(CCCN2CCC(c3ccc(F)cc3)CC2)nc2c(Cl)cccc12,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '15.76', 'le': '0.31', 'lle': '1.77', 'sei': '12.86'}",CHEMBL250490,,CHEMBL250490,6.30,0,http://www.openphacts.org/units/Nanomolar,4002085,=,1,1,=,,IC50,nM,,500.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,500.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679122,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(C2CCN(CCCc3nc4c(Cl)cccc4c(=O)[nH]3)CC2)cc1,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '17.35', 'le': '0.33', 'lle': '2.80', 'sei': '9.70'}",CHEMBL5398361,,CHEMBL5398361,7.06,0,http://www.openphacts.org/units/Nanomolar,4002084,=,1,1,=,,IC50,nM,,87.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,87.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679123,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(CCCN2CCC(c3ccccc3)CC2)nc2c(Cl)cccc12,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '16.27', 'le': '0.31', 'lle': '1.82', 'sei': '12.69'}",CHEMBL250489,,CHEMBL250489,6.21,0,http://www.openphacts.org/units/Nanomolar,4002083,=,1,1,=,,IC50,nM,,610.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,610.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679124,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(CCCN2CCC(c3ccccc3)CC2)nc2ccccc12,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '17.89', 'le': '0.33', 'lle': '2.48', 'sei': '12.69'}",CHEMBL249813,,CHEMBL249813,6.22,0,http://www.openphacts.org/units/Nanomolar,4002082,=,1,1,=,,IC50,nM,,608.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,608.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25679125,[],CHEMBL5379294,Inhibition of PARP-2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c(CCCN2CCN(c3ccccc3)CC2)nc2cccc(Cl)c12,,,CHEMBL5375994,J Med Chem,2023,"{'bei': '17.04', 'le': '0.33', 'lle': '3.19', 'sei': '12.49'}",CHEMBL5432033,,CHEMBL5432033,6.52,0,http://www.openphacts.org/units/Nanomolar,4002081,=,1,1,=,,IC50,nM,,300.0,CHEMBL5366,Homo sapiens,Poly [ADP-ribose] polymerase 2,9606,,,IC50,nM,UO_0000065,,300.0
